captopril has been researched along with enalapril in 785 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 339 (43.18) | 18.7374 |
| 1990's | 317 (40.38) | 18.2507 |
| 2000's | 88 (11.21) | 29.6817 |
| 2010's | 39 (4.97) | 24.3611 |
| 2020's | 2 (0.25) | 2.80 |
| Authors | Studies |
|---|---|
| Barton, J; Bruno, JG; Calvo, RR; Kornberg, BE; Menard, PR; Mencel, JJ; Neiss, ES; Regan, JR; Schwab, A; Suh, JT | 1 |
| Barton, JN; Desai, R; Goetzen, T; Golec, FS; Menard, PR; Piwinski, JJ; Regan, JR; Reilly, LW; Skiles, JW; Ueng, SN | 1 |
| Baum, T; Gold, EH; McNamara, P; Neustadt, BR; Smith, EM; Swiss, GF; Sybertz, EJ | 1 |
| Cushman, DW; DeForrest, JM; Duggan, M; Karanewsky, DS; Krapcho, J; Powell, JR; Rovnyak, G; Schwartz, J; Spitzmiller, ER; Turk, C | 1 |
| Jones, H; Khandwala, A; Loev, B; Mann, WS; Neiss, ES; Schwab, A; Skiles, JW; Suh, JT; Williams, BE; Youssefyeh, RD | 1 |
| Cohen, D; Essenburg, AD; Kaplan, HR; Roark, WH; Tinney, FJ | 1 |
| Babiarz, JE; Desai, MN; Finn, BM; Stanton, JL; Tomaselli, HC; Watthey, JW | 1 |
| Barton, JN; Jones, H; Loev, B; Mann, WS; Menard, PR; Neiss, ES; Schwab, A; Skiles, JW; Suh, JT; Williams, BE | 1 |
| Blankley, CJ; Cohen, DM; Essenburg, AD; Fleming, RW; Hinkley, JM; Hoefle, ML; Holmes, A; Klutchko, S; Nordin, I; Werner, AE | 1 |
| Bennett, LR; Blankley, CJ; Bobowski, G; DeJohn, DE; Hoefle, ML; Johnson, DR; Kaltenbronn, JS; Krolls, U; Pearlman, WM; Werner, A | 1 |
| Badia, MC; Cushman, DW; DeForrest, JM; Dejneka, T; Karanewsky, DS; Loots, MJ; Perri, MG; Petrillo, EW; Powell, JR | 1 |
| Boyd, CA; Temple, CS | 1 |
| Graves, P; Kuze, K; Leahy, A; Stuhlmann, H; Wilson, P; You, G | 1 |
| Abbenante, G; Fairlie, DP; Leung, D | 1 |
| Funakoshi, J; Kakumoto, M; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Armoush, N; Becker, DP; Gillner, D; Holz, RC | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ishida, R; Kobayashi, K; Kubo, M | 1 |
| McElligott, S; Perlroth, M; Raish, L | 1 |
| Elliott, HL; Hughes, DM; Meredith, PA; Wade, JR | 1 |
| Diehl, KL; Wernze, H | 1 |
| Leite, R; Salgado, MC | 1 |
| Alhenc-Gelas, F; Clauser, E; Corvol, P; Wei, L | 1 |
| Mookherjee, S; Smulyan, H; Vardan, S | 1 |
| Manso, C; Mira, ML; Queirós, MJ; Silva, MM | 1 |
| Dzau, VJ; Hirsch, AT; Ingelfinger, JR; Schunkert, H; Smith, AD; Talsness, CE | 1 |
| Bloch, G; Grousset, C; Menasché, P; Mouas, C; Peynet, J; Piwnica, A | 1 |
| Boissel, JP; Chifflet, R; Girard, P; Leizorovicz, A; Lievre, M; Nony, P | 1 |
| Dietz, R; Harder, K; Kübler, W; Osterziel, KJ | 1 |
| Opie, LH | 1 |
| Hayakawa, M | 1 |
| de Angelis, E; Grassi, M; Lombardi, ML; Ruocco, V | 1 |
| Bakhshaliev, AB; Gadzhiev, RF; Khalilova, KD; Vekilova, NF | 1 |
| Hartter, E; Kargl, R; Zirm, A; Zirm, B | 1 |
| Reisin, L; Schneeweiss, A | 2 |
| Abe, I; Fujishima, M; Kobayashi, K; Tsuchihashi, T; Tsukashima, A; Ueno, M | 1 |
| Dahlöf, C; Dimenäs, E | 1 |
| Bailey, RR; Lewis-Barned, NJ; Livesey, J; Pratt, MC; Shand, BI; Walker, RJ | 1 |
| Fujishima, M; Ito, Y; Iwase, M; Kobayashi, K; Takata, Y; Tsukashima, A; Ueno, M; Yoshizumi, T | 1 |
| Dobroschke, R; Georgi, R; Krier, C | 1 |
| Cohn, JN | 1 |
| Brooks, DP; Edwards, RM; Gellai, M; Jugus, J; Ohlstein, EH; Ruffolo, RR; Sulpizio, A; Vickery, L; Weinstock, J | 1 |
| Kato, M; Nagano, M; Takeda, N; Yang, J | 1 |
| Haynie, R; Vertes, V | 1 |
| Andrén, L; Hedner, T; Lindholm, L; Lunde, H; Samuelsson, O; Wiholm, BE | 1 |
| Baz, M; Berland, Y; Brunet, P; Jaber, K | 1 |
| Bianchetti, MG; Caflisch, M; Oetliker, OH | 1 |
| Benak, RL; Hagley, MT; Hulisz, DT | 1 |
| De Mey, JG; Schiffers, PM; Struyker-Boudier, HA | 1 |
| Whelton, A | 1 |
| Becker, BF; Gerlach, E; Leipert, B; Raschke, P; Reinholz, N | 1 |
| Brozovich, FV; Gottlieb, NB; Gottlieb, RS; Morganroth, J | 1 |
| Lees, KR; MacFadyen, RJ; Reid, JL | 2 |
| Aber, GM; Harding, P; Stonier, C | 2 |
| Filatova, MP; Gracheva, IN; Krit, NA; Maksimova, EM; Reĭssmann, Z; Uskova, NN | 1 |
| Barnes, NM; Costall, B; Egli, P; Horovitz, ZP; Ironside, JW; Naylor, RJ; Williams, TJ | 1 |
| Rappelli, A | 1 |
| Graham, RD | 1 |
| Dietz, R; Nagel, F; Osterziel, KJ | 2 |
| Oakley, C; Pouleur, H; Rousseau, MF; Rydén, L | 1 |
| Brown, MJ; Dickerson, JE | 1 |
| Bennett, T; Gardiner, SM; Tomlinson, KC | 1 |
| Goldstein, RJ | 1 |
| Frank, GJ; Knapp, LE; McLain, R; Posvar, E; Rieger, MM; Singer, R | 1 |
| Giles, T | 1 |
| Bönner, G; Kaufmann, W; Preis, S; Schunk, U; Toussaint, C | 1 |
| Danilov, S; Fanburg, BL; Lanzillo, JJ; Stevens, J | 1 |
| Lantz, I; Nyberg, F; Terenius, L | 1 |
| Katsumata, U; Sasaki, H; Sekizawa, K; Takishima, T; Ujiie, Y | 1 |
| Mendelsohn, FA; Sun, Y | 1 |
| Rambausek, MH; Ritz, E | 1 |
| Guerrera, V; Ruocco, V; Satriano, RA | 1 |
| Kato, M; Nagai, M; Nagano, M; Yang, J | 1 |
| Bennett, T; Gardiner, SM; Kemp, PA; Phillips, K | 1 |
| Bain, SC; Barnett, AH; Le Guen, CA; Lunec, J | 1 |
| Beleslin, BD; Japundzić, N; Jovanović-Mićić, D; Prostran, M; Samardzić, R; Todorović, Z | 1 |
| de Graeff, PA; de Langen, CD; Pinto, YM; van Gilst, WH; van Wijngaarden, J; Wesseling, H | 1 |
| Roberts, JR; Wuerz, RC | 1 |
| Dietz, R; Lemmer, B; Osterziel, KJ | 1 |
| Franco-Saenz, R; Lotshaw, DP; Mulrow, PJ; Oda, H | 1 |
| Giles, TD | 3 |
| Braun, U; Brilla, GG; Heitkamp, HC; Klärner, HG; Krämer, BK; Müller-Schauenburg, W; Risler, T; Seipel, L | 1 |
| Amadi, AA; Davies, JR; Keywood, C; Patterson, DL; Stevenson, RN | 1 |
| Rey, AM | 1 |
| Beutler, JJ; Boer, P; Dorhout Mees, EJ; Koomans, HA; Rabelink, AJ; Vos, PF | 1 |
| Bräunlich, H; Fleck, C; Sprott, H | 1 |
| Harada, N; Inoue, G; Kaku, T; Tsujino, M; Yamasaki, H | 1 |
| Buff, L; Katz, RJ; Levy, WS; Wasserman, AG | 1 |
| Inukai, T; Katsumura, H; Nakao, K; Ogawa, N; Ohara, N; Ono, H; Shukunobe, K; Tanaka, M; Yamamoto, S | 1 |
| Chander, P; Gutstein, WH; Itskovitz, HD; Levine, S; Stier, CT | 1 |
| Fujimi, S; Fujishima, M; Makita, Y; Onoyama, K; Washio, M | 1 |
| Chen, L; Mondal, D; Prakash, O; Re, RN | 1 |
| Katahira, K; Mikami, H; Ogihara, T; Otsuka, A | 1 |
| Higashimori, K; Inagami, T; Mikami, H; Nagano, M; Nakamaru, M; Ogihara, T; Tabuchi, Y | 1 |
| Avila, P; Capellà, D; Laporte, JR; Moreno, V; Torres, F | 1 |
| Dietz, R; Osterziel, KJ | 1 |
| Posvar, EL; Sedman, AJ | 1 |
| Höfling, B; Lorenz, HM; von Pölnitz, A | 1 |
| Frewin, DB; Rennie, GC; Ryan, GJ | 1 |
| Fischer, A; Kummer, W | 1 |
| Pitt, B | 1 |
| Abe, K; Hiwatari, M; Kanazawa, M; Kohzuki, M; Kudo, K; Sato, T; Takeuchi, K; Tsunoda, K; Yasujima, M; Yoshida, K | 1 |
| Carson, P; Odum, J; Russell, G | 1 |
| Ajayi, AA; Ajayi, AT | 1 |
| Anderson, G; DeDio, RM; DiNardo, LJ; Hendrix, RA | 1 |
| Iijima, M; Kajiwara, Y; Kitabatake, K; Shirota, M; Ushijima, T | 1 |
| Herlitz, H | 1 |
| Bigorgne, JC; Corvol, P; Denolle, T; Galland, F; Guyene, TT; Rohmer, V; Saint-Adnré, JP; Schambelan, M | 1 |
| Lewandowski, CA; Potesta, E; Sarpa, JR; Schweitzer, VG; Seidman, MD | 1 |
| Arauz-Pacheco, C; Ramirez, LC; Raskin, P; Rios, JM | 1 |
| Etienne, P; Mondadori, C | 1 |
| Inagami, T; Mikami, H; Nakamaru, M; Ogihara, T; Rakugi, H; Saito, H | 1 |
| Ikram, H; White, HD | 1 |
| Franchi, F; Puddu, GM | 1 |
| Bönner, G; Düsing, R; Göbel, BO; Hoffmann, G; Pietsch, R; Vetter, H; Weisser, B | 1 |
| Ambrosioni, E; Malini, PL; Strocchi, E; Valtancoli, G | 1 |
| Iijima, M; Kajiwara, Y; Kitabatake, K; Matsui, S; Saito, S; Shirota, M; Waga, T; Watanabe, M | 1 |
| Ganten, D; Hellmann, T; Keuneke, C; Metzger, R; Peters, J; Yacullo, R | 1 |
| Beevers, DG; Bulpitt, CJ; Butler, A; Coles, EC; Conway, J; Fletcher, AE; Ledingham, JG; Nicholls, A; O'Riordan, PW; Palmer, AJ | 1 |
| Hiwada, K; Inoue, Y; Kokubu, T | 1 |
| Iijima, M; Kajiwara, Y; Kitabatake, K; Shirota, M | 1 |
| Bennett, T; Compton, AM; Gardiner, SM; Muller, AF | 1 |
| Amodeo, C | 1 |
| Lambert, M; Luccioni, R | 1 |
| Dunne, B; Hait, HI; Miller, WE; Tresznewsky, ON; Whelton, A | 1 |
| Kurkus, J; Thysell, H | 1 |
| Coll, J; Miralles, R; Pedro-Botet, J; Rubiés-Pŕat, J | 1 |
| Bernardin, AS; Sebastian, CS | 1 |
| Braso, MA; Gubert, S; Ortiz, JA; Sacristán, A | 1 |
| Haugen, O | 1 |
| Mulcahy, WS; Price, BA; Rodel, PV; Smith, RD | 1 |
| Antonini, P; Damiani, S; Germanò, G; Germanò, U; Pecchioli, V; Pica, B | 1 |
| Frishman, WH | 1 |
| Saito, I; Saruta, T | 1 |
| Maier, H; Tasman, A; Zech, J | 1 |
| Friedhoff, AJ; Santo, JP; Steiner, SS; Wecker, JR; Wilson, BL | 1 |
| Averbukh, Z; Cohen, N; Dolev, E; Golik, A; Modai, D; Shaked, U; Shamis, A; Sheffy, M | 1 |
| Ishizaki, T; Murakami, S; Ohnishi, A; Tanaka, T | 1 |
| Greminger, P; Hess, OM; Jenni, R; Krayenbuehl, HP; Maire, R; Tjon-A-Meeuw, L | 1 |
| Berg, M; Boosalis, P; Cohn, JN; Francis, GS; Johnson, TH; Ziesche, S | 1 |
| Brenner, S; Tamir, A; Wolf, R | 1 |
| Wang, X | 1 |
| Chan, MK; Cheng, IK; Ma, JT; Yeh, GR | 1 |
| Galvao, M | 1 |
| Hirabayashi, T; Kawakami, Y; Kobayashi, S | 1 |
| Lucas Guillén, E; Molina Boix, M; Ortega González, G; Pérez Gracia, A | 1 |
| Eby, TL; Gannon, TH | 1 |
| Dietz, R; Kübler, W; Manthey, J; Mikulaschek, K; Osterziel, KJ; Schmid, W | 1 |
| Leadbetter, RA; Vieweg, WV | 1 |
| Abushi, A; Dietz, R; Kübler, W; Osterziel, KJ | 1 |
| Anthony, BL; Catravas, JD; Chung, AY; Quinn, NE; Ryan, JW | 1 |
| Carlsten, H; Herlitz, H; Tarkowski, A; Westberg, G | 1 |
| Bhounsule, SA; D'Souza, RS; Dhume, VG | 1 |
| Drummer, OH; Johnson, H; Kourtis, S | 1 |
| Hitzenberger, G | 1 |
| Kleber, FX | 1 |
| Fouad, FM; Tarazi, RC | 1 |
| Bunnett, NW; Orloff, MS; Turner, AJ | 1 |
| Belz, GG; Essig, J; Wellstein, A | 3 |
| Chiaramida, A; DeMaria, AN; Giles, TD; Hackshaw, B; Hart, W; Haugland, M; Johnston, R; Katz, R; Kirlin, P; Powers, ER | 1 |
| Fujishima, M; Motomura, K; Onoyama, K; Sanai, T | 1 |
| Firth, NA; Reade, PC | 1 |
| Cohen, KR | 1 |
| Galvanek, EG; Stoff, JS; Strongwater, SL | 1 |
| Boland, MJ; Cinquegrani, MP; Insel, J; Mirvis, DM; Rubin, SA; Shanes, J; Whalen, JJ | 1 |
| Casanova, JE; Kaufman, J; Riendl, P; Schlueter, DP | 1 |
| Beneton, C; Grosbois, B; Jacomy, D; Milton, D | 1 |
| Straughan, JL; Talmud, J | 1 |
| Dabbeni-Sala, F; Finotti, P; Palatini, P | 1 |
| Chiaramida, A; Giles, TD; Hackshaw, B; Haugland, M; Katz, R; Kirlin, P; Powers, E; Rich, S; Sullivan, JM; Wolfson, P | 1 |
| Jessup, M | 1 |
| Dworkin, LD; Feiner, HD; Grosser, M; Parker, M; Ullian, M | 1 |
| Katsumata, H; Nakamoto, H; Ohishi, A; Sakaguchi, H; Saruta, T; Suzuki, H | 1 |
| Ferguson, RK; Marshall, MK; Pixley, JS; Stanley, H; Starich, GH | 1 |
| Ferner, RE; Paterson, JR; Rawlins, MD; Wilkinson, R; Wilson, D | 1 |
| Ackroyd, JF | 1 |
| Aggio, S; Ansani, L; Baracca, E; Fraccaroli, GP; Longhini, C; Mele, D; Musacci, GF; Vaccari, M | 2 |
| Abedi, E; Barna, JS; Frable, MA | 1 |
| Lahdensuo, A; Moilanen, E; Nieminen, M; Puolijoki, H; Reinikainen, P; Siitonen, L; Vapaatalo, H | 1 |
| Beierwaltes, WH; Carretero, OA | 1 |
| Coulter, DM; Edwards, IR | 2 |
| Beaufils, M; Liote, H; Petroff, C; Witchitz, S | 1 |
| Feinstein, AR; Fisher, MB; Pigeon, JG | 1 |
| Ino, Y; Iwaki, M; Iwamoto, S; Oda, M; Sato, T; Suzuki, K | 1 |
| Pincus, RL; Werber, JL | 1 |
| Hashimoto, M; Hayashi, K; Hosoki, K; Kadokawa, T; Minato, H; Sawayama, T | 1 |
| Dallocchio, M; Gosse, P; Gourgon, R | 1 |
| Canini, F; Gambini, G; Marinelli, M; Pinchi, G; Rossi, S; Valori, C | 1 |
| Gueron, M; Katz, A; Krauss, A; Krauss, S; Ovsyscher, I | 1 |
| Gribnau, FW; Koopmans, PP; Thien, T; van Megen, T | 1 |
| Sinzinger, H; Stetina, Z; Weiss, K | 1 |
| Brime, JI; Costales, M; Diaz, F; Lopez-Sela, P; Marin, B; Vijande, M | 1 |
| Allain, P; Granry, JC; Leblondel, G | 1 |
| Frank, GJ | 1 |
| Inaba, M; Ishii, J; Itabashi, A; Katayama, S; Kawazu, S; Maruno, Y; Omoto, A | 1 |
| Fettman, MJ; Hamar, DW; Mikita, DJ; VanHouten, DS; Wilke, WL | 1 |
| Lieberman, J; Zakria, F | 1 |
| Saruta, T | 1 |
| Cushman, DW; DeForrest, JM; Fung, WC; Grover, GJ; Harvey, CM; Mitch, SL; Scalese, RJ; Wang, FL | 1 |
| Raij, L; Shultz, PJ | 1 |
| Aber, GM; Harding, P; Messenger, A; Stonier, C | 1 |
| Ferguson, RK; Ujhelyi, MR; Vlasses, PH | 1 |
| Ambrosioni, E; Strocchi, E; Valtancoli, G | 1 |
| Muir, S; Spiller, HA; Udicious, TM | 1 |
| Ayers, CR; Baker, KM; Lehman, MR; Lewis, RA; Weaver, BA | 1 |
| Brunner, HR; Nussberger, J; Waeber, B | 1 |
| Bouthier, J; Levenson, JA; Maarek, B; Safar, ME; Simon, AC | 1 |
| Mimran, A; Ribstein, J | 2 |
| Burresi, A; Di Perri, T; Franchi, M; Landini, F; Puccetti, F | 1 |
| Guz, A; Hamilton, RD; Winning, AJ | 1 |
| Benjamin, N; Collier, JG; Robinson, BF; Webb, DJ | 1 |
| Gottlieb, SS; Kessler, PD; Lee, WH; Medina, N; Packer, M; Yushak, M | 2 |
| Kubo, T; Misu, Y; Shionoiri, H; Yasuda, G | 1 |
| Bendhack, LM; Lindsey, CJ; Paiva, AC | 1 |
| Gever, LN | 1 |
| Aouizerate, E; Benchimol, H; Bodkier, M; Courty, G; Dallocchio, M; Gosse, P; Granger Veyron, B; Granger, J; Vergeret, J | 1 |
| Bahner, U; Geiger, H; Heidland, A; Palkovits, M | 1 |
| Case, DB | 1 |
| Stokes, GS; Tugwell, S | 1 |
| Matthews, DM; McMurray, J | 1 |
| Dolva, LO; Gullestad, L; Kjekshus, J; Søyland, E | 1 |
| Miñano, FJ; Sancibrián, M; Serrano, JS; Serrano, MI | 1 |
| Milnes, JP; Shaw, AJ | 1 |
| Gonzalez, DG; Ram, CV | 1 |
| Cimino, R; Insinna, F; Zarcone, P | 1 |
| Andrejak, M; Andrejak, MT; Osterman, G | 1 |
| Bicknell, R; Holmquist, B; Lee, FS; Martin, MT; Riordan, JF | 1 |
| Bucknall, CE; Carter, R; Neilly, JB; Semple, PF; Stevenson, RD | 1 |
| Gauthier, B; Trachtman, H | 1 |
| Chen, X; Li, K | 1 |
| Francis, GS | 1 |
| Ikeda, Y; Kaneko, Y; Kimura, K; Minamisawa, K; Nomura, S; Oda, H; Onishi, T; Shionoiri, H; Takagi, N; Yoshimura, H | 1 |
| Grupp, LA; Leenen, FH; Perlanski, E; Spinosa, G; Stewart, RB | 1 |
| Breckenridge, A | 1 |
| Carapelle, E; Carone, MB; Cerasola, G; Contorno, A; Cottone, S; D'Ignoto, G; Fulantelli, MA; Grasso, L; Ziletti, T | 1 |
| Alicandri, C; Muiesan, G | 1 |
| Cherchi, A; Lai, C; Onnis, E; Orani, E; Pirisi, R; Soro, A | 1 |
| Hunyor, SN; O'Neill, ME; Pigott, P; Stokes, GS; Tugwell, S | 1 |
| O'Donnell, D | 1 |
| Ondetti, MA | 1 |
| Herlitz, H; Svalander, C; Tarkowski, A; Westberg, G | 2 |
| Berthoux, FC; Berthoux, P; Guérin, C | 1 |
| Hallwright, GP; Maling, TJ; O'Donnell, TV; Town, GI | 1 |
| Begg, EJ | 1 |
| Boutroy, MJ; Kreft-Jais, C; Plouin, PF; Tchobroutsky, C | 1 |
| Rydén, L | 1 |
| Bidiville, J; Brunner, HR; Mooser, V; Nussberger, J; Waeber, B; Waeber, G | 1 |
| Jackson, B; Johnston, CI; Maher, D; Matthews, PG; McGrath, BP | 1 |
| Murchison, LE; Robb, OJ; Webster, J | 1 |
| Dale, DC; Hammond, WP; Miller, JE; Rosenthal, AS; Starkebaum, G; Zweerink, HJ | 1 |
| Drinovec, J; Marinković, M; Rumboldt, Z | 1 |
| Frohlich, ED; Garavaglia, GE; Messerli, FH; Nunez, BD; Schmieder, RE | 1 |
| Rietbrock, N; Thürmann, P | 1 |
| Gordon, RD; Hamlet, SM; Klemm, SA; Tunny, TJ | 1 |
| Fisher, MB; Giles, TD; Rush, JE | 1 |
| Schofer, J | 1 |
| Goering, JL; Raich, PC; Zimmerman, BG | 1 |
| Bilezikian, JP; Cannon, PJ; Chow, YK; Corwin, SJ; Horn, EM; Neuberg, GW; Powers, ER; Steinberg, SF | 1 |
| de Abajo, FJ; Lopo, CR | 1 |
| Goldszer, RC; Lilly, LS; Solomon, HS | 1 |
| Bajaj, AK | 1 |
| Wyvratt, MJ | 1 |
| Dietz, R; Kübler, W; Manthey, J; Mikulaschek, K; Osterziel, KJ; Röhrig, N; Schmid, W | 1 |
| Noack, E | 1 |
| Scheler, F; Schilling, H | 1 |
| Mann, JF; Rambausek, M; Ritz, E | 1 |
| Wernze, H | 1 |
| Rahn, KH | 1 |
| Fregly, MJ; Rowland, NE | 1 |
| Salituri, S; Striano, U | 1 |
| Cumming, AM; Meredith, PA; Morton, JJ; Semple, PF | 1 |
| Ribuot, C; Rochette, L | 1 |
| Aliot, E; Gilgenkrantz, JM; Marie, PY; Trechot, P; Zannad, F | 1 |
| Edwards, CR; Padfield, PL | 1 |
| Cooper, WD; Currie, WJ | 1 |
| Hill, JF | 1 |
| Richardson, PJ | 1 |
| DiBianco, R | 1 |
| Bluth, R; Langnickel, R | 1 |
| Leblanc, H; Marre, M; Passa, P | 2 |
| Fraser, DM; McMurray, J | 1 |
| Tomov, I | 1 |
| Rutland, MD; Stuart, RA | 1 |
| Slany, J | 1 |
| Greminger, P; Siegenthaler, W; Vetter, W | 1 |
| Krassnigg, F; Placzek, R; Schill, WB | 1 |
| Skillrud, DM | 1 |
| Levine, TB | 2 |
| Ball, SG; Robertson, JI | 1 |
| Packer, M | 2 |
| Bhatnagar, D; Henkel, TW; Johnson, A; Thind, GS | 1 |
| Bullock, WE; Deepe, GS; Srivastava, L; Taylor, CL | 1 |
| Bal, IS; Chrysant, SG; Johnson, B; McPherson, M | 1 |
| Reihl, WP; Shapiro, AP | 1 |
| Ferguson, RK; Riley, LJ; Vlasses, PH | 2 |
| Brooks, RR; Huang, CT; Moore, AF; Pong, SF | 1 |
| Gillis, CN; Howell, RE; Moalli, R | 1 |
| Higa, T; Kida, O; Kodama, K; Kondo, K; Morotomi, Y; Someya, N; Tanaka, K | 1 |
| Amoroso, A; Bossini, A; Di Veroli, C | 1 |
| Di Perr, T | 1 |
| Lee, WH; Medina, N; Packer, M; Yushak, M | 2 |
| Ayers, CR; Baker, KM; Lehman, MR; Weaver, BA | 1 |
| Baldoli, E; Barone, D; Cecchi, R; Ciabatti, R; Favara, D | 1 |
| Johnson, AL; Price, WA; Stump, JM; Vavala, RF; Wong, PC | 1 |
| Herd, GW; Semple, PF | 1 |
| Sancho Rof, J | 1 |
| Autry, WL; Barbaz, BS; Norman, JA | 1 |
| Plouin, PF; Tchobroutsky, C | 1 |
| Lee, WH; Packer, M | 2 |
| Asami, T; Chen, CS; Ikeda, N; Maki, E; Naruse, T; Ohmura, I | 1 |
| Asami, T; Ikeda, N; Maki, E; Naruse, T; Ohmura, I; Sagawa, N | 1 |
| Davies, RO; Irvin, JD; Kramsch, DK; Moncloa, F; Walker, JF | 2 |
| Dahan, M; Gourgon, R; Juliard, JM; Merillon, JP; Solal, AC | 1 |
| Conner, DP; Danzeisen, JR; Ferguson, RK; Fruncillo, RJ; Rotmensch, HH; Shepley, KJ; Vlasses, PH | 1 |
| Hidaka, H; Oka, H; Sato, R; Sawada, S; Yasuda, Y | 1 |
| Kawashima, K; Kimura, M; Kobayashi, Y; Sokabe, H; Watanabe, TX | 1 |
| Snyder, SH; Strittmatter, SM | 1 |
| Buckner, FS; Chen, FN; Ganong, WF; Wade, CE | 1 |
| Hackenthal, E; Hilgenfeldt, U; Radziwill, R; Stuzmann, M | 1 |
| Atkinson, AB; Webb, DJ | 1 |
| Crozier, IG; Ikram, H; Lewis, GR; Nicholls, MG; Richards, AM; Webster, MW | 1 |
| Dzau, VJ | 2 |
| Thind, GS | 1 |
| Brunner, HR; Nussberger, J; Waeber, B; Waeber, G | 1 |
| Carruthers, SG | 1 |
| Rand, MJ; Story, DF; Ziogas, J | 1 |
| Sennesael, J; Verbeelen, D | 1 |
| Jackson, B; Johnston, CI; Matthews, PG; McGrath, BP; Wong, C | 1 |
| Schultheiss, HP; Zähringer, J | 1 |
| Furness, PN; Goodfield, MJ; MacLennan, KA; Millard, LG; Stevens, A | 1 |
| Chadwick, B; Le Jemtel, TH; Maskin, CS | 1 |
| Levens, NR | 1 |
| Kessler, PD; Lee, WH; Packer, M | 1 |
| Koster, M | 1 |
| Burkart, W | 1 |
| Bergmans, RJ; Verboom, CN | 1 |
| Gottlieb, SS; Kessler, PD; Packer, M | 1 |
| Nelson, EB; Pool, JL; Taylor, AA | 1 |
| Bauer, JH; Reams, GP | 1 |
| Gavras, H; Gavras, I | 2 |
| Cohn, JN; Levine, TB; Olivari, MT | 1 |
| Irvin, JD; Viau, JM | 1 |
| Cole, T; Conlon, M; Nau, R; Schäfer, G | 1 |
| Huang, CT; Miller, KE; Portlock, DE; Wright, GC | 1 |
| de Deus, RB; Henriques, OB; Santos, RA | 1 |
| Gilchrist, NL; Hood, S; Nicholls, MG | 1 |
| Cochat, P | 1 |
| Chung, AY; Ryan, JW | 1 |
| Berryer, P; Hart, MA; Ryan, JW; Ryan, US | 1 |
| Holmquist, B; Neels, H; Scharpé, S; van Sande, M | 1 |
| Abe, K; Kohzuki, M; Kudo, K; Omata, K; Onoda, Y; Sasaki, S; Tajima, J; Takeuchi, K; Tanno, M; Tsunoda, K | 1 |
| Kessler, PD; Lee, WH; Medina, N; Packer, M; Yushak, M | 1 |
| Allen, TA; Fettman, MJ; Wilke, WL | 1 |
| Chobanian, AV | 1 |
| Rossetto, BJ | 1 |
| Weber, MA | 2 |
| Neal, W | 1 |
| Artman, M; Graham, TP | 1 |
| Mann, RD; Rawlins, MD; Wood, SM | 1 |
| Cleland, JG; Dargie, HJ; East, BW; Ford, I; Inglis, CG; Leckie, BJ | 1 |
| Bouthier, JD; Laurent, SL; London, GM; Mimran, AR; Safar, ME | 1 |
| Karlberg, BE; Ohman, KP; Sjöstrand, A | 1 |
| Doussau, MP; Giudicelli, JF; Richer, C | 3 |
| Ganten, D; Lang, RE; Unger, T | 1 |
| Ferner, RE; Rawlins, MD; Simpson, JM | 1 |
| Amery, A; Fagard, R; Lijnen, P; M'Buyamba-Kabangu, JR; Staessen, J; Van Hoof, R | 1 |
| Lazowski, J; Rewerski, W | 1 |
| Droniou, J; Ducrocq, MB; Ollivier, JP | 1 |
| Forlani, A; Guzzon, V; Lazzaroni, A; Milani, S; Monopoli, A | 1 |
| Gans, RO; Hoorntje, SJ | 1 |
| Zusman, RM | 1 |
| Cushman, DW; Ondetti, MA; Petrillo, EW; Powell, JR | 1 |
| Itaya, Y; Kumagai, H; Matsukawa, S; Saruta, T; Suzuki, H | 1 |
| Abe, K; Kanazawa, M; Kasai, Y; Kohzuki, M; Omata, K; Sato, M; Takeuchi, K; Tanno, M; Yasujima, M; Yoshinaga, K | 1 |
| Kawashima, K; Saito, K; Sokabe, H; Watanabe, TX | 1 |
| Asahina, S; Kaneko, Y; Miyazaki, N; Ochiai, H; Ohta, T; Shionoiri, H; Tochikubo, O | 1 |
| Kawano, Y; Omae, T; Yoshida, K | 1 |
| Alagna, S; Bandiera, F; Dessì-Fulgheri, P; Glorioso, N; Madeddu, P; Masala, A; Rappelli, A; Rovasio, PP; Rubattu, S; Soro, A | 1 |
| Kanayama, Y; Kohno, M; Matsuura, T; Murakawa, K; Takaori, K; Takeda, T; Yasunari, K | 1 |
| Bauer, JH; Holmes, RA; Logan, KW; Reams, GP; Singh, A | 1 |
| Greminger, P | 1 |
| Atlas, SA; Case, DB; Cody, RJ; Laragh, JH | 1 |
| Gaul, SL; Martin, GE; Sweet, CS | 1 |
| Abe, K; Chiba, S; Goto, T; Kasai, Y; Omata, K; Sato, K; Seino, M; Tajima, J; Tanno, M; Yasujima, M | 1 |
| Vidt, DG | 1 |
| Enghoff, E; Hägg, A; Hedlund, A; Lantz, P | 1 |
| Forslund, T; Fyhrquist, F; Grönhagen-Riska, C; Hortling, L | 1 |
| Danielson, BG; Lindsjö, M; Weiss, L; Wikström, B | 1 |
| Atlas, SA; Case, DB; Laragh, JH; Yu, ZY | 1 |
| Lazowski, J | 1 |
| Abe, K; Tajima, J; Tanno, M; Yasujima, M; Yoshinaga, K | 1 |
| Johnston, CI | 1 |
| Maier, R; Metzger, H; Sitter, C; Stern, HO | 1 |
| Bünning, P | 1 |
| Becker, RH; Metzger, M; Schölkens, BA; Schulze, KJ | 1 |
| Bagdon, WJ; Bokelman, DL; Minsker, DH; Robertson, RT | 1 |
| Casellas, D; Dupont, M; Jover, B; Mimran, A | 1 |
| Jover, B; Mimran, A | 1 |
| Casley, D; Cubella, R; Jackson, BJ; Johnston, CI; Larmour, I | 1 |
| Davies, RO; Gabriel, MA; Kramsch, DM; McFate Smith, W; Moncloa, F; Rush, JE; Walker, JF | 1 |
| Schölkens, BA; Tilly, H; Xiang, JZ | 1 |
| Campbell, BC; Millar, JA; Reid, JL | 1 |
| Dollery, CT | 1 |
| Forslund, T; Fyhrquist, F; Grönhagen-Riska, C; Hortling, L; Tikkanen, I | 1 |
| Bouhnik, J; Clauser, E; Corvol, P; Gonzalez, MF; Ménard, J | 1 |
| Blaine, EH; Gaul, SL; Reitz, PM; Ribeiro, LT; Sweet, CS | 1 |
| Berecek, KH; Nagahama, S; Oparil, S | 1 |
| Kramsch, DM; Kulaga, SF; Walker, JF | 1 |
| Kulaga, SF; McFate Smith, W; Moncloa, F; Pingeon, R; Walker, JF | 1 |
| Bensala-Alaoui, A; Corvol, P; Evin, G; Gardes, J; Ménard, J; Michel, JB | 1 |
| de Jong, PE; de Monchy, J; de Zeeuw, D; Kallenberg, CG; Navis, GJ | 1 |
| Csicsmann, J; Hutchinson, JS; Mendelsohn, FA | 1 |
| Arbegast, PT; Blaine, EH; Gaul, SL; Gross, DM; Sweet, CS | 1 |
| Di Nicolantonio, R; Hutchinson, JS; Takata, Y | 1 |
| Ashworth, RW | 1 |
| Cervoni, P; Chan, PS; Ronsberg, MA | 1 |
| Cody, RJ | 1 |
| Bauer, JH | 1 |
| Materson, BJ | 2 |
| Backlund, EP; Bohn, DL; Gross, DM; Morris, AA; Stone, CA; Sweet, CS; Ulm, EH; Vassil, TC; Weitz, D; Wenger, HC | 1 |
| Anderson, T; Cohen, ML; Kurz, K | 1 |
| Cohen, ML; Kurz, KD | 1 |
| DiNicolantonio, R; Doyle, AE; Hutchinson, JS; Mendelsohn, FA | 1 |
| Antonaccio, MJ; McGill, M | 1 |
| Biollaz, J; Brunner, HR; Burnier, M; Gavras, H; Turini, GA | 1 |
| Ferguson, RK; Rotmensch, HH; Sheaffer, SL; Vlasses, PH | 1 |
| Angus, JA; Johnston, CI; Nakashima, A | 1 |
| Biollaz, J; Brunner, DB; Brunner, HR; Desponds, G; Gomez, HJ; Hichens, M; Jacot Des Combes, B; Schelling, JL; Ulm, EH | 1 |
| Ganten, D; Lang, RE; Rascher, W; Schüll, B; Unger, T | 1 |
| Sweet, CS | 1 |
| Cohen, ML; Kurz, K | 1 |
| Austin, JE; Clark, KE; Holroyd, JC; Siddiqi, TA | 1 |
| Fassett, RG; Kincaid-Smith, P; Walker, RG; Whitworth, JA | 1 |
| Baum, T; Becker, FT; Sybertz, EJ | 1 |
| Cohen, ML; Kurz, KD; Wiley, KS | 1 |
| Brunner, HR; Turini, GA; Waeber, B | 1 |
| Bazilinski, N | 1 |
| Wilkin, JK | 1 |
| Hutchinson, JS; Takata, Y | 1 |
| De Jonge, A; Timmermans, PB; Van Zwieten, PA | 1 |
| Attwood, MR; Francis, RJ; Hassall, CH; Kröhn, A; Lawton, G; Natoff, IL; Nixon, JS; Redshaw, S; Thomas, WA | 1 |
| Lefer, AM; Lefer, DJ | 1 |
| Abe, K; Omata, K; Tanno, M; Yasujima, M; Yoshinaga, K | 1 |
| Cremer, W | 1 |
| Cody, RJ; Kubo, SH | 1 |
| Kincaid-Smith, P; Murphy, BF; Whitworth, JA | 1 |
| Abrams, WB; Davies, RO; Ferguson, RK | 1 |
| Cohen, DM; Essenburg, AD; Kaplan, HR; Major, TC; Mertz, TE; Ryan, MJ | 1 |
| Boucher, DM; Cohen, DM; Kaplan, HR; Olszewski, BJ; Ryan, MJ; Singer, RM; Smith, RD | 1 |
| Gillespie, JB; McCaa, RE | 1 |
| Nakane, H; Nakane, Y; Ogihara, T; Saruta, T; Yasui, T; Yoshizawa, M | 1 |
| Forslund, T; Fyhrquist, F; Kouvonen, I | 1 |
| Reynolds, CH | 1 |
| Dunkman, WB; Franciosa, JA; Leddy, CL | 1 |
| Galluzzo, TS; Gardner, DV; Molteni, A; Ts'ao, C | 1 |
| Dinicolantonio, R; Doyle, AE; Hutchinson, JS; Mendelsohn, FA; Takata, Y | 1 |
| Korn, JH; Smith, CD; Smith, RD | 1 |
| Challenor, VF | 1 |
| Cruickshank, HE | 1 |
| Araki, M; Imai, S; Kanda, T; Kobayashi, I; Murata, K; Suzuki, T | 1 |
| Amrah, SS; Noor, AR; Sharma, JN | 1 |
| Crozier, IG; Foy, SG; Frampton, CM; Ikram, H; Nicholls, MG; Richards, AM; Turner, JG | 2 |
| Bridges, A; Haffner, CA; Kendall, MJ; Stott, DJ; Struthers, AD | 1 |
| Gibson, KJ; Lumbers, ER; Stevenson, KM | 1 |
| Abete, P; Acanfora, D; Ferrara, N; Furgi, G; Guerra, N; Leosco, D; Longobardi, G; Nicolino, A; Papa, A; Rengo, F | 1 |
| Wood, R | 1 |
| Chanudet, X; Janin, G; Madonna, O; Mayaudon, H | 1 |
| Belch, JJ; Bridges, AB; McLaren, M | 1 |
| Barcina Sánchez, C; Fernández Fernández, A; Martín Cortés, M | 1 |
| Bos, JD; Kozel, MM; Mekkes, JR | 1 |
| Cimmerer, AL; Fregly, MJ; Rowland, NE | 1 |
| Collins, TJ; Mehra, MR; Ramee, SR; Smart, FW; Stapleton, DD; Ventura, HO | 1 |
| de Graeff, PA; Girbes, AR; Hillege, H; Lie, KI; Smit, AJ; van den Broek, SA; van Gilst, WH; van Veldhuisen, DJ; Wesseling, H | 1 |
| Nicholls, G; Norris, RM; Woo, KS | 1 |
| Jugdutt, BI | 1 |
| Bakker, A; Paes, AH; Stricker, BH; van der Velden, J; Visser, LE | 1 |
| Soyeur, D | 1 |
| Botyánszki, J; Fehér, E; Hepp, J; Magyar, A; Medzihradszky, K; Rónai, AZ | 1 |
| Doohan, MM; Hool, LC; Rasmussen, HH; Whalley, DW | 1 |
| Jung, HC; Kim, CY; Kim, NY; Lee, DH; Song, S; Yim, KW; Yoon, BC | 1 |
| Abe, I; Fujishima, M; Kobayashi, K; Ohmori, S; Ohya, Y; Takata, Y; Tominaga, M; Ueno, M | 1 |
| de Cavanagh, EM; Ercole, L; Ferder, L; Fraga, CG; Inserra, F; Romano, L | 1 |
| Belz, GG; Breithaupt, K; Erb, K | 1 |
| Gerasimenko, OI; Kutyrina, IM; Rogov, VA; Sheremet'eva, OV; Shestakova, MV; Tareeva, IE; Zverev, KV | 1 |
| Alciati, E; Casciani, CU; Pieragostini, E; Pisani, F; Tisone, G; Vennarecci, G | 1 |
| Aviram, M; Brook, JG; Kaplan, M; Keidar, S; Shapira, C | 1 |
| Hutton, KP; Kuechle, MK; Muller, SA | 1 |
| Ferrer, JM; Morales-Olivas, FJ; Palop, V; Rubio, E | 1 |
| Fregly, MJ; Li, BH; Rowland, NE; Smith, GC | 1 |
| Bastani, B; Redington, J | 1 |
| Cooke, HM; De Besse, A | 1 |
| Robinson, AV; Schulak, JA; Vargas, AV | 1 |
| Coriat, P; Douraki, T; Giudicelli, JF; Gomez, C; Hendricks, K; Richer, C; Viars, P | 1 |
| Broderick, GT; DiBianco, R; Gottlieb, SS; Kostis, J; Lang, RM; Lyle, PA; Makris, L; Rajfer, SI; Rucinska, EJ | 1 |
| Cohen, EP; Fish, BL; Hill, P; Moulder, JE | 1 |
| Creager, MA; Roddy, MA | 1 |
| Bayata, S; Postaci, N; Yeşil, M; Yeşil, S | 1 |
| Lewis-Barned, NJ; Pratt, MC; Walker, RJ | 1 |
| Bassenge, E; Zanzinger, J; Zheng, X | 1 |
| Li Wan Po, A; Zhou, XH | 1 |
| Crozier, IG; Donald, RA; Ellis, MJ; Foy, SG; Ikram, H; Livesey, JH; Mattioli, L; Richards, AM | 1 |
| Banks, RJ; Dourish, CT; Mozley, L | 1 |
| Reid, J | 1 |
| Elkayam, U; Hurst, A; Shotan, A; Widerhorn, J | 1 |
| Mazzotta, G; Vecchio, C | 1 |
| Byyny, RL; Franca, G; Gerber, JG; LoVerde, M; Nies, AS | 1 |
| Ikeda, M; Kishi, K | 1 |
| O'Mara, NB; Zimmerman, WB | 1 |
| Atienza Fernández, M; Carvajal Gragera, E; Piña Vera, MJ; Santos Ramos, B | 1 |
| da Silva, SV; da Silva, VJ; Salgado, HC; Salgado, MC | 1 |
| Burns, CM; Hagley, MT; Hulisz, DT | 1 |
| Andrén, L; Hedner, T; Lindholm, L; Lötvall, J; Lunde, H; Samuelsson, O; Wiholm, BE | 1 |
| Birnbaum, AJ; Brottman, MD; Skosey, JL; Sobotka, PA; Weitz, Z; Zarling, EJ | 1 |
| Waud, DR | 1 |
| Kaplan, NM | 1 |
| Fletcher, A | 1 |
| Ware, JE | 1 |
| Aoki, K; Nakajima, T; Setoguchi, M; Yaoka, O | 1 |
| Mollace, V; Pistelli, A; Salvemini, D | 1 |
| Cohen, EP; Fish, BL; Moulder, JE | 2 |
| Kozyreva, MP; Martsevich, SIu; Metelitsa, VI; Vakulovskaia, MK | 1 |
| Brooks, DP; DePalma, PD; Fredrickson, TA; Ruffolo, RR; Spielman, WS | 1 |
| Guess, H; Heyse, JF; Santanello, NC | 1 |
| Frable, MA; Thompson, T | 1 |
| Bindlish, V; Jaber, LA; Melchior, WR | 1 |
| Lees, KR; MacFadyen, RJ; Reid, JL; Squire, IB | 2 |
| Coulter, DM; Pillans, PI | 1 |
| Bindels, AJ; Vandenbroucke, JP | 1 |
| Munger, MA | 1 |
| Sharpe, N | 1 |
| Anderson, RB; Hollenberg, NK; Nackley, JF; Testa, MA | 1 |
| Oparil, S | 1 |
| Cooke, ED; Li Kam Wa, TC; Turner, P | 1 |
| Aurell, M; Granerus, G; Jensen, G; Moonen, M; Volkmann, R | 1 |
| Chabot, M; Lewis, AB | 1 |
| Bujor, MA; Davis, BB; Myles, PS; Olenikov, I | 1 |
| Adams, KF; Cody, RJ; Costantini, PJ; Gheorghiade, M; Gourley, LA; Jolly, MK; Packer, M; Smith, LK; Van Voorhees, L; Young, JB | 1 |
| Schneeweiss, A | 1 |
| Reisin, L | 1 |
| Arvidsson, N; Herlitz, H; Lukes, D; Mjörnstedt, L; Olausson, M | 2 |
| Krishna, EV; Mehta, AV; Subrahmanyam, AB; Wattad, AA | 1 |
| Nicholls, MG; Woo, KS | 1 |
| Kobayasi, R; Sanbe, A; Takeo, S; Tanonaka, K | 1 |
| Cohen, N; Cotariu, D; Evans, S; Golik, A; Modai, D; Weissgarten, J; Zaidenstein, R | 1 |
| Hopkins, WE; Kelly, DP | 1 |
| Hess, E; Sperschneider, H; Stein, G | 1 |
| Fang, Z; Hao, F; Li, Y; Liu, D; Liu, Z | 1 |
| Kanno, Y; Okada, H; Saruta, T; Suzuki, H; Takenaka, T | 1 |
| Averbukh, Z; Cohen, N; Cotariu, D; Evans, S; Golik, A; Modai, D; Weissgarten, J; Zaidenstein, R | 1 |
| Eintracht, S; Reddy, K; Sareli, P; Skoularigis, J; Smith, D; Strugo, V; Tshele, E; Zambakides, C | 1 |
| Brault, Y; Chastang, C; Di Perri, T; Guez, D; Laurandin, I; Luccioni, R; Redon, J; Sever, PS | 1 |
| Black, P; Coulter, DM; Pillans, PI | 1 |
| Cozzolino, A; Esposito, C; Lombardi, ML; LoSchiavo, A; Porta, R; Ruocco, V | 1 |
| Amadi, A; Coats, A; Gibson, DG; Henein, MY; O'Sullivan, C | 1 |
| Adewole, AD; Adigun, AQ; Ajayi, AA; Akintomide, AO; Balogun, MO; Ikem, RT | 1 |
| Fogo, A; Freeman, M; Lo, W; Oikawa, T; Vaughan, DE | 1 |
| Antunes, E; De Nucci, G; Muscará, MN; Teixeira, SA; Zappellini, A; Zatz, R | 1 |
| Anderssson, PE; Berglund, L; Haenni, A; Lind, L; Lithell, H; Reneland, R | 1 |
| Colvill, LM; Giles, ME; McKinley, MJ; Oldfield, BJ | 1 |
| Aurell, M; Johnsen, SA; Persson, IB | 1 |
| Moore, JN; Tillman, LG | 1 |
| de Cavanagh, EM; Ferder, L; Fraga, CG; Inserra, F | 2 |
| Cvetković, T; Deljanin-Ilić, M; Djordjević, VB; Lecić, N; Pavlović, D; Pejović, M | 1 |
| Kaseda, Y; Kitagawa, S; Sato, S; Takeda, J | 1 |
| Maier, H; Tisch, M | 1 |
| Bagriy, AE; Dyadyk, AI; Lebed, IA; Schukina, EV; Taradin, GG; Yarovaya, NF | 1 |
| Anderson, B; Dhalla, AK; Khaper, N; Singal, PK | 1 |
| Brown, RS; Choksi, SK; Douglas, T; Krakow, AM | 1 |
| Bental, T; Elis, A; Lalkin, A; Lishner, M; Ravid, M | 1 |
| Dorszewski, A; Dorsźewski, B; Figulla, HR; Göhmann, E; Kreuzer, H; Werner, GS | 1 |
| Jugdutt, BI; Khan, MI; Lucas, A | 1 |
| Pojoga, L; Raicu, M; Simionescu, M; Simionescu, N | 1 |
| Haneda, T; Kikuchi, K; Takeda, H | 1 |
| Bartosz, G; Bartosz, M; Kedziora, J | 1 |
| Bagriĭ, AE; Diadyk, AI; Diadyk, IA; Gaĭdukov, VO; Gritsenko, PV; Iarovaia, NF; Lebed', IA; Shchukina, EV | 1 |
| Dachman, W; Székács, B; Vajo, Z | 1 |
| de Graeff, PA; Hillege, H; Lie, KI; van den Broek, SA; van Gilst, WH; van Veldhuisen, DJ; Wesseling, H | 1 |
| Bachowski, R; Biernat, J; Deja, MA; Golba, KS; Mrozek, R; Wos, S | 1 |
| Rao, NM; Udupa, EG | 2 |
| Ikezawa, K; Kaminuma, O; Kikkawa, H; Matsubara, S | 1 |
| Berman, S; Blatt, A; Cohen, N; Cotter, G; Dishi, V; Golik, A; Weissgarten, J; Zaidenstein, R | 1 |
| Benzie, IF; Tomlinson, B | 1 |
| Amado Guirado, E; Aymamí, A; Catalán Ramos, A; Madridejos Mora, R; Pérez Rodríguez, M; Rey Abella, ME; Sáenz Hernáiz, I; Torralba Guirao, M | 1 |
| Bestetti, RB; Bombonato, R; Brasil, JC; Caixe, SH; Finzi, LA; Kato, M; Muccillo, G | 1 |
| Takahashi, M; Uehara, Y | 1 |
| Fujitani, B; Honda, Y; Hosoki, K; Masuda, Y; Minato, H | 1 |
| Edwards, EA; Lewis-Barned, NJ; Robertson, MC; Tillmann, HC; Walker, RJ | 1 |
| Gheorghiade, M; Lee, P; McDermott, MM; Mehta, S | 1 |
| Bunnett, NW; Emanueli, C; Figini, M; Geppetti, P; Grady, EF; Madeddu, P; Parisi, D; Regoli, D | 1 |
| Chan, JC; Crevi, DL; Narla, LD; Scheinman, JI | 1 |
| Hamlin, R; Mandigers, PJ; Pijpers, FS | 1 |
| Azzadin, A; Buczko, W; Chabielska, E; Golatowski, J; Pawlak, R | 1 |
| Rowland, NE | 1 |
| D'Alessio, O; Falcone, G; Giassa, T; Mangrella, M; Mazzeo, F; Motola, G; Rossi, F; Russo, F | 1 |
| Dudás, M; Hidas, I; Iványi, J; Molnár, S; Ruszty, L | 1 |
| Albert, P; Braunwald, E; Domanski, M; Geller, N; Hsia, J; Pfeffer, MA; Rosenberg, Y; Verter, J | 1 |
| Rady, MY; Ryan, T | 1 |
| Cvetković, T; Djordjević, VB; Grubor-Lajsić, G; Jovanovic-Galović, A; Lecić, N; Pavlović, D; Pejović, M | 1 |
| Kedziora-Kornatowska, K; Luciak, M | 1 |
| Burrows, EA; Burrows, RF | 1 |
| Arishima, K; Kawahata, M; Masaoka, T; Takizawa, T; Togashi, H; Yamamoto, M | 1 |
| Gu, PK; Huang, MZ; Jin, ZJ; Qi, JH; Wang, HY; Wang, J; Wei, PJ; Zhang, L | 1 |
| Bombin, C; Figueredo, E; Lluch-Bernal, M; Novalbos, A; Sastre, J; Umpierrez, A | 1 |
| Abreu, SH; Levey, CS; Schraml, FV; Silverman, ED | 1 |
| Bestetti, RB; Bombonato, R; Brasil, JC; Haddad, J; Moreira-Neto, F; Sgarbieri, RN | 1 |
| Bermejo, A; Cabo, P; Duarte, J; Gámez, MJ; Martinez, A; Vera, B; Zarzuelo, A | 1 |
| Gunasekaran, H; Gunasekaran, S; Rabb, H; Saba, SR | 1 |
| Driscoll, WJ; Mueller, GP; Mueller, SA | 1 |
| Akarawut, W; Lin, CJ; Smith, DE | 1 |
| Battler, A; Behar, S; Boyko, V; Goldbourt, U; Gottlieb, S; Leor, J; Reicher-Reiss, H | 1 |
| Lee, AF; MacFadyen, RJ; Morton, JJ; Pringle, SD; Struthers, AD | 1 |
| Ebert, U; Kirch, W | 1 |
| Binevski, PV; Gomazkov, OA; Grinshtein, SV; Kost, OA; Nikolskaya, II; Pozdnev, VF | 1 |
| Riegger, GA | 1 |
| Acosta Gómez, MJ; Llamas Elvira, JM; López Ruiz, JM; Martínez del Valle, MD; Rodríguez Fernández, A | 1 |
| Adzhienko, LM; Kozhevnikova, EV | 1 |
| Bianchetti, MG; Meregalli, P; Mozzettini, S; Ramelli, GP; Truttmann, AC; von Vigier, RO | 1 |
| Berger, R; Frey, B; Kozanly, I; Kuchling, G; Pacher, R; Stanek, B | 1 |
| Somlev, B; Subev, M | 1 |
| Gmiński, J; Goss, M; Machalski, M; Siemianowicz, K; Stajszczyk, M; Wojakowski, W | 1 |
| Gallardo, J; García-Robles, R; Rodríguez-García, JL; Serrano, M; Villa, E | 1 |
| Kammerl, MC; Krämer, BK; Riegger, GA; Schaefer, RM; Schreiber, M; Schweda, F | 1 |
| Hayashi, K; Kumagai, H; Kumamaru, H; Saruta, T | 1 |
| Kedziora-Kornatowska, KZ; Luciak, M; Paszkowski, J | 1 |
| Gminski, J; Goss, M; Machalski, M; Siemianowicz, K; Wojakowski, W | 2 |
| Hoagland, KM; Ito, O; Ito, S; Omata, K; Roman, RJ | 1 |
| Aliev, FR; Isaeva, BG; Kraĭsman, VA; Polimbetov, DS | 1 |
| Akçiçek, F; Asçi, G; Basçi, A; Duman, S; Günal, AI; Ozkahya, M; Töz, H | 1 |
| Chen, YT; Krumholz, HM; Radford, MJ; Wang, Y | 1 |
| Bässler, A; Fischer, M; Hengstenberg, C; Holmer, S; Klein, G; Löwel, H; Mayer, B; Riegger, G; Schunkert, H | 1 |
| Francis, GS; Gassler, JP | 1 |
| Haas, GJ | 1 |
| Chauhan, SS; Hasija, PK; Karloopia, SD; Shahi, BN | 1 |
| Agarwal, A; Anuradha, S; Rizvi, SN; Singh, NP; Uppal, M | 1 |
| Brook, MM; Culbertson, CB; Hanley, FL; Hardy, CE; McElhinney, DB; Reddy, VM; Thompson, LD | 1 |
| Borhani, M; Curci, JA; Kelley, BJ; Liao, S; Miralles, M; Thompson, RW | 1 |
| Ahonen, P; Saltevo, J | 1 |
| Muto, R; Ohashi, H | 1 |
| Fujisawa, K; Hiraoka, M; Hori, C; Mayumi, M; Ohshima, Y; Tsukahara, H; Tsuzuki, K; Yoshida, Y; Yoshikawa, N; Yoshioka, K | 1 |
| Kolina, IB; Neverov, NI; Shilov, EM; Shvetsov, MIu; Stavrovskaia, EV; Zakharova, EV | 1 |
| Andrejak, M; Fournier, A; Mazouz, H; Monge, M; Oprisiu, R | 1 |
| Karvonen, KE; Kerola, TV; Männistö, TK; Ryhänen, LJ | 1 |
| Camacho Díaz, JA; García García, L; Giménez Llort, A; Jiménez González, R | 1 |
| Cohen, EP; Fish, BL; Molteni, A; Moulder, JE; Taylor, JM; Veno, PA; Ward, WF; Wolfe, LF | 1 |
| Andreini, I; Bonaduce, D; Casini, A; Condorelli, M; D'Armiento, FP; de Nigris, F; De Rosa, G; Mansueto, G; Napoli, C; Sarlo, F; Somma, P | 1 |
| Barretto, AC | 1 |
| Bartra, J; Bonet, A; Gaig, P; García-Ortega, P; San Miguel-Moncin, MM | 1 |
| Remme, WJ | 1 |
| Boner, G; Erman, A; van Dijk, DJ | 1 |
| Crivelli, F; Dal Bo, L; Giusti, A; Ismaili, S; Marzo, A; Mazzucchelli, P; Monti, NC; Uhr, MR | 1 |
| Ahmed, A; Allman, RM; Bodner, EV; DeLong, JF; Howard, G | 1 |
| Bicket, DP | 1 |
| Huang, CM; Young, MS | 1 |
| Bartels, T; Dominiak, P; Häuser, W; Raasch, W; Rütten, H; Schwartz, C | 1 |
| Qui, XS; Sim, MK | 1 |
| Iversen, BM; Myking, O; Ofstad, J; Svarstad, E | 1 |
| Baggi, JM; Brandi, JM; Cordeiro, JA; de Godoy, MF; Joaquim, MR; Maia, LN; Nicolau, JC; Santos, M; Vítola, JV | 1 |
| Böger, GI; Böger, RH; Budinger, M; Busse, R; Hoopmann, M; Welte, T | 1 |
| Jacobsen, P; Parving, HH; Pietraszek, L; Rossing, K | 1 |
| Ebrahimi, SA; Mahmoudian, M; Rostami, P; Zareie, MR | 1 |
| Gardiner, G; Guindi, M; Joshi, S; Shiota, K; Wanless, IR; Wong, FS; Yeung, E | 1 |
| Gensini, GF; Modesti, PA; Vanni, S | 1 |
| Djahanguiri, B; Hesami, A; Pazoki-Toroudi, HR; Sahebjam, F; Seifi, B; Vahidi, S | 1 |
| Geng, L; Nilsson, SF; Persson, K | 1 |
| Kvan, E; Reikvam, A | 1 |
| Proesmans, W; Van Dyck, M | 1 |
| Keltai, M | 1 |
| Braszko, JJ; Gard, PR; Halicka, D; Karwowska-Polecka, W | 1 |
| Iakubov, AV; Usmanova, ShE | 1 |
| Baroni, A; Buommino, E; Orlando, M; Paoletti, I; Ruocco, E; Ruocco, V | 1 |
| Condorelli, M; de Nigris, F; Ignarro, LJ; Liguori, A; Napoli, C; Pignalosa, O; Sica, V | 1 |
| Arneja, AS; Dhalla, NS; Ganguly, PK; Netticadan, T; Shah, KR | 1 |
| Katada, K; Kuroda, M; Manabe, H; Naito, Y; Nakabe, N; Shimozawa, M; Uchiyama, K; Yoshida, N; Yoshikawa, T | 1 |
| Chen, Z; Jiang, JL; Li, YJ; Xu, HY; Zhu, HQ | 1 |
| Buczko, W; Chabielska, E; Cylwik, D; Kramkowski, K; Mogielnicki, A | 1 |
| Cohen-Solal, A; Dietz, R; Eichhorn, E; Erhardt, L; Hobbs, FD; Krum, H; Maggioni, A; McKelvie, RS; McMurray, J; Piña, IL; Soler-Soler, J; Swedberg, K | 1 |
| Alcaraz, A; Atucha, NM; Evangelista, S; García-Estañ, J; Navarro, EG; O'Valle, F; Ortiz, MC; Vargas, F | 1 |
| Kuster, DJ; Marshall, GR | 1 |
| Nedogoda, SV | 1 |
| Bertoluci, MC; Oliveira, FR; Schmid, H; Schmidt, A; Thomazelli, FC; Uebel, D | 1 |
| Chen, SX; Liu, LY; Liu, YH; Sun, YX; Wu, JX | 1 |
| Borghi, C; Cosentino, E; De Sanctis, D | 1 |
| Bauriedel, G; Lüderitz, B; Nickenig, G; Schneider-Schmitt, M; Skowasch, D; Viktor, A | 1 |
| Babar, S; Ducobu, J; Legssyer, I; Moguilevsky, N; Moreau, P; Nève, J; Van Antwerpen, P; Vanhaeverbeek, M; Zouaoui Boudjeltia, K | 1 |
| Bates, JN; Hashmi-Hill, MP; Lewis, SJ; Owen, JR; Robertson, TP; Sandock, K | 1 |
| Buczko, W; Chabielska, E; Domaniewski, T; Karp, A; Kramkowski, K; Malinowska-Zaprzałka, M; Mogielnicki, A; Opadczuk, A; Wojewódzka-Zelezniakowicz, M | 1 |
| Anderson, WP; Edgley, AJ; Evans, RG; Gao, Y; Shweta, A | 1 |
| Chen, JL; Gao, RL; Pei, WD; Sun, YH; Yang, YJ; Zhang, YH; Zhao, JL | 1 |
| Bacal, F; Bocchi, EA; Chizzola, PR; Guimarães, GV; Issa, VS; Mangini, S; Moreira, SF; Pires, PV; Silva, CP; Souza, GE | 1 |
| Anania, V; Demontis, MP; Gianorso, S; Pais, GL; Palomba, D; Varoni, MV | 1 |
| Pechánová, O | 1 |
| Mallion, JM | 1 |
| Ghazi-Khansari, M; Ghobadi, G; Karimian, G; Mohammadi-Karakani, A; Shakiba, B; Sotoudeh, M | 1 |
| Chen, SX; Liu, LY; Liu, YH; Song, T; Wu, SJ; Zhou, SH | 1 |
| Asif, H; Chaudhari, MP; Crossland, DS; Kirk, RC; O'Sullivan, JJ; Roche, SL | 1 |
| Plaisance, M; Roux, VD | 1 |
| Celiński, K; Czechowska, G; Korobowicz, E; Korolczuk, A; Madro, A; Prozorow-Król, B; Słomka, M | 1 |
| Bruzzese, G; Cacciatore, F; Crimi, E; de Nigris, F; Fiorito, C; Ignarro, LJ; Libardi, S; Liguori, A; Mancini, FP; Napoli, C; Sommese, L; Williams-Ignarro, S | 1 |
| Bocchi, EA; Carvalho, VO; Guimarães, GV | 1 |
| Albuquerque, D; Cardillo, F; Nihei, J; Singh, R | 1 |
| Bogdanski, P; Czaplicka, E; Jablecka, A; Krauss, H; Olszewski, J; Smolarek, I | 1 |
| Briggs, JP; Chen, L; Chen, M; Eisner, C; Gomez, RA; Huang, Y; Kim, SM; Li, L; Mizel, D; Oppermann, M; Schnermann, J; Sequeira Lopez, ML; Weinstein, LS | 1 |
| Anania, V; Antuofermo, E; Baralla, E; Deiana, G; Demontis, MP; Macciotta, NP; Palomba, D; Varoni, MV | 1 |
| Harford-Wright, E; Thornton, E; Vink, R | 1 |
| Anzai, N; Endou, H; Enomoto, A; Fujimura, M; Miyazaki, H; Shin, HJ; Takeda, M | 1 |
| Bruzzese, G; Cacciatore, F; de Nigris, F; Donatelli, F; Fiorito, C; Ignarro, LJ; Infante, T; Liguori, A; Minucci, PB; Napoli, C; Vitale, DF | 1 |
| Harty, DWS; Hunter, N | 1 |
| Chou, J; Debanne, SM; Fang, JC; Mishra, P; Simon, DI; Sipahi, I | 1 |
| Citraro, R; Gallelli, L; Gareri, P; Gratteri, S; Paola, ED; Rispoli, V; Russo, E; Sarro, GD; Siniscalchi, A; Tripepi, G | 1 |
| Amore, C; Cugino, D; Cutrone, A; de Gaetano, G; Di Santo, A; Donati, MB; Iacoviello, L; Lorenzet, R; Napoleone, E | 1 |
| Fish, BL; Gao, F; Jacobs, ER; Kma, L; Medhora, M; Moulder, JE | 1 |
| Bozcali, E; Dedeoglu, DB; Karpuz, H; Karpuz, V; Suzer, O | 1 |
| Czuczwar, SJ; Jakubus, T; Janowska, A; Lukawski, K; Raszewski, G | 1 |
| Djuric, JM; Folic, MM; Jankovic, SM; Jankovic, SV; Stojic, I | 1 |
| Denfield, SD; Dinh, K; Knudson, JD; Kyle, WB; Lindle, KA; Moffett, BS; Montgomery, NM | 1 |
| Álvarez, J; Casas, M; Lucero, MJ | 1 |
| Cabrera, AG; Ghazi, P; Moffett, BS | 1 |
| Helal, F; Lane, ME | 1 |
| Andersson, P; Bratt, J; Cederholm, T; Heimbürger, M; Palmblad, J | 1 |
| Chang, CH; Lai, MS; Lee, YC; Lin, JW; Lin, MS; Ruan, SY; Wu, LC | 1 |
| Becerril, C; Checa, M; Díaz-Piña, G; García de Alba, C; Montes, E; Ordoñez-Razo, R; Páramo, I; Ruiz, V; Vega, A | 1 |
| Shen, S; Shi, Y; Yang, X | 1 |
| Djuric, JM; Jankovic, SM; Jankovic, SV; Kostic, M; Stojadinovic, D; Stojadinovic, M; Stojic, I | 1 |
| Gibas-Dorna, M; Kozlik, J; Krauss, H; Kupsz, J; Mikrut, K; Pruszynska-Oszmałek, E | 1 |
| Cass, QB; de Almeida, FG; Vanzolini, KL | 1 |
| Adibi, H; Ashrafi-Kooshk, MR; Esmaeili, S; Khodarahmi, R | 1 |
| Biojone, C; Casarotto, PC; Castrén, E; Diniz, CRAF; Fred, SM; Joca, SRL | 1 |
| de Moura Leão, MF; de Oliveira, LFS; Duarte, JA; Machado, MM; Piccoli, JDCE; Sauzen, PD | 1 |
| Jaiswal, V; Khan, A; Khan, H; Kulshreshtha, S | 1 |
| Diniz, LF; Gonçalves, RV; Lia Mazzeti, A; Mendonça, AAS; Novaes, RD; Souza-Silva, TG | 1 |
| Chuang, LY; Guh, JY; Huang, JS; Hwang, JY; Kan, WC; Liu, YB; Yang, YL | 1 |
| Abouelkheir, M; El-Metwally, TH | 1 |
| Brusco, I; Justino, AB; Machado-de-Ávila, RA; Oliveira, SM; Scussel, R; Silva, CR | 1 |
| Choi, JG; Choi, SR; Hwang, J; Kang, DW; Kim, HW; Lee, M; Shin, HJ | 1 |
88 review(s) available for captopril and enalapril
| Article | Year |
|---|---|
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Relative efficacy of angiotensin converting enzyme inhibitors on mortality of patients with congestive heart failure: implications of randomized trials and role of the aetiology (ischaemic or non-ischaemic) of heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Coronary Disease; Enalapril; Follow-Up Studies; Heart Failure; Humans; Indoles; Meta-Analysis as Topic; Perindopril; Survival Rate | 1992 |
Comparative pharmacokinetics of captopril, enalapril, and quinapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Humans; Hypertension; Isoquinolines; Quinapril; Reference Values; Tetrahydroisoquinolines | 1992 |
The treatment of moderate to severe hypertension with ACE inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atenolol; Captopril; Double-Blind Method; Drug Therapy, Combination; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Multicenter Studies as Topic; Quinapril; Tetrahydroisoquinolines | 1990 |
"Two-step" pemphigus induction by ACE-inhibitors.
Topics: Anti-Inflammatory Agents; Captopril; Enalapril; Humans; Male; Middle Aged; Pemphigus; Pregnenediones; Recurrence | 1992 |
Clinical characteristics of angiotensin-converting enzyme inhibitor-induced angioedema.
Topics: Angioedema; Captopril; Enalapril; Female; Humans; Male; Middle Aged | 1991 |
Comparison of lisinopril and captopril in the treatment of left ventricular congestive heart failure--influence of duration of action on efficacy and safety.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Administration Schedule; Enalapril; Heart Failure; Hemodynamics; Humans; Kidney Function Tests; Lisinopril; Ventricular Function, Left | 1991 |
ACE inhibitors in the elderly.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Humans; Hypertension; Isoquinolines; Quinapril; Tetrahydroisoquinolines | 1991 |
ACE-inhibitors and quality of life.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Captopril; Enalapril; Health Status; Humans; Hypertension; Methyldopa; Middle Aged; Oxprenolol; Quality of Life | 1990 |
[ACE inhibitors and heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Isoquinolines; Lisinopril; Quinapril; Tetrahydroisoquinolines | 1990 |
Long-term renal effects of enalapril therapy in patients with renal insufficiency.
Topics: Aged; Blood Pressure; Captopril; Enalapril; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension; Hypertension, Renovascular; Kidney Diseases; Male; Middle Aged; Proteinuria; Time Factors | 1990 |
The safety and efficacy of quinapril in the treatment of mild to moderate essential hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Enalapril; Humans; Hypertension; Isoquinolines; Quinapril; Tetrahydroisoquinolines | 1990 |
Role of angiotensin-converting enzyme inhibitors in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Hemodynamics; Humans; Multicenter Studies as Topic; Renin-Angiotensin System | 1990 |
[Clinical pharmacology of ACE inhibitors].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Humans; Kallikreins; Kinins; Prostaglandins; Regional Blood Flow; Vascular Resistance | 1990 |
[Heart insufficiency and life expectancy--the role of ACE inhibitors].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Heart Failure; Humans; Prognosis; Randomized Controlled Trials as Topic | 1990 |
Lisinopril in the treatment of congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Double-Blind Method; Enalapril; Heart Failure; Humans; Lisinopril; Random Allocation | 1989 |
Does the duration of action of angiotensin converting enzyme inhibitors affect their safety and adverse effects?
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Hypertension; Hypotension; Isoquinolines; Kidney; Quinapril; Tetrahydroisoquinolines; Time Factors | 1989 |
Angiotensin-converting enzyme inhibitors: mechanistic controversies.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dogs; Enalapril; Heart; Hemodynamics; Humans; Kallikreins; Nervous System; Prostaglandins; Rabbits; Rats; Rats, Inbred Strains; Renin-Angiotensin System | 1989 |
The present molecules of converting enzyme inhibitors.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Bridged Bicyclo Compounds; Captopril; Cilazapril; Cyclopentanes; Dipeptides; Enalapril; Humans; Indoles; Lisinopril; Perindopril; Pyridazines; Ramipril; Renin-Angiotensin System | 1985 |
Angiotensin-converting enzyme inhibitors: are they all alike?
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Humans; Hypertension; Renin-Angiotensin System | 1987 |
Heart failure management: the impact of drug therapy on survival.
Topics: Captopril; Clinical Trials as Topic; Digitalis Glycosides; Diuretics; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Time Factors | 1988 |
Angiotensin converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Hypertension | 1988 |
[When and how to use angiotensin-converting enzyme inhibitors in heart failure].
Topics: Captopril; Enalapril; Heart Failure; Humans; Prognosis | 1987 |
Structural relationships of angiotensin converting-enzyme inhibitors to pharmacologic activity.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Humans; Structure-Activity Relationship | 1988 |
When and how to use angiotensin-converting enzyme inhibition in congestive heart failure.
Topics: Captopril; Enalapril; Heart Failure; Humans; Renin-Angiotensin System | 1988 |
ACE inhibitors--state of the art. An overview.
Topics: Captopril; Enalapril; Humans | 1988 |
[Therapy of chronic heart failure with angiotensin-converting enzyme inhibitors].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Male; Renin-Angiotensin System; Sympathetic Nervous System; Time Factors | 1988 |
[Converting enzyme inhibitors in the treatment of chronic heart insufficiency: a meta-analysis of controlled clinical trials with placebo].
Topics: Captopril; Chronic Disease; Clinical Trials as Topic; Enalapril; Evaluation Studies as Topic; Heart Failure; Humans; Multicenter Studies as Topic; Placebos; Random Allocation | 1988 |
Enalapril: a second-generation angiotensin converting enzyme inhibitor.
Topics: Captopril; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Hypertension | 1988 |
Evolution of angiotensin-converting enzyme inhibitors.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Drug Design; Enalapril; Heart Failure; Humans; Hypertension; Renin-Angiotensin System | 1988 |
[Differential therapeutic topics in antihypertensive therapy. What can angiotensin-converting enzyme inhibitors accomplish?].
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Enalapril; Humans; Hypertension; Vascular Resistance | 1988 |
[Angiotensin-converting enzyme inhibition: side effects and risks].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Hypertension; Risk Factors | 1988 |
[Renal effects of angiotensin-converting enzyme inhibitors and their therapeutic use in chronic terminal renal failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Humans; Hypertension, Renal; Hypertension, Renovascular; Kidney Failure, Chronic; Product Surveillance, Postmarketing; Renal Circulation | 1988 |
[Angioneurotic edema caused by angiotensin-converting enzyme inhibitors: incidence, clinical characteristics, mechanisms of action].
Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Hypertension | 1988 |
Angiotensin-converting enzyme inhibitors: past, present, and bright future.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Dipeptides; Drug Eruptions; Drug Interactions; Enalapril; Heart Failure; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal; Kidney Diseases; Neutropenia; Proline; Taste Disorders | 1985 |
[New trends in the treatment of moderate arterial hypertension].
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Blood Pressure; Calcium Channel Blockers; Captopril; Combined Modality Therapy; Coronary Disease; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Hypokalemia; Male; Methods; Middle Aged; Reserpine; Risk | 1986 |
ACE inhibitors--the trickle becomes a flood.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Humans; Lisinopril | 1988 |
Converting-enzyme inhibition for severe chronic heart failure: views from a skeptic.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Dipeptides; Enalapril; Heart Failure; Hemodynamics; Humans; Hyperkalemia; Hypotension; Proline; Renin-Angiotensin System; Risk; Time Factors; Vasodilator Agents | 1985 |
Clinical pharmacology and therapeutic applications of the new oral converting enzyme inhibitor, enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Dipeptides; Enalapril; Heart Failure; Hemodynamics; Humans; Hyperaldosteronism; Hypertension; Kinetics; Oligopeptides; Renin; Teprotide | 1985 |
Significance of the vascular renin-angiotensin pathway.
Topics: Angiotensin II; Animals; Blood Vessels; Captopril; Enalapril; Humans; Hypertension; Hypertension, Renovascular; Receptors, Adrenergic, beta; Renin; Renin-Angiotensin System; Vascular Resistance | 1986 |
Pharmacology of angiotensin converting enzyme inhibitors. A review.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Binding Sites; Blood Pressure; Captopril; Eating; Enalapril; Half-Life; Humans; Intestinal Absorption; Kinetics; Oligopeptides; Peptidyl-Dipeptidase A; Renin; Teprotide | 1986 |
Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Dizziness; Dose-Response Relationship, Drug; Enalapril; Half-Life; Headache; Humans; Hypertension; Kidney Diseases; Neutropenia; Oligopeptides; Skin Diseases; Sulfhydryl Compounds; Taste Disorders; Teprotide | 1986 |
Captopril and enalapril: angiotensin-converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Humans | 1987 |
Effect of converting enzyme inhibitors on hypertensive large arteries in humans.
Topics: Angiotensin-Converting Enzyme Inhibitors; Brachial Artery; Bridged Bicyclo Compounds; Captopril; Carotid Arteries; Enalapril; Humans; Hypertension; Ramipril | 1986 |
ACE-inhibitors in the treatment of elderly hypertensives.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Diuretics; Enalapril; Female; Humans; Hypertension; Male | 1987 |
Effects of converting-enzyme inhibitors on the renin-angiotensin-aldosterone, bradykinin, and arachidonic acid-prostaglandin systems: correlation of chemical structure and biologic activity.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Bradykinin; Captopril; Enalapril; Humans; Prostaglandins; Renin-Angiotensin System; Structure-Activity Relationship | 1987 |
Clinical experience with converting-enzyme inhibitors in hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Diuretics; Dose-Response Relationship, Drug; Enalapril; Humans; Hypertension; Renin-Angiotensin System | 1987 |
Adaptive and maladaptive actions of angiotensin II in patients with severe congestive heart failure.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Enalapril; Glomerular Filtration Rate; Heart Failure; Humans; Renin-Angiotensin System; Risk | 1987 |
[Therapy of severe hypertension].
Topics: Acute Disease; Calcium Channel Blockers; Captopril; Enalapril; Humans; Hypertension; Minoxidil; Prazosin | 1987 |
Advances in the medical management of renovascular hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Atenolol; Captopril; Dipeptides; Enalapril; Female; Humans; Hypertension, Renovascular; Male; Metoprolol; Middle Aged; Nadolol; Pindolol; Propanolamines; Propranolol; Renal Artery Obstruction; Renin-Angiotensin System; Saralasin; Timolol | 1984 |
Physiological and pharmacological aspects of angiotensin converting enzyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dipeptides; Enalapril; Female; Hemodynamics; Humans; Kidney; Male; Peptidyl-Dipeptidase A; Placenta; Pregnancy; Regional Blood Flow; Species Specificity; Testis | 1984 |
Enalapril worldwide experience.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Cell Count; Blood Pressure; Captopril; Dipeptides; Drug Evaluation; Drug Therapy, Combination; Enalapril; Enalaprilat; Humans; Hydrochlorothiazide; Hypertension; Peptidyl-Dipeptidase A; Posture; Propranolol; Renin-Angiotensin System | 1984 |
[Angiotensin converting enzyme inhibitors--a new group of hypotensive drugs].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Dipeptides; Drug Evaluation; Enalapril; Humans; Hypertension; Proline; Renin-Angiotensin System | 1984 |
Treatment of hypertension with angiotensin converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Dipeptides; Drug Interactions; Enalapril; Humans; Hypertension; Hypertension, Malignant; Hypertension, Renal; Kinetics; Proline | 1984 |
Current concepts in the treatment of congestive heart failure.
Topics: Calcium Channel Blockers; Captopril; Digitalis Glycosides; Dipeptides; Diuretics; Enalapril; Enzyme Inhibitors; Heart Failure; Humans; Hydralazine; Hypernatremia; Isosorbide Dinitrate; Nitroprusside; Prazosin; Vasoconstriction | 1984 |
Drugs affecting the renin-angiotensin system.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dipeptides; Enalapril; Humans; Renin; Renin-Angiotensin System; Teprotide | 1982 |
Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Captopril; Dipeptides; Enalapril; Heart Failure; Hemodynamics; Humans; Hypertension; Hypertension, Pulmonary; Kinetics; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Renin; Renin-Angiotensin System; Teprotide | 1984 |
Role of angiotensin converting enzyme inhibitors in essential and renal hypertension. Effects of captopril and enalapril on renin-angiotensin-aldosterone, renal function and hemodynamics, salt and water excretion, and body fluid composition.
Topics: Body Fluids; Captopril; Dipeptides; Drug Evaluation; Enalapril; Glomerular Filtration Rate; Hemodynamics; Humans; Hydrochlorothiazide; Hypertension; Hypertension, Renal; Potassium; Proline; Renin-Angiotensin System; Sodium; Teprotide | 1984 |
Monotherapy of hypertension with angiotensin-converting enzyme inhibitors.
Topics: Acute Kidney Injury; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Dipeptides; Enalapril; Heart Failure; Humans; Hypertension; Proline; Racial Groups; Teprotide; Time Factors | 1984 |
Inhibitors of the angiotensin I converting enzyme as antihypertensive drugs.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bradykinin; Captopril; Dipeptides; Drug Interactions; Enalapril; Hemodynamics; Humans; Kallikreins; Renin; Renin-Angiotensin System; Sympathetic Nervous System; Vasodilator Agents | 1983 |
Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enalapril; Heart Failure; Hemodynamics; Humans; Hypertension; Kinetics; Natriuresis; Renin; Vasodilator Agents | 1984 |
Angiotensin converting enzyme inhibitors in Raynaud's phenomenon.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Controlled Clinical Trials as Topic; Cross-Over Studies; Enalapril; Humans; Raynaud Disease | 1994 |
[Lisinopril in the treatment of heart insufficiency].
Topics: Captopril; Clinical Trials as Topic; Digoxin; Enalapril; Exercise Test; Heart Failure; Hemodynamics; Humans; Lisinopril; Quality of Life | 1995 |
[Role of converting enzyme inhibitors in myocardial infarction].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic | 1995 |
Optimizing the treatment of heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcium Channel Blockers; Captopril; Clinical Trials as Topic; Contraindications; Digitalis; Digoxin; Diuretics; Enalapril; Heart Failure; Humans; Hydralazine; Lisinopril; Nitrates; Plants, Medicinal; Plants, Toxic; Randomized Controlled Trials as Topic; Stroke Volume | 1994 |
Angiotensin-converting enzyme inhibitor-induced pemphigus: three case reports and literature review.
Topics: Aged; Autoantibodies; Captopril; Enalapril; Female; Humans; Male; Middle Aged; Pemphigus; Retrospective Studies; Skin | 1994 |
Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use.
Topics: Abnormalities, Drug-Induced; Animals; Blood Pressure; Captopril; Ductus Arteriosus, Patent; Enalapril; Female; Fetal Death; Fetus; Goats; Kidney; Maternal-Fetal Exchange; Oligohydramnios; Pregnancy; Rabbits; Regional Blood Flow; Renal Insufficiency; Risk Factors; Sheep; Uterus; Vascular Resistance | 1994 |
[Angiotensin converting enzyme inhibitors during acute phase of myocardial infarct].
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Enalapril; Female; Humans; Injections, Intravenous; Lisinopril; Male; Multicenter Studies as Topic; Myocardial Infarction; Nitroglycerin; Ramipril; Thrombolytic Therapy; Time Factors | 1994 |
Hepatotoxicity associated with angiotensin-converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Chemical and Drug Induced Liver Injury; Enalapril; Female; Humans; Male; Middle Aged; Time Factors | 1993 |
[The use of angiotensin-converting enzyme inhibitors in patients with ischemic heart disease].
Topics: Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Evaluation; Enalapril; Humans; Hypertension; Myocardial Ischemia | 1993 |
Angiotensin-converting enzyme inhibitors in diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Capillary Resistance; Captopril; Diabetic Nephropathies; Dipeptides; Enalapril; Humans; Hyperglycemia; Lisinopril | 1993 |
Renal functional alterations induced by angiotensin-converting enzyme inhibitors in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Hemodynamics; Humans; Kidney; Renin-Angiotensin System | 1993 |
Angiooedema and urticaria with angiotensin converting enzyme inhibitors.
Topics: Adverse Drug Reaction Reporting Systems; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Drug Monitoring; Enalapril; Humans; Lisinopril; Urticaria | 1996 |
Assessing the teratogenic potential of angiotensin-converting enzyme inhibitors in pregnancy.
Topics: Abnormalities, Drug-Induced; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Humans; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Pregnancy Trimester, Third | 1998 |
[ACE inhibitors or AT1 receptor antagonists?].
Topics: Age Factors; Aged; Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Captopril; Clinical Trials as Topic; Death, Sudden, Cardiac; Enalapril; Heart Failure; Humans; Losartan; Prodrugs; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Tetrazoles; Time Factors | 1999 |
[Nuclear medicine in the study of renovascular hypertension].
Topics: Adrenal Cortex; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Enalapril; Glomerular Filtration Rate; Humans; Hypertension, Renovascular; Juxtaglomerular Apparatus; Kidney Function Tests; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Renal Artery Obstruction; Renin-Angiotensin System; Technetium Tc 99m Pentetate; Vasoconstriction | 1999 |
Management of asymptomatic left ventricular dysfunction.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Coronary Disease; Drug Therapy, Combination; Echocardiography; Enalapril; Female; Heart Failure; Humans; Hypertension; Indoles; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Ramipril; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Ventricular Dysfunction, Left; Ventricular Function, Left | 2001 |
[Fetal angiotensin converting enzyme (ACE) inhibition renal failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Fetal Diseases; Humans; Infant, Newborn; Pregnancy; Renal Insufficiency | 2001 |
Using ACE inhibitors appropriately.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Contraindications; Diabetic Nephropathies; Drug Costs; Enalapril; Fosinopril; Heart Failure; Humans; Hypertension; Indoles; Isoquinolines; Lisinopril; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Quinapril; Ramipril; Renin-Angiotensin System; Risk; Tetrahydroisoquinolines; United States | 2002 |
[Angiotensin-converting enzyme inhibitors :from vasoactive drugs to cardiovascular prevention tools].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Drug Therapy, Combination; Enalapril; Heart Diseases; Heart Failure; Humans; Hypertension; Myocardial Infarction; Survival Rate; Treatment Outcome | 2003 |
[Preventive therapy with ACE inhibitors for coronary patients].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Coronary Disease; Death, Sudden, Cardiac; Enalapril; Humans; Indoles; Lisinopril; Myocardial Infarction; Perindopril; Ramipril; Treatment Outcome | 2004 |
[Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
Topics: Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Captopril; Cardiovascular Diseases; Enalapril; Heart Failure; Humans; Hypertension; Myocardial Infarction; Myocardial Ischemia; Renin-Angiotensin System; Ventricular Dysfunction | 2005 |
[The use of angiotensin converting enzyme inhibitors in patients after myocardial infarction].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Complications; Enalapril; Heart Failure; Humans; Indoles; Middle Aged; Myocardial Infarction; Ramipril; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Ventricular Dysfunction | 2008 |
Meta-analysis of randomized controlled trials on effect of angiotensin-converting enzyme inhibitors on cancer risk.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Enalapril; Fosinopril; Humans; Lisinopril; Neoplasms; Quinapril; Ramipril; Randomized Controlled Trials as Topic; Tetrahydroisoquinolines | 2011 |
Transdermal delivery of Angiotensin Converting Enzyme inhibitors.
Topics: Administration, Cutaneous; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Diabetic Nephropathies; Enalapril; Heart Failure; Humans; Hypertension; Indoles; Lisinopril; Perindopril; Skin | 2014 |
Could angiotensin-modulating drugs be relevant for the treatment of Trypanosoma cruzi infection? A systematic review of preclinical and clinical evidence.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Captopril; CD8-Positive T-Lymphocytes; Chagas Cardiomyopathy; Chagas Disease; Clinical Studies as Topic; Cytokines; Drug Evaluation, Preclinical; Enalapril; Humans; Losartan; Mice; Trypanosoma cruzi | 2019 |
150 trial(s) available for captopril and enalapril
| Article | Year |
|---|---|
The effect of saturation of ACE binding sites on the pharmacokinetics of enalaprilat in man.
Topics: Adult; Analysis of Variance; Binding Sites; Captopril; Double-Blind Method; Enalapril; Enalaprilat; Humans; Male; Peptidyl-Dipeptidase A; Random Allocation | 1992 |
Comparison of captopril with enalapril in the treatment of heart failure: influence on hemodynamics and measures of renal function.
Topics: Captopril; Catecholamines; Electrolytes; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Kidney; Male; Middle Aged | 1992 |
Platelet angiotensin II in cerebrovascular accident and the effect of angiotensin-converting enzyme inhibitors.
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Platelets; Captopril; Enalapril; Humans; Indans; Reference Values | 1992 |
General well-being during treatment with different ACE-inhibitors: two double-blind placebo-controlled cross-over studies in healthy volunteers.
Topics: Adult; Affect; Captopril; Cough; Double-Blind Method; Enalapril; Female; Health Status; Humans; Male; Middle Aged; Quality of Life; Surveys and Questionnaires; Time Factors | 1992 |
Effect of angiotensin converting enzyme inhibitors on erythropoietin concentrations in healthy volunteers.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Erythropoietin; Hematologic Tests; Humans; Male; Middle Aged; Renin-Angiotensin System; Single-Blind Method | 1992 |
The prevention of heart failure--a new agenda.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Enalapril; Follow-Up Studies; Heart Failure; Humans; Myocardial Infarction; Ventricular Function, Left | 1992 |
Application of ambulatory blood pressure monitoring to clinical therapeutic decisions in hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Blood Pressure Monitors; Captopril; Circadian Rhythm; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Prospective Studies | 1991 |
Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Chronic Disease; Double-Blind Method; Enalapril; Female; Heart Failure; Heart Rate; Humans; Indoles; Male; Middle Aged; Peptidyl-Dipeptidase A; Perindopril; Renin | 1991 |
Controlling hypertension: lisinopril-hydrochlorothiazide vs captopril-hydrochlorothiazide. An Italian multicentre study.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Combinations; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Italy; Lisinopril; Male; Middle Aged | 1991 |
Treating mild-to-moderate hypertension: a comparison of lisinopril-hydrochlorothiazide fixed combination with captopril and hydrochlorothiazide free combination.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged | 1991 |
[Changes in kidney function during treatment of heart failure patients with ACE inhibitors].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Hemodynamics; Humans; Kidney Function Tests; Lisinopril | 1991 |
Difference in mortality between patients treated with captopril or enalapril in the Xamoterol in Severe Heart Failure Study.
Topics: Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Captopril; Cardiomyopathy, Dilated; Cause of Death; Double-Blind Method; Drug Interactions; Enalapril; Female; Follow-Up Studies; Humans; Life Tables; Male; Middle Aged; Probability; Propanolamines; Xamoterol | 1991 |
Synergism between alpha 1-blockade and angiotensin converting enzyme inhibition in essential hypertension.
Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Doxazosin; Drug Synergism; Drug Therapy, Combination; Enalapril; Humans; Hypertension; Prazosin | 1991 |
The treatment of moderate to severe hypertension with ACE inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atenolol; Captopril; Double-Blind Method; Drug Therapy, Combination; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Multicenter Studies as Topic; Quinapril; Tetrahydroisoquinolines | 1990 |
The safety and tolerability of quinapril.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Hypertension; Hypotension; Isoquinolines; Kidney; Male; Middle Aged; Potassium; Quinapril; Tetrahydroisoquinolines | 1990 |
Enalapril in the treatment of congestive heart failure.
Topics: Captopril; Double-Blind Method; Enalapril; Heart Failure; Hemodynamics; Humans; Physical Exertion; Randomized Controlled Trials as Topic | 1990 |
Bradykinin-induced cough reflex markedly increases in patients with cough associated with captopril and enalapril.
Topics: Adult; Aerosols; Aged; Bradykinin; Captopril; Citrates; Citric Acid; Cough; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Reflex; Respiratory Function Tests; Substance P | 1991 |
Comparison of the free radical scavenging activity of captopril versus enalapril: a three month in vivo study in hypertensive diabetic patients.
Topics: Adult; Aged; Blood Proteins; Captopril; Diabetes Mellitus, Type 2; Enalapril; Female; Free Radical Scavengers; Free Radicals; Humans; Hypertension; Lipid Peroxides; Male; Middle Aged; Thiobarbiturates | 1991 |
Circadian rhythm of blood pressure in congestive heart failure and effects of ACE inhibitors.
Topics: Blood Pressure; Captopril; Circadian Rhythm; Drug Administration Schedule; Enalapril; Female; Heart Failure; Humans; Kidney; Male; Middle Aged | 1991 |
Blood pressure responses to low-dose oral ester or intravenous diacid angiotensin converting enzyme inhibitors.
Topics: Administration, Oral; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Enalapril; Humans; Hypertension; Indoles; Infusions, Intravenous; Middle Aged; Perindopril; Prodrugs | 1991 |
[Comparison of lisinopril and captopril in treatment of severe heart failure (NYHA III-IV) in high risk patients. Preliminary results of the trial].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiomyopathy, Dilated; Coronary Disease; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Kidney Function Tests; Lisinopril; Male; Middle Aged | 1991 |
Angiotensin converting enzyme inhibitors and magnesium conservation in patients with congestive cardiac failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cohort Studies; Creatine; Diuretics; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Magnesium | 1991 |
Prevention of nitrate tolerance with angiotension converting enzyme inhibitors.
Topics: Administration, Cutaneous; Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Tolerance; Enalapril; Female; Forearm; Humans; Male; Middle Aged; Nitroglycerin; Plethysmography; Vasodilation | 1991 |
Comparative study of the effects of three angiotensin converting enzyme inhibitors on the cough reflex.
Topics: Administration, Inhalation; Adult; Angiotensin-Converting Enzyme Inhibitors; Capsaicin; Captopril; Citrates; Citric Acid; Cough; Enalapril; Humans; Hypertension; Indans; Male; Middle Aged; Reference Values; Reflex | 1991 |
[Enalapril versus captopril in heart failure--effect on blood pressure and kidney function].
Topics: Blood Pressure; Captopril; Creatinine; Electrolytes; Enalapril; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Function Tests; Male; Middle Aged | 1991 |
A comparison of the efficacy of captopril and enalapril given once daily for the treatment of hypertension: a study using 24-hour ambulatory blood pressure monitoring.
Topics: Adult; Aged; Ambulatory Care; Blood Pressure; Blood Pressure Determination; Captopril; Drug Administration Schedule; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Monitoring, Physiologic | 1991 |
Effect of the circulating renin-angiotensin system on prolactin release in humans.
Topics: Adenoma; Aldosterone; Angiotensin I; Angiotensin II; Captopril; Circadian Rhythm; Enalapril; Humans; Hypertension; Prolactin; Renin; Renin-Angiotensin System; Thyrotropin-Releasing Hormone | 1990 |
ACE inhibition and pressor responsiveness to norepinephrine in hypertensive patients.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Drug Administration Schedule; Enalapril; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Norepinephrine; Random Allocation | 1990 |
Once-daily lisinopril compared with twice-daily captopril in the treatment of mild to moderate hypertension: assessment of office and ambulatory blood pressures.
Topics: Ambulatory Care; Blood Pressure; Blood Pressure Determination; Captopril; Diastole; Double-Blind Method; Drug Administration Schedule; Enalapril; Heart Rate; Humans; Hypertension; Lisinopril; Research Design; Single-Blind Method; Systole | 1990 |
Comparison of enalapril and captopril in the management of self-induced water intoxication.
Topics: Adult; Captopril; Chronic Disease; Clinical Trials as Topic; Enalapril; Humans; Male; Schizophrenia; Schizophrenic Psychology; Water Intoxication | 1990 |
Evaluation of the effect-duration of once-daily enalapril compared with once-daily captopril.
Topics: Adult; Blood Pressure; Captopril; Drug Administration Schedule; Enalapril; Humans; Hypertension; Male; Middle Aged; Random Allocation; Time Factors | 1990 |
The safety and efficacy of quinapril in the treatment of mild to moderate essential hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Enalapril; Humans; Hypertension; Isoquinolines; Quinapril; Tetrahydroisoquinolines | 1990 |
Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol.
Topics: Adult; Aged; Analysis of Variance; Atenolol; Captopril; Cognition; Double-Blind Method; Enalapril; Humans; Hypertension; Male; Middle Aged; Propranolol; Psychometrics; Quality of Life; Randomized Controlled Trials as Topic; Sexual Behavior; Sleep; Surveys and Questionnaires | 1990 |
[Comparison of enalapril and captopril in the treatment of chronic heart failure].
Topics: Blood Pressure; Captopril; Cardiac Output; Cardiomyopathy, Dilated; Coronary Disease; Enalapril; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic | 1990 |
[Effect of enalapril in patients with essential hypertension].
Topics: Adult; Aged; Captopril; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Single-Blind Method | 1990 |
Comparison of captopril and enalapril in the treatment of hypertension in patients with non-insulin dependent diabetes mellitus and nephropathy.
Topics: Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enalapril; Female; Humans; Hypertension; Male; Middle Aged | 1990 |
[24-hour blood pressure and renal function in cardiac failure during the titration phase of captopril and enalapril].
Topics: Adult; Aged; Blood Pressure; Captopril; Circadian Rhythm; Enalapril; Female; Heart Failure; Heart Rate; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; Regression Analysis | 1990 |
[Heart insufficiency and life expectancy--the role of ACE inhibitors].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Heart Failure; Humans; Prognosis; Randomized Controlled Trials as Topic | 1990 |
Hemodynamic responses to angiotensin I in normal volunteers and the antagonism by the angiotensin-converting enzyme inhibitor cilazapril.
Topics: Administration, Oral; Adolescent; Adult; Angiotensin I; Blood Pressure; Captopril; Cilazapril; Diastole; Dose-Response Relationship, Drug; Enalapril; Humans; Male; Pyridazines; Systole; Vascular Resistance | 1987 |
A double-blind comparison of lisinopril with captopril in patients with symptomatic congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Double-Blind Method; Enalapril; Female; Heart Failure; Heart Function Tests; Humans; Lisinopril; Male; Middle Aged; Physical Exertion; Random Allocation | 1987 |
Worsening of anemia by angiotensin converting enzyme inhibitors and its prevention by antiestrogenic steroid in chronic hemodialysis patients.
Topics: Androstanols; Anemia; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Erythropoiesis; Erythropoietin; Estrogen Antagonists; Humans; Kidney Failure, Chronic; Middle Aged; Renal Dialysis; Renin-Angiotensin System | 1989 |
A multicenter study of the safety and efficacy of benazepril hydrochloride, a long-acting angiotensin-converting enzyme inhibitor, in patients with chronic congestive heart failure.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Chronic Disease; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Multicenter Studies as Topic; Peptidyl-Dipeptidase A; Renin; Time Factors | 1989 |
Short- and long-acting angiotensin-converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. The Multicenter Lisinopril-Captopril Congestive Heart Failure Study Group.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Enalapril; Female; Heart Failure; Humans; Lisinopril; Male; Middle Aged; Multicenter Studies as Topic; Random Allocation | 1989 |
The assessment of ACE activity in man following angiotensin I challenges: a comparison of cilazapril, captopril and enalapril.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cilazapril; Dose-Response Relationship, Drug; Enalapril; Humans; Peptidyl-Dipeptidase A; Pyridazines; Time Factors; Vascular Resistance | 1989 |
ACE inhibitors in mild to moderate hypertension: comparison of lisinopril and captopril administered once daily. French Cooperative Study Group.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Multicenter Studies as Topic; Random Allocation | 1989 |
Lisinopril in the treatment of congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Double-Blind Method; Enalapril; Heart Failure; Humans; Lisinopril; Random Allocation | 1989 |
[Comparison of the efficacy of captopril and enalapril in single doses in the treatment of arterial hypertension. Evaluation by means of non-invasive ambulatory monitoring].
Topics: Administration, Oral; Adult; Aged; Captopril; Drug Evaluation; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Monitoring, Physiologic; Random Allocation | 1989 |
The interaction between indomethacin and captopril or enalapril in healthy volunteers.
Topics: Adult; Blood Pressure; Captopril; Clinical Trials as Topic; Drug Combinations; Drug Interactions; Enalapril; Female; Humans; Indomethacin; Male; Random Allocation | 1989 |
Therapeutic regime of enalapril maleate in Japan.
Topics: Blood Pressure; Captopril; Circadian Rhythm; Clinical Trials as Topic; Double-Blind Method; Enalapril; Humans; Hypertension; Japan | 1989 |
Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
Topics: Adult; Aldosterone; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Dipeptides; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Peptidyl-Dipeptidase A; Potassium; Proline; Renin; Sodium; Time Factors | 1985 |
Effects of acute and chronic angiotensin-converting enzyme inhibition on large arteries in human hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Arteries; Captopril; Dipeptides; Enalapril; Forearm; Heart Rate; Humans; Hypertension; Muscle, Smooth, Vascular; Potassium; Regional Blood Flow; Vascular Resistance | 1985 |
[Clinical pharmacology of a single doses of captopril and enalapril. Controlled study in subjects with essential hypertension].
Topics: Adult; Aged; Aldosterone; Blood Pressure; Captopril; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Renin; Time Factors | 1987 |
[Angiotensin-converting enzyme inhibitors in heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Enalapril; Heart Failure; Hemodynamics; Humans; Prognosis | 1987 |
Heart failure management: the impact of drug therapy on survival.
Topics: Captopril; Clinical Trials as Topic; Digitalis Glycosides; Diuretics; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Time Factors | 1988 |
[Influence of the acetylcholinesterase inhibitors enalapril and captopril on exercise tolerance in hypertensive patients].
Topics: Adult; Blood Pressure; Captopril; Clinical Trials as Topic; Double-Blind Method; Enalapril; Heart Rate; Humans; Hypertension; Male; Middle Aged; Physical Exertion | 1988 |
Enalapril versus captopril: a double-blind multicentre comparison in essential hypertension.
Topics: Blood Pressure; Captopril; Clinical Trials as Topic; Double-Blind Method; Enalapril; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Random Allocation | 1988 |
Lisinopril and captopril in the treatment of heart failure in older patients. Comparison of a long- and short-acting angiotensin-converting enzyme inhibitor.
Topics: Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Enalapril; Exercise Test; Female; Heart Failure; Humans; Lisinopril; Male; Random Allocation; Stroke Volume; Time Factors | 1988 |
[Therapy of chronic heart failure with angiotensin-converting enzyme inhibitors].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Male; Renin-Angiotensin System; Sympathetic Nervous System; Time Factors | 1988 |
[Converting enzyme inhibitors in the treatment of chronic heart insufficiency: a meta-analysis of controlled clinical trials with placebo].
Topics: Captopril; Chronic Disease; Clinical Trials as Topic; Enalapril; Evaluation Studies as Topic; Heart Failure; Humans; Multicenter Studies as Topic; Placebos; Random Allocation | 1988 |
Enalapril: a second-generation angiotensin converting enzyme inhibitor.
Topics: Captopril; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Hypertension | 1988 |
Evolution of angiotensin-converting enzyme inhibitors.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Drug Design; Enalapril; Heart Failure; Humans; Hypertension; Renin-Angiotensin System | 1988 |
[Comparison of captopril with enalapril in the therapy of heart failure: effect on hemodynamics and kidney function].
Topics: Adult; Aged; Captopril; Clinical Trials as Topic; Electrolytes; Enalapril; Epinephrine; Female; Heart Failure; Hemodynamics; Humans; Kidney Function Tests; Male; Middle Aged; Norepinephrine; Random Allocation | 1988 |
[Drug effects on myocardial oxygen consumption, systolic arterial pressure, diastolic arterial pressure and heart rate at rest and during exercise: comparison of enalapril and captopril].
Topics: Adult; Blood Pressure; Captopril; Clinical Trials as Topic; Double-Blind Method; Enalapril; Exercise Test; Humans; Hypertension; Male; Middle Aged; Myocardium; Oxygen Consumption; Rest; Time Factors | 1988 |
Angiotensin-converting-enzyme inhibitors in treatment of heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Enalapril; Heart Failure; Humans | 1985 |
Enalapril, captopril, and blood glucose.
Topics: Captopril; Enalapril; Humans; Hypoglycemia | 1986 |
[Do vasodilators help in chronic heart failure?].
Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Vasodilator Agents | 1987 |
Role of vasodilators in the treatment of congestive heart failure.
Topics: Captopril; Clinical Trials as Topic; Dipeptides; Double-Blind Method; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Prazosin; Random Allocation; Regional Blood Flow; Vascular Resistance; Vasodilator Agents | 1985 |
Converting-enzyme inhibition for severe chronic heart failure: views from a skeptic.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Dipeptides; Enalapril; Heart Failure; Hemodynamics; Humans; Hyperkalemia; Hypotension; Proline; Renin-Angiotensin System; Risk; Time Factors; Vasodilator Agents | 1985 |
A parallel study of enalapril and captopril and 1 year of experience with enalapril treatment in moderate-to-severe essential hypertension.
Topics: Blood Pressure; Captopril; Clinical Trials as Topic; Dipeptides; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Male; Methyldopa; Middle Aged; Proline; Pulse; Random Allocation | 1985 |
A comparative study of captopril and enalapril in patients with severe hypertension.
Topics: Antihypertensive Agents; Captopril; Clinical Trials as Topic; Dipeptides; Double-Blind Method; Enalapril; Humans; Hypertension; Proline; Random Allocation; Time Factors | 1985 |
Enalapril maleate versus captopril. A comparison of the hormonal and antihypertensive effects.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Enalapril; Female; Hormones; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Random Allocation | 1985 |
ACE inhibitors: enalapril and captopril compared.
Topics: Captopril; Clinical Trials as Topic; Double-Blind Method; Enalapril; Heart Failure; Humans; Hypertension | 1985 |
[Worldwide experience with enalapril].
Topics: Captopril; Clinical Trials as Topic; Drug Eruptions; Enalapril; Gout; Humans; Hypertension; Kidney Diseases; Leukocyte Count | 1985 |
Double-blind comparison of captopril and enalapril in mild to moderate hypertension.
Topics: Adult; Angiotensin II; Benzothiadiazines; Blood Pressure; Captopril; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Enalapril; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Random Allocation; Renin; Sodium Chloride Symporter Inhibitors | 1986 |
Comparison of captopril and enalapril in patients with severe chronic heart failure.
Topics: Adult; Aged; Blood Pressure; Captopril; Chronic Disease; Clinical Trials as Topic; Creatinine; Digoxin; Diuretics; Drug Therapy, Combination; Electrolytes; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Hypotension; Male; Middle Aged; Random Allocation | 1986 |
Clinical utility of angiotensin converting enzyme inhibitors in hypertension.
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Creatinine; Enalapril; Humans; Hypertension; Oligopeptides; Teprotide | 1986 |
Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Dizziness; Dose-Response Relationship, Drug; Enalapril; Half-Life; Headache; Humans; Hypertension; Kidney Diseases; Neutropenia; Oligopeptides; Skin Diseases; Sulfhydryl Compounds; Taste Disorders; Teprotide | 1986 |
An overview of angiotensin-converting enzyme inhibitors in the treatment of hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Drug Therapy, Combination; Enalapril; Humans; Hypertension | 1987 |
Different effects of two angiotensin converting enzyme inhibitors in primary hypertension--a comparison of captopril and enalapril.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Random Allocation; Renin | 1986 |
Effects of intradermal bradykinin after inhibition of angiotensin converting enzyme.
Topics: Adult; Angioedema; Bradykinin; Captopril; Dose-Response Relationship, Drug; Enalapril; Humans; Middle Aged; Skin; Time Factors | 1987 |
Inhibition of angiotensin-I response by cilazapril and its time course in normal volunteers.
Topics: Adolescent; Adult; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cilazapril; Dose-Response Relationship, Drug; Double-Blind Method; Enalapril; Humans; Male; Pyridazines; Random Allocation; Time Factors | 1987 |
Clinical experience with converting-enzyme inhibitors in hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Diuretics; Dose-Response Relationship, Drug; Enalapril; Humans; Hypertension; Renin-Angiotensin System | 1987 |
The effects of twice daily captopril and once daily enalapril on ambulatory intraarterial blood pressure in essential hypertension.
Topics: Adult; Blood Pressure; Captopril; Electrocardiography; Enalapril; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged | 1987 |
Total and split renal function in patients with renovascular hypertension: effects of angiotensin-converting enzyme inhibition.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Enalapril; Female; Heart Rate; Humans; Hypertension, Renovascular; Kidney; Kidney Function Tests; Male; Middle Aged; Renal Circulation; Sodium | 1987 |
Tolerance and safety of enalapril.
Topics: Captopril; Clinical Trials as Topic; Dipeptides; Drug Eruptions; Enalapril; Enzyme Inhibitors; Heart Failure; Humans; Hypertension; Leukocyte Count; Proteinuria; Taste; Uremia | 1984 |
Safety and efficacy of enalapril. Summing up the evidence.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Hypertension | 1983 |
The efficacy and safety of enalapril in moderate to severe essential hypertension.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Methyldopa; Middle Aged; Random Allocation; Statistics as Topic | 1984 |
Overall tolerance and safety of enalapril.
Topics: Captopril; Clinical Trials as Topic; Creatinine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enalapril; Global Health; Heart Failure; Humans; Hydrochlorothiazide; Hypertension; Kidney Diseases; Leukopenia; Skin Diseases; Taste Disorders | 1984 |
Monotherapy of hypertension with angiotensin-converting enzyme inhibitors.
Topics: Acute Kidney Injury; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Dipeptides; Enalapril; Heart Failure; Humans; Hypertension; Proline; Racial Groups; Teprotide; Time Factors | 1984 |
Hemodynamic effects of vasodilators and long-term response in heart failure.
Topics: Antihypertensive Agents; Captopril; Dipeptides; Enalapril; Exercise Test; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Minoxidil; Oxygen Consumption; Pulmonary Wedge Pressure; Stroke Volume; Vascular Resistance; Vasodilator Agents | 1984 |
Neurohormonal changes after acute myocardial infarction. Relationships with haemodynamic indices and effects of ACE inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Creatine Kinase; Double-Blind Method; Enalapril; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Neurotransmitter Agents; Stroke Volume | 1995 |
Effects of captopril and enalapril on renal function in elderly patients with chronic heart failure.
Topics: Aged; Aged, 80 and over; Captopril; Double-Blind Method; Enalapril; Glomerular Filtration Rate; Heart Failure; Humans; Hypotension; Kidney; Renal Circulation | 1995 |
Failure of protective effect of captopril and enalapril on exercise and dipyridamole-induced myocardial ischemia.
Topics: Adult; Aged; Angina Pectoris; Captopril; Cross-Over Studies; Dipyridamole; Double-Blind Method; Echocardiography; Enalapril; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Treatment Failure | 1995 |
[Comparison of the efficacy of enalapril + hydrochlorothiazide and captopril + hydrochlorothiazide combinations in mild-to-moderate arterial hypertension by ambulatory measurement of blood pressure].
Topics: Adult; Aged; Ambulatory Care; Blood Pressure Determination; Captopril; Double-Blind Method; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged | 1995 |
A comparative study of captopril and enalapril on endothelial cell function in congestive heart failure patients.
Topics: Aged; Antigens; Captopril; Double-Blind Method; Enalapril; Endothelium, Vascular; Female; Heart Failure; Humans; Male; Middle Aged; Plasminogen Inactivators; Time Factors; Tissue Plasminogen Activator | 1995 |
Effects of spirapril and captopril on regional blood flow in chronic congestive heart failure: a comparison between a short- and a long-acting angiotensin-converting enzyme inhibitor.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Circulation; Captopril; Cerebrovascular Circulation; Double-Blind Method; Enalapril; Exercise Test; Female; Heart Failure; Humans; Leg; Liver Circulation; Male; Middle Aged; Peptidyl-Dipeptidase A; Regional Blood Flow; Renal Circulation | 1995 |
[Therapy with ACE inhibitors in chronic heart failure and limited kidney function].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Blood Flow Velocity; Blood Pressure; Captopril; Creatinine; Drug Therapy, Combination; Enalapril; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Failure, Chronic; Kidney Function Tests; Lisinopril; Male; Middle Aged; Renal Circulation | 1994 |
Crossover comparison of the effects of enalapril and captopril on potassium homeostasis in patients with mild hypertension.
Topics: Aldosterone; Blood Pressure; Captopril; Circadian Rhythm; Cross-Over Studies; Drug Administration Schedule; Enalapril; Female; Homeostasis; Humans; Hypertension; Male; Middle Aged; Potassium; Sodium | 1994 |
Review of studies on the clinical pharmacodynamics of cilazapril.
Topics: Administration, Oral; Aged; Angiotensin I; Blood Pressure; Captopril; Cardiac Output; Cilazapril; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Enalapril; Female; Half-Life; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Propranolol | 1994 |
Role of ACE inhibitors in the treatment of erythrocytosis in patients with renal allograft.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Azathioprine; Captopril; Cyclosporine; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Hematocrit; Humans; Immunosuppression Therapy; Kidney Transplantation; Male; Middle Aged; Polycythemia; Postoperative Complications; Steroids; Time Factors | 1994 |
Angiotensin converting enzyme inhibitor-induced renal dysfunction: recommendations for prevention.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Creatinine; Drug Interactions; Enalapril; Guidelines as Topic; Humans; Kidney; Kidney Diseases; Prospective Studies | 1994 |
Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction.
Topics: Anesthesia; Anesthetics; Captopril; Drug Antagonism; Drug Monitoring; Enalapril; Female; Humans; Hypertension; Hypotension; Male | 1994 |
First-dose effects of enalapril 2.5 mg and captopril 6.25 mg in patients with heart failure: a double-blind, randomized, multicenter study. The Enalapril-Captopril Investigators.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Captopril; Double-Blind Method; Drug Tolerance; Enalapril; Heart Failure; Humans; Middle Aged; Peptidyl-Dipeptidase A; Safety | 1994 |
Effect of captopril and enalapril on endothelial function in hypertensive patients.
Topics: Adult; Aged; Captopril; Enalapril; Endothelium, Vascular; Female; Forearm; Hemodynamics; Humans; Hypertension; Male; Methacholine Chloride; Middle Aged; Nitric Oxide; Nitroglycerin; Regional Blood Flow; Vascular Resistance; Vasodilation | 1994 |
A comparison between enalapril and captopril on insulin sensitivity in normotensive healthy volunteers.
Topics: Adult; Captopril; Enalapril; Female; Glucose; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Single-Blind Method | 1993 |
Plasma corticotrophin releasing hormone, vasopressin, ACTH and cortisol responses to acute myocardial infarction.
Topics: Adrenocorticotropic Hormone; Angiotensin-Converting Enzyme Inhibitors; Arginine Vasopressin; Captopril; Corticotropin-Releasing Hormone; Double-Blind Method; Enalapril; Female; Humans; Hydrocortisone; Male; Myocardial Infarction | 1994 |
Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the "PRACTICAL" study).
Topics: Aged; Angiotensin II; Blood Pressure; Captopril; Cardiac Volume; Cause of Death; Double-Blind Method; Drug Tolerance; Enalapril; Female; Follow-Up Studies; Gated Blood-Pool Imaging; Humans; Male; Middle Aged; Myocardial Infarction; Placebos; Stroke Volume; Survival Rate; Ventricular Function, Left | 1994 |
The hypotensive action of captopril and enalapril is not prostacyclin dependent.
Topics: Blood Pressure; Captopril; Double-Blind Method; Enalapril; Epoprostenol; Female; Humans; Hypertension; Indomethacin; Male; Middle Aged | 1993 |
Blood pressure response to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Enalapril; Enalaprilat; Female; Heart Failure; Humans; Indoles; Male; Middle Aged; Perindopril; Prodrugs | 1993 |
Angiotensin-converting enzyme inhibitors in heart failure: blood pressure changes after the first dose.
Topics: Acetylcholinesterase; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Enalapril; Enalaprilat; Female; Heart Failure; Humans; Indoles; Male; Middle Aged; Perindopril | 1993 |
[Do ACE inhibitors help prevent heart failure? Results of 3 clinical trials].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Double-Blind Method; Enalapril; Heart Failure; Humans | 1993 |
Quality of life and antihypertensive therapy in men. A comparison of captopril with enalapril. The Quality-of-Life Hypertension Study Group.
Topics: Affective Symptoms; Aged; Captopril; Double-Blind Method; Enalapril; Humans; Hypertension; Male; Middle Aged; Psychiatric Status Rating Scales; Quality of Life; Stress, Physiological | 1993 |
A comparison of the effects of captopril and enalapril on skin responses to intradermal bradykinin and skin blood flow in the human forearm.
Topics: Adult; Bradykinin; Captopril; Double-Blind Method; Enalapril; Female; Forearm; Humans; Laser-Doppler Flowmetry; Male; Regional Blood Flow; Skin | 1993 |
Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.
Topics: Captopril; Confidence Intervals; Digoxin; Double-Blind Method; Drug Therapy, Combination; Enalapril; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Physical Endurance; Systole | 1993 |
[Therapy conversion to cilazapril in angiotensin conversion enzyme inhibitor-induced cough. Evaluation of the effect].
Topics: Adult; Aged; Captopril; Cilazapril; Cough; Dose-Response Relationship, Drug; Drug Administration Schedule; Enalapril; Female; Humans; Hypertension; Male; Middle Aged | 1993 |
High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chi-Square Distribution; Coronary Disease; Cough; Enalapril; Female; Hong Kong; Humans; Hypertension; Male; Middle Aged; New Zealand | 1995 |
Changes in red blood cell glutathione and glutathione-dependent enzymes on long-term treatment with captopril and enalapril.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Enalapril; Erythrocytes; Female; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Humans; Hypertension; Lipid Peroxidation; Lipids; Male; Middle Aged; Reference Values | 1995 |
Calcium channel blockers versus ACE inhibitors as antihypertensives in polycystic kidney disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Captopril; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Nicardipine; Nifedipine; Polycystic Kidney Diseases | 1996 |
Erythrocyte Na+, K+ and Ca2+, Mg(2+)-ATPase activities in hypertensives on angiotensin-converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Ca(2+) Mg(2+)-ATPase; Captopril; Enalapril; Erythrocyte Membrane; Female; Humans; Hypertension; Longitudinal Studies; Male; Middle Aged; Sodium-Potassium-Exchanging ATPase | 1996 |
Comparison of captopril-thiazide and enalapril-thiazide combinations in the management of mild to moderate black hypertensive patients: how important is diuretic dose and duration of action of the ACE-inhibitor?
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzothiadiazines; Black People; Blood Pressure; Body Weight; Captopril; Diuretics; Double-Blind Method; Drug Combinations; Echocardiography; Echocardiography, Doppler; Enalapril; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Time Factors; Ventricular Function, Left | 1996 |
An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Blood Pressure; Captopril; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Indoles; Male; Middle Aged; Perindopril; Potassium; Retrospective Studies; Therapeutic Equivalency | 1995 |
The alterations in insulin sensitivity during angiotensin converting enzyme inhibitor treatment are related to changes in the calcium/magnesium balance.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium; Captopril; Double-Blind Method; Enalapril; Female; Fosinopril; Humans; Hypertension; Insulin; Lisinopril; Magnesium; Male; Middle Aged | 1997 |
ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Diastole; Drug Tolerance; Enalapril; Female; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Single-Blind Method; Systole; Ventricular Function, Left | 1997 |
Comparison of enalapril to captopril by 24-hour ambulatory blood pressure monitoring.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure Monitoring, Ambulatory; Captopril; Enalapril; Humans; Hypertension; Middle Aged | 1997 |
Vasodilation by urapidil in the treatment of chronic congestive heart failure in addition to angiotensin-converting enzyme inhibitors is not beneficial: results of a placebo-controlled, double-blind study.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Enalapril; Exercise Tolerance; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Odds Ratio; Oxygen Consumption; Piperazines; Quality of Life; Survival Analysis; Vasodilation; Vasodilator Agents | 1997 |
Effect of ACE inhibition by benazepril, enalapril and captopril on chronic and post exercise proteinuria.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Chronic Disease; Diabetes Mellitus, Type 2; Enalapril; Exercise; Female; Glomerulonephritis; Humans; Male; Proteinuria | 1996 |
Clinical and neurohumoral differences between spirapril and captopril in mild to moderate chronic congestive heart failure.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Enalapril; Exercise; Female; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Peptidyl-Dipeptidase A; Renin | 1997 |
Effects of captopril and enalapril on zinc metabolism in hypertensive patients.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Enalapril; Female; Humans; Hypertension; Male; Monocytes; Prospective Studies; Zinc | 1998 |
[Clinical course of patients treated with partial left ventriculectomy].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiac Surgical Procedures; Enalapril; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Terminally Ill | 1997 |
A long-term comparison between enalapril and captopril on insulin sensitivity in normotensive non-insulin dependent diabetic volunteers.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Captopril; Cross-Over Studies; Diabetes Mellitus, Type 2; Enalapril; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipoproteins; Male; Middle Aged; Single-Blind Method; Time Factors | 1997 |
[Evaluation of captopril-enalapril replacement therapy in hypertensive patients under ambulatory blood pressure monitoring].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Captopril; Dose-Response Relationship, Drug; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Patient Compliance | 1996 |
Prevention of events with angiotensin-converting enzyme inhibition (the PEACE study design). Prevention of Events with Angiotensin-Converting Enzyme Inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Coronary Angiography; Coronary Disease; Double-Blind Method; Echocardiography; Enalapril; Female; Follow-Up Studies; Humans; Male; Middle Aged; Safety; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 1998 |
Selenium-dependent GSH-Px in erythrocytes of patients with hypertension treated with ACE inhibitors.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Enalapril; Erythrocytes; Female; Glutathione Peroxidase; Humans; Hypertension; Male; Middle Aged; Selenium; Superoxide Dismutase | 1998 |
Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Coronary Disease; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Israel; Male; Middle Aged; Platelet Aggregation Inhibitors; Registries; Risk Factors; Survival Rate | 1999 |
Effects of captopril and enalapril on electroencephalogram and cognitive performance in healthy volunteers.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Cognition; Cross-Over Studies; Double-Blind Method; Electroencephalography; Enalapril; Humans; Male; Quality of Life | 1999 |
Prostacyclin: its pathogenic role in essential hypertension and the class effect of ACE inhibitors on prostaglandin metabolism.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Case-Control Studies; Enalapril; Epoprostenol; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Prostaglandins; Ramipril | 1999 |
Amlodipine is comparable to angiotensin-converting enzyme inhibitor for long-term renoprotection in hypertensive patients with renal dysfunction: a one-year, prospective, randomized study.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Captopril; Chronic Disease; Enalapril; Female; Glomerulonephritis; Humans; Hypertension; Kidney; Male; Middle Aged; Prospective Studies; Time Factors | 2000 |
Exercise-induced ventricular arrhythmias in congestive heart failure and role of ACE inhibitors.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Exercise Test; Exercise Tolerance; Female; Heart Failure; Humans; Male; Middle Aged; Physical Endurance; Prospective Studies; Reference Values; Tachycardia, Ventricular | 1998 |
Perioperative administration of angiotensin converting enzyme inhibitors decreases the severity and duration of pleural effusions following bidirectional cavopulmonary anastomosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Child, Preschool; Controlled Clinical Trials as Topic; Enalapril; Female; Heart Bypass, Right; Humans; Infant; Male; Pleural Effusion | 2001 |
Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Enalapril; Humans; Middle Aged; Peptidyl-Dipeptidase A; Renin; Time Factors | 2000 |
Pharmacokinetic and pharmacodynamic comparative study of zofenopril and enalapril in healthy volunteers.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Area Under Curve; Biotransformation; Blood Pressure; Captopril; Chromatography, High Pressure Liquid; Enalapril; Female; Heart Rate; Humans; Male; Peptidyl-Dipeptidase A | 2002 |
Long-term survival of non-elderly patients with severe heart failure treated with angiotensin-converting enzyme inhibitors assessment of treatment with captopril and enalapril survival study (ACESS).
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cause of Death; Dose-Response Relationship, Drug; Drug Evaluation; Enalapril; Female; Heart Failure; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Survival Analysis; Survivors; Treatment Outcome | 2002 |
Prospective evaluation comparing the effects of enalapril and losartan in left ventricular remodeling after acute myocardial infarction.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Radionuclide Ventriculography; Stroke Volume; Ventricular Function, Left; Ventricular Remodeling | 2003 |
Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Captopril; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Kidney; Lisinopril; Male; Middle Aged; Tetrazoles; Treatment Outcome | 2003 |
Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Arginine; Captopril; Enalapril; Female; Humans; Hypertension; Lipid Peroxidation; Lipoproteins, LDL; Male; Middle Aged; Nitrates; Nitric Oxide; Nitrites; Oxidative Stress | 2004 |
[Comparative efficacy of fixed dose combinations of enalapril with hydrochlorothiazide and captopril with hydrochlorothiazide in patients with high risk hypertension].
Topics: Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cost-Benefit Analysis; Diuretics; Drug Combinations; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Time Factors; Treatment Outcome | 2005 |
Urinary TGF-beta1 reduction related to a decrease of systolic blood pressure in patients with type 2 diabetes and clinical diabetic nephropathy.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Captopril; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Potassium; Propranolol; Ramipril; Transforming Growth Factor beta1 | 2006 |
An evaluation of the initial and long-term antihypertensive efficacy of zofenopril compared with enalapril in mild to moderate hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Male; Middle Aged | 2007 |
Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Carotid Arteries; Carotid Stenosis; Dinoprost; Enalapril; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Tunica Intima; Tunica Media; Ultrasonography | 2008 |
Effects of ACE inhibition on circulating endothelial progenitor cells, vascular damage, and oxidative stress in hypertensive patients.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Carotid Arteries; Cell Count; Cell Movement; Cells, Cultured; Enalapril; Endothelial Cells; Follow-Up Studies; Humans; Hypertension; Isoprostanes; Middle Aged; Nitrates; Nitrites; Regression Analysis; Stem Cells; Treatment Outcome; Tunica Intima; Ultrasonography | 2011 |
560 other study(ies) available for captopril and enalapril
| Article | Year |
|---|---|
Angiotensin converting enzyme inhibitors. 10. Aryl sulfonamide substituted N-[1-carboxy-3-phenylpropyl]-L-alanyl-L-proline derivatives as novel antihypertensives.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzothiadiazines; Dipeptides; Diuretics; Drug Design; Enalaprilat; Male; Rats; Sodium Chloride Symporter Inhibitors | 1990 |
Angiotensin-converting enzyme inhibitors. 9. Novel [[N-(1-carboxy-3-phenylpropyl)amino]acyl]glycine derivatives with diuretic activity.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diuretics; Drug Design; Glycine; Male; Propylamines; Rats; Rats, Inbred SHR | 1990 |
Angiotensin converting enzyme inhibitors: spirapril and related compounds.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Chemical Phenomena; Chemistry; Dogs; Enalapril; Male; Phenylbutyrates; Rats; Rats, Inbred Strains; Spiro Compounds | 1989 |
Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Enalapril; Enalaprilat; Kinetics; Male; Phosphinic Acids; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1988 |
Angiotensin-converting enzyme inhibitors. New orally active antihypertensive (mercaptoalkanoyl)- and [(acylthio)alkanoyl]glycine derivatives.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Glycine; Male; Rats; Rats, Inbred SHR; Structure-Activity Relationship; Sulfhydryl Compounds; Sulfides | 1985 |
Synthesis and biological activity of modified peptide inhibitors of angiotensin-converting enzyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Chemical Phenomena; Chemistry; Dipeptides; Enalapril; Guinea Pigs; Hypertension, Renal; Indoles; Isoquinolines; Quinapril; Rats; Structure-Activity Relationship; Tetrahydroisoquinolines | 1985 |
Angiotensin converting enzyme inhibitors: structure-activity profile of 1-benzazepin-2-one derivatives.
Topics: Amino Acids; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Chemical Phenomena; Chemistry; Dogs; Hypertension; Rats; Rats, Inbred SHR; Structure-Activity Relationship | 1985 |
Angiotensin-converting enzyme inhibitors: new orally active 1,4-thiazepine-2,5-diones, 1,4-thiazine-2,5-diones, and 1,4-benzothiazepine-2,5-diones possessing antihypertensive activity.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Magnetic Resonance Spectroscopy; Mathematics; Rats; Structure-Activity Relationship; Thiazepines; Thiazines | 1986 |
Synthesis of novel angiotensin converting enzyme inhibitor quinapril and related compounds. A divergence of structure-activity relationships for non-sulfhydryl and sulfhydryl types.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Isoquinolines; Male; Molecular Conformation; Quinapril; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Sulfhydryl Compounds; Tetrahydroisoquinolines | 1986 |
Synthesis and structure-activity relationships of potent new angiotensin converting enzyme inhibitors containing saturated bicyclic amino acids.
Topics: Amino Acids; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Enzyme Inhibitors; Male; Rats; Rats, Inbred Strains; Stereoisomerism; Structure-Activity Relationship | 1987 |
(Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme (ACE). 1. Discovery of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L -proline a novel orally active inhibitor of ACE.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Indicators and Reagents; Lung; Magnetic Resonance Spectroscopy; Male; Optical Rotation; Organophosphorus Compounds; Proline; Rabbits; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1988 |
Proton-coupled oligopeptide transport by rat renal cortical brush border membrane vesicles: a functional analysis using ACE inhibitors to determine the isoform of the transporter.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Transport; Captopril; Carrier Proteins; Dipeptides; Enalapril; Kidney Cortex; Kinetics; Microvilli; Peptide Transporter 1; Rats; Symporters | 1998 |
Heterologous expression and functional characterization of a mouse renal organic anion transporter in mammalian cells.
Topics: Animals; Anion Transport Proteins; Biological Transport; Carrier Proteins; COS Cells; Glycosylation; Histidine; In Situ Hybridization; Kidney; Kinetics; Mice; p-Aminohippuric Acid; Probenecid; Protein Processing, Post-Translational; Renal Agents; Substrate Specificity; Tunicamycin | 1999 |
Interaction of digoxin with antihypertensive drugs via MDR1.
Topics: Animals; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Digoxin; Drug Interactions; Humans; Time Factors | 2002 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Inhibitors of bacterial N-succinyl-L,L-diaminopimelic acid desuccinylase (DapE) and demonstration of in vitro antimicrobial activity.
Topics: Amidohydrolases; Amino Acid Sequence; Anti-Bacterial Agents; Binding Sites; Diaminopimelic Acid; Enzyme Inhibitors; Escherichia coli; Haemophilus influenzae; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Substrate Specificity | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Effects of long-term administration of (4S)-1-methyl-3-[(2S)-2-[N-((1S)-1-ethoxycarbonyl-3- phenylpropyl)amino]propionyl]-2-oxoimidazolidine-4-carboxylic acid hydrochloride (TA-6366), a new angiotensin I converting enzyme (ACE) inhibitor, from the pre-hyp
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Body Weight; Captopril; Cardiomegaly; Dose-Response Relationship, Drug; Enalapril; Imidazoles; Imidazolidines; Male; Muscle Contraction; Muscle, Smooth, Vascular; Organ Size; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sodium | 1992 |
Angioedema after substituting lisinopril for captopril.
Topics: Adult; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Hypersensitivity; Enalapril; Humans; Lisinopril; Male | 1992 |
[Angioneurotic edema caused by angiotensin-converting enzyme inhibitors].
Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Captopril; Complement C1 Inactivator Proteins; Enalapril; Epinephrine; Glucocorticoids; Histamine Antagonists; Humans; Lisinopril; Time Factors | 1992 |
Increased vascular formation of angiotensin II in one-kidney, one clip hypertension.
Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Blood Vessels; Captopril; Enalapril; Hypertension, Renovascular; In Vitro Techniques; Male; Mesenteric Arteries; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Strains; Reference Values; Saralasin | 1992 |
The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Captopril; Chlorides; CHO Cells; Cricetinae; Enalapril; Enalaprilat; Humans; Indoles; Kinetics; Lisinopril; Mutation; Peptidyl-Dipeptidase A | 1992 |
Captopril administered every three hours in difficult-to-control hypertension.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Administration Schedule; Enalapril; Humans; Hypertension, Renovascular; Lisinopril; Male | 1992 |
[Angiotensin-converting enzyme inhibitors as neutralizers of hydroxyl radical].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Edetic Acid; Enalapril; Free Radical Scavengers; Hydroxides; Hydroxyl Radical; Lisinopril | 1992 |
Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure.
Topics: Angiotensinogen; Animals; Blood Pressure; Captopril; Enalapril; Heart Failure; Kidney; Male; Natriuresis; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; RNA, Messenger; Time Factors | 1992 |
Pretreatment with captopril improves myocardial recovery after cardioplegic arrest.
Topics: Animals; Captopril; Coronary Circulation; Coronary Disease; Diastole; Enalapril; Heart; Heart Arrest, Induced; Male; Myocardial Reperfusion Injury; Rats; Rats, Inbred Strains; Time Factors; Ventricular Function, Left | 1992 |
Choice of ACE inhibitor for congestive heart failure.
Topics: Captopril; Dose-Response Relationship, Drug; Enalapril; Heart Failure; Humans | 1992 |
Enalapril: a powerful in vitro non-thiol acantholytic agent.
Topics: Acantholysis; Captopril; Culture Techniques; Enalapril; Female; Humans; Immunoglobulin G; Penicillamine; Skin; Time Factors; Tiopronin; Tissue Survival | 1992 |
[Long-term treatment of hypertensive patients with captopril, enalapril and prazosin].
Topics: Adult; Captopril; Enalapril; Female; Heart; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Prazosin; Time Factors | 1992 |
[Effects of treatment of arrhythmias requiring therapy in dilated cardiomyopathy with amiodarone on alpha human atrial natriuretic peptide].
Topics: Aged; Aldosterone; Amiodarone; Arginine Vasopressin; Arrhythmias, Cardiac; Atrial Natriuretic Factor; Captopril; Cardiomyopathy, Dilated; Drug Therapy, Combination; Electrocardiography, Ambulatory; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Longitudinal Studies; Male; Middle Aged | 1992 |
Complete spontaneous remission of cough induced by ACE inhibitors during chronic therapy in hypertensive patients.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cough; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Remission, Spontaneous | 1992 |
Comparison of effects of enalapril and captopril on serum potassium concentration in the treatment of malignant hypertension.
Topics: Adult; Analysis of Variance; Blood Pressure; Captopril; Creatinine; Enalapril; Female; Humans; Hypertension, Malignant; Male; Middle Aged; Potassium; Retrospective Studies | 1992 |
Comparison of withdrawing antihypertensive therapy between diuretics and angiotensin converting enzyme inhibitors in essential hypertensives.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diuretics; Drug Therapy, Combination; Enalapril; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Potassium; Renin; Treatment Outcome; Uric Acid | 1992 |
[Acute angioneurotic edema due to ACE inhibitors].
Topics: Acute Disease; Adult; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Humans; Male | 1992 |
The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.
Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Captopril; Decerebrate State; Enalapril; Imidazoles; Losartan; Male; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Receptors, Angiotensin; Spinal Cord; Tetrazoles; Thiophenes | 1992 |
The effects of angiotensin converting enzyme inhibitors and the role of the renin-angiotensin-aldosterone system in J-2-N cardiomyopathic hamsters.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomyopathies; Creatine Kinase; Cricetinae; Electrocardiography; Enalapril; Fructose-Bisphosphate Aldolase; Heart Ventricles; Kallikrein-Kinin System; Male; Malondialdehyde; Mesocricetus; Myosins; Renin-Angiotensin System | 1992 |
Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors.
Topics: Adult; Aged; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Humans; Male; Middle Aged; Prognosis; Time Factors | 1992 |
Anaphylactoid reactions during hemodialysis and hemofiltration: role of associating AN69 membrane and angiotensin I-converting enzyme inhibitors.
Topics: Acrylic Resins; Acrylonitrile; Adult; Anaphylaxis; Captopril; Enalapril; Hemofiltration; Humans; Male; Membranes, Artificial; Middle Aged; Renal Dialysis | 1992 |
Cough and converting enzyme inhibitors.
Topics: Adolescent; Captopril; Child; Cough; Enalapril; Female; Humans; Infant; Male | 1992 |
Suspected cross-reactivity of enalapril- and captopril-induced hepatotoxicity.
Topics: Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Captopril; Chemical and Drug Induced Liver Injury; Enalapril; Humans; Liver Diseases; Male; Middle Aged | 1992 |
Spontaneous disappearance of cough induced by angiotensin-converting enzyme inhibitors (captopril or enalapril).
Topics: Aged; Captopril; Cough; Enalapril; Female; Humans; Male; Middle Aged; Remission, Spontaneous | 1992 |
Effects of angiotensin II and angiotensin converting enzyme inhibitors on contractile and growth responses in isolated carotid arteries of the rat.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Carotid Arteries; DNA; Enalapril; In Vitro Techniques; Lisinopril; Male; Rats; Rats, Inbred WKY; Vasoconstriction | 1991 |
[Are the radical scavenging properties of ACE inhibitors with sulfhydryl groups in therapeutically effective concentrations of quantitative significance?].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bridged Bicyclo Compounds; Captopril; Coronary Disease; Dose-Response Relationship, Drug; Enalapril; Guinea Pigs; Hemodynamics; Hydroxides; Hydroxyl Radical; Luminescent Measurements; Myocardial Reperfusion Injury; Pyrroles; Ramipril; Sulfhydryl Reagents; Uric Acid | 1991 |
Effect of angiotensin converting enzyme inhibition on the incidence of restenosis after percutaneous transluminal coronary angioplasty.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Captopril; Combined Modality Therapy; Coronary Disease; Enalapril; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Lisinopril; Male; Middle Aged; Recurrence | 1991 |
Effect of angiotensin-converting enzyme inhibitors on glomerular eicosanoid production in normotensive and spontaneously hypertensive rats.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Culture Techniques; Dinoprostone; Eicosanoids; Enalapril; Fosinopril; Hypertension; Kidney Glomerulus; Male; Proline; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Thromboxane A2 | 1991 |
[Synthesis of angiotensin converting enzyme inhibitors containing residues of substituted quinolines and a study of their biological activity].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Captopril; Enalapril; Peptidyl-Dipeptidase A; Quinolines; Rats | 1991 |
Characterisation of [3H]ceranapril recognition sites in rat and human brain tissue.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Brain; Captopril; Enalapril; Female; Fosinopril; Humans; Kinetics; Lisinopril; Male; Middle Aged; Organophosphorus Compounds; Proline; Rats; Thiorphan | 1991 |
Hypotensive effects of angiotensin II analogues and angiotensin converting enzyme inhibitors in water-deprived Brattleboro rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Captopril; Enalapril; Heart Rate; Lisinopril; Male; Rats; Rats, Brattleboro; Saralasin; Water Deprivation | 1990 |
Hemodynamic effects of bradykinin on systemic and pulmonary circulation in healthy and hypertensive humans.
Topics: Adult; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bradykinin; Captopril; Cardiac Output; Enalapril; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Lisinopril; Male; Middle Aged; Pulmonary Circulation; Vascular Resistance | 1990 |
A sensitive two-site sandwich enzyme immunoassay for human angiotensin converting enzyme utilizing monoclonal antibodies.
Topics: Animals; Antibodies, Monoclonal; Captopril; Cattle; Cross Reactions; Dose-Response Relationship, Immunologic; Enalapril; Epitopes; Humans; Immunoenzyme Techniques; Lisinopril; Peptidyl-Dipeptidase A; Protein Denaturation | 1990 |
Molecular heterogeneity of angiotensin converting enzyme in human cerebrospinal fluid.
Topics: Amino Acid Sequence; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chlorides; Chromatography, High Pressure Liquid; Enalapril; Enkephalin, Leucine; Humans; Molecular Sequence Data; Molecular Weight; Neurokinin A; Peptidyl-Dipeptidase A; Radioimmunoassay; Substance P | 1991 |
Angiotensin converting enzyme inhibition in heart, kidney, and serum studied ex vivo after administration of zofenopril, captopril, and lisinopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Autoradiography; Captopril; Enalapril; Iodine Radioisotopes; Kidney; Lisinopril; Male; Myocardium; Oxidation-Reduction; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Strains | 1991 |
[Converting enzyme inhibitors in preterminal renal failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Creatinine; Enalapril; Humans; Hypertension; Kidney; Kidney Failure, Chronic; Male; Middle Aged | 1992 |
Protective effect of ACE- and kininase-inhibitor on the onset of cardiomyopathy.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomyopathies; Cholinesterase Inhibitors; Cricetinae; Enalapril; Mesocricetus; Prostaglandins | 1991 |
Factors affecting the regional haemodynamic responses to glyceryl trinitrate and molsidomine in conscious rats.
Topics: Animals; Arginine; Blood Pressure; Captopril; Enalapril; Heart Rate; Hemodynamics; Hindlimb; Male; Molsidomine; NG-Nitroarginine Methyl Ester; Nitroglycerin; Rats; Regional Blood Flow; Renal Circulation; Renin-Angiotensin System; Splanchnic Circulation; Vasodilation | 1991 |
The potentiation of cardiodepressant and hypotensive effects of bradykinin by enalapril and captopril both in vitro and in vivo.
Topics: Anesthesia; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Bradykinin; Captopril; Dose-Response Relationship, Drug; Drug Synergism; Enalapril; Female; Guinea Pigs; Heart Rate; In Vitro Techniques; Isometric Contraction; Male | 1991 |
Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Disease Models, Animal; Enalapril; Heart; Heart Rate; Isoproterenol; Male; Myocardial Infarction; Myocardium; Rats; Rats, Inbred Strains | 1991 |
Local generation of angiotensin II as a mechanism of aldosterone secretion in rat adrenal capsules.
Topics: Adrenal Glands; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Female; In Vitro Techniques; Lisinopril; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Strains | 1991 |
Dosage of ACE inhibitors.
Topics: Captopril; Drug Therapy, Combination; Enalapril; Humans; Hypertension | 1991 |
Response of urinary angiotensin to challenges of the renin-angiotensin system.
Topics: Adult; Angiotensin I; Angiotensin II; Captopril; Enalapril; Female; Furosemide; Humans; Immersion; Indomethacin; Male; Renin; Renin-Angiotensin System; Sodium, Dietary | 1991 |
Influence of vasoactive substances on uremic bleeding in rats.
Topics: 4-Aminobenzoic Acid; Angiotensin II; Animals; Bleeding Time; Blood Coagulation; Captopril; Chlorisondamine; Enalapril; Female; Fibronectins; Histamine; Nephrectomy; para-Aminobenzoates; Platelet Aggregation; Rats; Rats, Inbred Strains; Uremia; Ureteral Obstruction; Vasopressins | 1991 |
[Dry cough in the elderly patients treated with angiotensin converting enzyme inhibitor].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cough; Enalapril; Female; Heart Failure; Humans; Hypertension; Indans; Male; Smoking; Surveys and Questionnaires | 1991 |
Antihypertensive action of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride in hypertensive rat models.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzazepines; Captopril; Desoxycorticosterone; Enalapril; Hypertension; Hypertension, Renovascular; Male; Rats; Rats, Inbred SHR; Rats, Inbred Strains | 1991 |
Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hypotensive effect.
Topics: Administration, Oral; Animals; Blood Pressure; Brain; Captopril; Cerebrovascular Disorders; Enalapril; Heart; Hypertension; Hypotension; Kidney; Male; Myocardium; Potassium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; Risk Factors; Sodium | 1991 |
Hypoglycemia associated with the administration of angiotensin-converting enzyme inhibitor in a diabetic hemodialysis patient.
Topics: Adult; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Enalapril; Humans; Hypertension; Hypoglycemia; Male; Nifedipine | 1991 |
Angiotensin-converting enzyme inhibition reduces neuroblastoma cell growth rate.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cell Count; Cell Division; DNA Replication; Dose-Response Relationship, Drug; Enalapril; Humans; Insulin; Neuroblastoma; Renin-Angiotensin System; Saralasin | 1991 |
Angiotensin converting enzyme inhibitors suppress the vascular renin-angiotensin system of spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Indans; Male; Mesenteric Arteries; Rats; Rats, Inbred SHR; Renin-Angiotensin System | 1991 |
[Cough caused by angiotensin-converting enzyme inhibitors. A series of cases collected by spontaneous notification of adverse reactions].
Topics: Aged; Captopril; Cough; Enalapril; Humans; Middle Aged; Product Surveillance, Postmarketing | 1991 |
Ambulatory blood pressure monitoring for the evaluation of once-daily ACE inhibition: a comparison study of captopril and enalapril combined with hydrochlorothiazide.
Topics: Adolescent; Adult; Aged; Blood Pressure; Captopril; Drug Administration Schedule; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Male; Middle Aged; Monitoring, Physiologic | 1991 |
Tissue distribution of neutral endopeptidase 24.11 ('enkephalinase') activity in guinea pig trachea.
Topics: Animals; Bacitracin; Captopril; Enalapril; Epithelium; Female; Glycopeptides; Guinea Pigs; Immunohistochemistry; Neprilysin; Thiorphan; Trachea | 1991 |
Angiotensin-converting inhibitors in patients with congestive heart failure: a class effect?
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans | 1991 |
Antihypertensive effect of captopril and enalapril in endothelin-infused rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Enalapril; Endothelins; Male; Natriuresis; Rats; Rats, Inbred Strains | 1991 |
Congestive heart failure and converting enzyme inhibition: failure of current prognostic criteria for predicting subsequent renal insufficiency.
Topics: Aged; Captopril; Contraindications; Enalapril; Female; Heart Failure; Humans; Kidney Diseases; Male; Middle Aged | 1991 |
Angiotensin converting enzyme inhibition reduces proteinuria in Nigerians with chronic renal disease.
Topics: Adult; Captopril; Chronic Disease; Enalapril; Female; Humans; Kidney Failure, Chronic; Male; Nigeria; Proteinuria | 1990 |
Angiotensin-converting enzyme inhibitor induced angioedema of the head and neck.
Topics: Adrenal Cortex Hormones; Aged; Angioedema; Captopril; Diphenhydramine; Enalapril; Female; Humans; Laryngeal Diseases; Male; Middle Aged; Mouth Diseases | 1990 |
Hypotensive and hemodynamic effects of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Desoxycorticosterone; Dipeptides; Enalapril; Hemodynamics; Hypertension; Hypertension, Renal; Injections, Intravenous; Male; Nephrectomy; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1990 |
Angioedema related to angiotensin-converting enzyme inhibitors.
Topics: Aged; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Humans; Male; Middle Aged | 1990 |
Hypoglycemia induced by angiotensin-converting enzyme inhibitors in patients with non-insulin-dependent diabetes receiving sulfonylurea therapy.
Topics: Captopril; Diabetes Mellitus, Type 2; Enalapril; Glyburide; Humans; Hypertension; Hypoglycemia; Male; Middle Aged | 1990 |
Nootropic effects of ACE inhibitors in mice.
Topics: Adrenalectomy; Amnesia; Angiotensin-Converting Enzyme Inhibitors; Animals; Avoidance Learning; Behavior, Animal; Captopril; Cognition; Electroshock; Enalapril; Learning; Male; Memory; Mice; Mice, Inbred Strains; Piracetam; Psychotropic Drugs; Receptors, Glucocorticoid; Receptors, Mineralocorticoid | 1990 |
Effects of chronic converting enzyme inhibition on the vascular renin-angiotensin system.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Captopril; Cilazapril; Enalapril; Male; Mesenteric Arteries; Perfusion; Pyridazines; Ramipril; Rats; Rats, Inbred Strains; Renin; Renin-Angiotensin System; Thiazepines | 1990 |
Long- versus short-acting angiotensin-converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Lisinopril | 1990 |
Converting enzyme inhibition and vascular prostacyclin synthesis: effect of kinin receptor antagonism.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Captopril; Eicosanoids; Enalapril; Epoprostenol; Female; In Vitro Techniques; Lisinopril; Muscle, Smooth; Rats; Rats, Inbred Strains; Receptors, Bradykinin; Receptors, Neurotransmitter | 1990 |
Synthesis and angiotensin converting enzyme inhibitory activity of N-carboxymethyldipeptides with omega-(4-piperidyl)alkyl group.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Chemical Phenomena; Chemistry; Dipeptides; Enalapril; Enalaprilat; In Vitro Techniques; Lung; Male; Piperidines; Rabbits; Rats; Rats, Inbred WKY | 1990 |
The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition.
Topics: Adrenal Glands; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Pressure; Captopril; Enalapril; Gene Expression Regulation; Heart; Hydralazine; Hypertension; Isoquinolines; Kidney; Lisinopril; Male; Quinapril; Rats; Rats, Inbred SHR; Renin; Renin-Angiotensin System; RNA, Messenger; Tetrahydroisoquinolines | 1990 |
Mortality associated with captopril and enalapril: a report from the DHSS Hypertension Care Computing Project.
Topics: Acute Kidney Injury; Captopril; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Product Surveillance, Postmarketing; Survival Rate; United Kingdom | 1990 |
Effect of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, on the activity of angiotensin converting enzyme from human kidney.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Enalaprilat; Humans; Kidney; Kinetics; Organophosphorus Compounds; Peptidyl-Dipeptidase A; Proline; Protease Inhibitors | 1990 |
Pharmacological properties of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Captopril; Dipeptides; Enalapril; Enalaprilat; Guinea Pigs; In Vitro Techniques; Lung; Male; Muscle Contraction; Muscle, Smooth; Peptidyl-Dipeptidase A; Rabbits; Rats; Rats, Inbred WKY | 1990 |
Regional haemodynamic effects of captopril, enalaprilat and lisinopril in conscious water-replete and water-deprived Brattleboro rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Enalapril; Enalaprilat; Heart Rate; Hemodynamics; Lisinopril; Male; Rats; Rats, Brattleboro; Regional Blood Flow; Water Deprivation | 1990 |
[Inhibitors of angiotensin-converting enzyme in cardiac insufficiency].
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Drug Synergism; Enalapril; Humans; Hypertension; Lisinopril | 1990 |
[The value of lysinopril in cardiac insufficiency].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Lisinopril | 1990 |
Reduction of albuminuria after angiotensin converting enzyme inhibition in various renal disorders.
Topics: Adolescent; Adult; Aged; Albuminuria; Blood Pressure; Captopril; Child; Creatinine; Enalapril; Female; Follow-Up Studies; Humans; Hypertension, Renal; Male; Middle Aged; Proteinuria; Serum Albumin | 1990 |
Captopril versus enalapril: cough versus pancreatitis.
Topics: Aged; Captopril; Cough; Enalapril; Female; Humans; Pancreatitis | 1990 |
Synthesis and pharmacological screening of new angiotensin converting enzyme inhibitors.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Availability; Blood Pressure; Bradykinin; Captopril; Chemical Phenomena; Chemistry; Enalapril; Guinea Pigs; Ileum; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Rats; Rats, Inbred Strains | 1990 |
[Do we need more ACE inhibitors?].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Humans; Hypertension; Male | 1990 |
[Therapeutic drug monitoring of inhibitors of renin-angiotensin system].
Topics: Aging; Angiotensin-Converting Enzyme Inhibitors; Biological Availability; Captopril; Enalapril; Humans; Radioligand Assay; Saralasin | 1990 |
[Angioneurotic edema of the tongue, induced by administration of ACE inhibitors].
Topics: Angioedema; Captopril; Enalapril; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Risk Factors; Tongue Diseases | 1990 |
Zinc metabolism in patients treated with captopril versus enalapril.
Topics: Captopril; Creatinine; Enalapril; Erythrocytes; Female; Humans; Hypertension; Male; Middle Aged; Zinc | 1990 |
Intrapatient comparison of acute hemodynamic, hormonal, and natriuretic responses to captopril versus enalapril in liver cirrhosis.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Captopril; Enalapril; Female; Heart Rate; Hemodynamics; Hormones; Humans; Liver Cirrhosis; Male; Middle Aged; Natriuresis; Renin; Time Factors | 1990 |
Marked spontaneous improvement in ejection fraction in patients with congestive heart failure.
Topics: Aged; Alcoholism; Captopril; Digoxin; Diuretics; Enalapril; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Remission Induction; Stroke Volume | 1990 |
Psoriasis related to angiotensin-converting enzyme inhibitors.
Topics: Aged; Captopril; Enalapril; Female; Humans; Male; Middle Aged; Psoriasis | 1990 |
[ACE inhibitors and cough].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cough; Enalapril; Humans; Hypertension; Male; Middle Aged; Reflex; Risk Factors | 1990 |
[Success with enalapril after captopril-induced neutropenia].
Topics: Adolescent; Captopril; Enalapril; Female; Humans; Hypertension; Neutropenia | 1990 |
Angioedema from angiotensin converting enzyme inhibitors: a cause of upper airway obstruction.
Topics: Adult; Airway Obstruction; Angioedema; Captopril; Enalapril; Female; Humans; Male; Middle Aged; Tongue Diseases | 1990 |
ACE inhibition improves vagal reactivity in patients with heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiomyopathy, Dilated; Carotid Sinus; Coronary Disease; Enalapril; Female; Humans; Male; Middle Aged; Pressoreceptors; Reflex; Vagus Nerve | 1990 |
Water intoxication treatment.
Topics: Body Weight; Captopril; Enalapril; Humans; Schizophrenia; Schizophrenic Psychology; Water Intoxication | 1990 |
Inhibition of endothelial-bound angiotensin converting enzyme, in vivo.
Topics: 5'-Nucleotidase; Angiotensin-Converting Enzyme Inhibitors; Animals; Binding, Competitive; Captopril; Enalapril; Endothelium, Vascular; Female; Kinetics; Lung; Oligopeptides; Proline; Rabbits | 1990 |
Differential effects of captopril and enalapril, two angiotensin converting enzyme inhibitors, on immune reactivity in experimental lupus disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antibody Formation; B-Lymphocytes; Captopril; Concanavalin A; Enalapril; Interleukin-2; Lupus Erythematosus, Systemic; Mice; Mice, Inbred Strains; T-Lymphocytes | 1990 |
Comparison of the effects of captopril and enalapril on oxyphenbutazone and ethanol-induced gastric lesions in rats.
Topics: Animals; Captopril; Enalapril; Ethanol; Male; Oxyphenbutazone; Rats; Rats, Inbred Strains; Stomach Ulcer | 1990 |
Effect of chronic enalapril treatment on enzymes responsible for the catabolism of angiotensin I and formation of angiotensin II.
Topics: Aminopeptidases; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Bacterial Agents; Captopril; Carboxypeptidases; Chromatography, High Pressure Liquid; Enalapril; Kidney; Neprilysin; Oligopeptides; Peptide Fragments; Peptides; Rats; Rats, Inbred WKY; Thiorphan | 1990 |
Restoration of cardiac function and structure by converting enzyme inhibition possibilities and limitations of long-term treatment in hypertension and heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomegaly; Coronary Circulation; Enalapril; Heart; Heart Failure; Heart Ventricles; Humans; Hypertension; Oligopeptides; Rats; Teprotide | 1986 |
Catabolism of substance P and neurotensin in the rat stomach wall is susceptible to inhibitors of angiotensin converting enzyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Chromatography, High Pressure Liquid; Enalapril; Enalaprilat; Gastric Mucosa; Glycopeptides; Kinetics; Male; Neurotensin; Peptide Fragments; Rats; Rats, Inbred Strains; Substance P; Thermolysin | 1986 |
Angiotensin-converting enzyme inhibitors implicated in oral mucosal lichenoid reactions.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Humans; Lichen Planus; Male; Middle Aged; Mouth Diseases | 1989 |
Flushing induced by angiotensin converting enzyme inhibitor therapy.
Topics: Captopril; Enalapril; Flushing; Humans; Male | 1989 |
Control of hypertension and reversal of renal failure in undifferentiated connective tissue disease by enalapril.
Topics: Acute Kidney Injury; Adult; Captopril; Connective Tissue Diseases; Enalapril; Female; Humans; Hypertension; Renin-Angiotensin System | 1989 |
Bronchial hyperreactivity and cough due to angiotensin-converting enzyme inhibitors.
Topics: Asthma; Bronchi; Bronchial Provocation Tests; Captopril; Cough; Enalapril; Female; Humans; Hypertension; Male; Maximal Expiratory Flow Rate; Methacholine Chloride; Methacholine Compounds; Middle Aged; Spirometry; Vital Capacity | 1989 |
Thrombocytopenia induced by angiotensin converting enzyme inhibitors.
Topics: Aged; Captopril; Enalapril; Female; Humans; Thrombocytopenia | 1989 |
Angiotensin-converting enzyme inhibitors and cough.
Topics: Captopril; Cough; Enalapril; Humans | 1989 |
Inhibition of dopamine beta-hydroxylase by captopril.
Topics: Adrenal Glands; Animals; Captopril; Cattle; Dopamine beta-Hydroxylase; Enalapril; Enalaprilat; Kinetics | 1989 |
Angiotensin-converting enzyme inhibitors: are there significant clinical differences?
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Lisinopril; Renin-Angiotensin System | 1989 |
Renal vascular effects of antihypertensive therapy in uninephrectomized SHR.
Topics: Animals; Antihypertensive Agents; Captopril; Enalapril; Hydralazine; Hydrochlorothiazide; Hypertension, Renovascular; Kidney; Kidney Glomerulus; Male; Rats; Rats, Inbred SHR; Renal Circulation; Reserpine | 1989 |
Differences in the effects of angiotensin converting enzyme inhibitors with or without a thiol group in chronic renal failure in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cysteine; Enalapril; Kidney Failure, Chronic; Male; Rats; Rats, Inbred Strains; Sulfhydryl Compounds | 1989 |
Comparison of once-daily captopril or enalapril in mild essential hypertension.
Topics: Adult; Aged; Blood Pressure; Captopril; Enalapril; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Peptidyl-Dipeptidase A; Renin | 1989 |
The effects of intradermal bradykinin are potentiated by angiotensin converting enzyme inhibitors in hypertensive patients.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Captopril; Drug Synergism; Enalapril; Female; Humans; Hypertension; Injections, Intradermal; Male; Middle Aged; Skin | 1989 |
Thrombocytopenia and angiotensin converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Humans; Purpura, Thrombocytopenic; Quinidine | 1989 |
[Evaluation of the cardiac and peripheral vascular effects of the administration of single-dose enalapril and captopril in essential arterial hypertension].
Topics: Adult; Aged; Arm; Blood Pressure; Captopril; Echocardiography; Enalapril; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Plethysmography, Impedance; Time Factors; Vascular Resistance | 1989 |
Report angioedema secondary to hypertension medications.
Topics: Airway Obstruction; Angioedema; Captopril; Enalapril; Humans; Tracheotomy | 1989 |
Cough induced by enalapril but not by captopril.
Topics: Aged; Captopril; Cough; Enalapril; Female; Humans; Hypertension; Respiratory Function Tests | 1989 |
Kinin antagonist reverses converting enzyme inhibitor-stimulated vascular prostaglandin I2 synthesis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Bradykinin; Captopril; Enalapril; Enalaprilat; Epoprostenol; In Vitro Techniques; Kidney Cortex; Kinins; Male; Prostaglandins; Rats; Rats, Inbred Strains | 1989 |
ACE inhibitors and anaemia.
Topics: Aged; Anemia; Captopril; Enalapril; Female; Humans; Middle Aged | 1989 |
[Respiratory complications of inhibitors of conversion enzyme].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cough; Enalapril; Humans; Retrospective Studies | 1989 |
Changes in dyspnea-fatigue ratings as indicators of quality of life in the treatment of congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Dyspnea; Enalapril; Fatigue; Heart Failure; Humans; Lisinopril; Quality of Life; Random Allocation | 1989 |
[Angiotensin converting enzyme inhibitory activity of MK-0521 in vivo and antihypertensive effect of its single oral administration on blood pressure and effect on the renin-angiotensin system in 2-kidney Goldblatt hypertensive dogs].
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dogs; Dose-Response Relationship, Drug; Enalapril; Female; Hypertension, Renovascular; Lisinopril; Male; Renin-Angiotensin System | 1989 |
Oropharyngeal angioedema associated with the use of angiotensin-converting enzyme inhibitors.
Topics: Airway Obstruction; Angioedema; Captopril; Enalapril; Female; Humans; Middle Aged; Mouth Diseases; Pharyngeal Diseases | 1989 |
Antihypertensive mechanism of alacepril. Effects of its metabolites on the peripheral sympathetic nervous system.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Electric Stimulation; Enalapril; Male; Nephrectomy; Norepinephrine; Rats; Rats, Inbred SHR; Sympathetic Nervous System | 1989 |
[Cough associated with captopril and enalapril].
Topics: Aged; Captopril; Cough; Enalapril; Female; Humans; Male; Middle Aged | 1989 |
ACE-inhibitor influence on rat glomerular prostaglandin-synthesis.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; In Vitro Techniques; Kidney Glomerulus; Male; Prostaglandins; Rats; Rats, Inbred Strains; Thromboxane B2 | 1989 |
Effects of inhibitors of the renin-angiotensin system on water intake after insulin administration.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Adrenalectomy; Angiotensin II; Animals; Blood Glucose; Captopril; Dose-Response Relationship, Drug; Drinking; Enalapril; Insulin; Nephrectomy; Rats; Rats, Inbred Strains; Renin-Angiotensin System | 1989 |
The effects of captopril and enalapril on tissue levels of various elements in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Captopril; Enalapril; Male; Rats; Rats, Inbred SHR; Trace Elements | 1989 |
Effect of captopril or enalapril on renal prostaglandin E2.
Topics: Animals; Blood Pressure; Captopril; Dinoprostone; Diuresis; Enalapril; Heart Rate; Kidney Medulla; Male; Natriuresis; Rats; Rats, Inbred Strains; Renin | 1989 |
Comparative effects of captopril and enalapril on the progression of chronic renal disease in partially nephrectomized rats.
Topics: Animals; Blood Cell Count; Blood Pressure; Body Weight; Captopril; Chronic Disease; Creatinine; Drinking; Electrolytes; Enalapril; Kidney Diseases; Male; Nephrectomy; Organ Size; Rats; Rats, Inbred Strains; Urodynamics | 1989 |
Effect of captopril and enalapril medication on the serum ACE test for sarcoidosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Enzyme Tests; Dialysis; Enalapril; Humans; Peptidyl-Dipeptidase A; Sarcoidosis | 1989 |
Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Captopril; Chemotherapy, Cancer, Regional Perfusion; Dose-Response Relationship, Drug; Enalapril; Fosinopril; Heart; Hypertension; Lisinopril; Male; Organophosphorus Compounds; Proline; Ramipril; Rats; Time Factors; Tissue Distribution | 1989 |
Effects of antihypertensive agents on endothelium-dependent and endothelium-independent relaxations.
Topics: Acetylcholine; Adenosine Diphosphate; Administration, Oral; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Captopril; Enalapril; Hydralazine; Indomethacin; Male; Nitric Oxide; Pyrogallol; Rats; Rats, Inbred Strains | 1989 |
[Evaluation of the cardiac and peripheral vascular effects of the single-dose administration of enalapril and captopril in essential arterial hypertension].
Topics: Blood Vessels; Captopril; Drug Combinations; Enalapril; Heart | 1989 |
The effect of angiotensin converting enzyme inhibitors on isolated glomeruli.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dinoprostone; Enalapril; Kidney Glomerulus; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1989 |
The incidence of cough during treatment with angiotensin converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cough; Enalapril; Humans; Hypertension; Incidence; Italy; Sex Factors; Surveys and Questionnaires | 1989 |
Angiotensin converting enzyme inhibitor ingestion in children.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Captopril; Child, Preschool; Enalapril; Epidemiologic Methods; Humans; Infant; Ipecac; Poison Control Centers; Retrospective Studies; United States | 1989 |
Effect of chronic nifedipine in patients inadequately controlled by a converting enzyme inhibitor and a diuretic.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Creatinine; Dipeptides; Drug Resistance; Enalapril; Female; Furosemide; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nifedipine; Potassium; Substance Withdrawal Syndrome | 1985 |
Cough associated with captopril and enalapril.
Topics: Captopril; Cough; Enalapril; Humans | 1987 |
Cough associated with captopril and enalapril.
Topics: Captopril; Cough; Enalapril; Female; Humans | 1987 |
Identification of hyponatremia as a risk factor for the development of functional renal insufficiency during converting enzyme inhibition in severe chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Enalapril; Female; Heart Failure; Humans; Hyponatremia; Kidney Diseases; Male; Middle Aged; Renin; Risk Factors; Sodium | 1987 |
Presynaptic angiotensin II receptors and captopril-induced adrenergic transmission failure probably not via converting enzyme inhibition in guinea-pig pulmonary arteries.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Enalaprilat; Guinea Pigs; In Vitro Techniques; Male; Norepinephrine; Pulmonary Artery; Receptors, Angiotensin | 1987 |
Effects of teprotide, captopril and enalaprilat on arterial wall kininase and angiotensin converting activity.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Captopril; Enalapril; Enalaprilat; Male; Mesenteric Arteries; Rats; Rats, Inbred Strains; Teprotide | 1987 |
ACE inhibitors improve compliance.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Humans; Hypertension | 1987 |
[Cough induced by converting enzyme inhibitors. 15 cases].
Topics: Aged; Captopril; Cough; Enalapril; Female; Humans; Male; Middle Aged | 1987 |
Effect of angiotensin-converting enzyme inhibitors captopril and enalapril on cAMP content of specific brain areas in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Brain; Captopril; Cyclic AMP; Enalapril; Hypertension; Male; Rats; Rats, Inbred SHR | 1987 |
Angiotensin converting-enzyme inhibitor agents and respiratory symptoms.
Topics: Asthma; Captopril; Cough; Enalapril; Humans; Respiratory Sounds | 1987 |
Consequences of fluid loss in patients treated with ACE inhibitors.
Topics: Acute Kidney Injury; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dehydration; Diarrhea; Enalapril; Hemodynamics; Humans; Male; Middle Aged | 1987 |
Effect of peptidyl-dipeptidase inhibitors in experimental convulsions in mice.
Topics: Animals; Bicuculline; Captopril; Dipeptidases; Enalapril; Enzyme Inhibitors; Female; Injections, Intraperitoneal; Injections, Intraventricular; Male; Mice; Seizures; Strychnine | 1987 |
Angiotensin converting enzyme inhibitors in the elderly.
Topics: Aged; Captopril; Enalapril; Heart Failure; Humans | 1987 |
New approaches for the treatment of hypertensive urgencies and emergencies.
Topics: Antihypertensive Agents; Captopril; Emergencies; Enalapril; Humans; Hypertension; Labetalol; Nifedipine | 1988 |
[Hypotensive drugs and first-dose syndrome. Considerations on 6 cases observed during treatment with ACE inhibitors].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Syndrome; Theophylline | 1987 |
Enalapril, captopril, and cough.
Topics: Aged; Aged, 80 and over; Captopril; Cough; Enalapril; Female; Humans; Male; Middle Aged | 1988 |
Electronic spectroscopy of cobalt angiotensin converting enzyme and its inhibitor complexes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cobalt; Enalapril; Enalaprilat; Enzyme Activation; Kinetics; Lung; Peptidyl-Dipeptidase A; Protein Binding; Rabbits; Spectrophotometry | 1987 |
Bronchial hyperreactivity in patients who cough after receiving angiotensin converting enzyme inhibitors.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Asthma; Bronchi; Bronchial Provocation Tests; Captopril; Cough; Enalapril; Female; Histamine; Humans; Hypertension; Male; Middle Aged | 1988 |
Effect of angiotensin-converting enzyme inhibitor therapy on proteinuria in children with renal disease.
Topics: Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Child; Child, Preschool; Enalapril; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Proteinuria; Time Factors | 1988 |
Protective effects of captopril and enalapril on myocardial ischemia and reperfusion damage of rat.
Topics: Angiotensin I; Animals; Captopril; Coronary Circulation; Coronary Disease; Enalapril; Epoprostenol; Female; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Infarction; Rats | 1987 |
[A case of severe heart failure complicating chronic hemodialysis in which angiotensin converting enzyme inhibitor was markedly effective].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Hemodialysis, Home; Humans; Indans; Male | 1987 |
Angiotensin converting enzyme inhibitors: animal experiments suggest a new pharmacological treatment for alcohol abuse in humans.
Topics: Alcohol Drinking; Alcoholism; Animals; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Enalapril; Ethanol; Rats; Rats, Inbred Strains; Renin | 1988 |
Captopril versus enalapril: a comparison of 24 h humoral and hypotensive effects.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Captopril; Enalapril; Humans; Hypertension; Peptidyl-Dipeptidase A; Renin | 1987 |
A.C.E. inhibitors and cough.
Topics: Adult; Aged; Asthma; Captopril; Cough; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies | 1988 |
Renal failure due to enalapril and captopril in bilateral renal artery stenosis: greater awareness needed.
Topics: Acute Kidney Injury; Aged; Captopril; Creatinine; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Renal Artery Obstruction; Smoking | 1988 |
Influence of antihypertensive treatment on renal and extrarenal lupus manifestations in MRL/l mice.
Topics: Animals; Blood Pressure; Bretylium Compounds; Captopril; Enalapril; Female; Hypertension; Lupus Nephritis; Mice; Mice, Inbred Strains | 1988 |
[Reversible acute renal insufficiency caused by converting enzyme inhibitors in a patient with mesangial glomerulonephritis].
Topics: Acute Kidney Injury; Aldosterone; Blood Pressure; Captopril; Enalapril; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Male; Middle Aged; Renal Circulation | 1987 |
Angiotensin converting enzyme inhibitors and cough.
Topics: Adult; Aged; Captopril; Cough; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Retrospective Studies | 1987 |
Dosing regimens of captopril and enalapril in elderly patients and those with renal insufficiency.
Topics: Aged; Captopril; Enalapril; Humans; Kidney; Kidney Failure, Chronic | 1987 |
Angiotensin-converting enzyme inhibitors during pregnancy: a survey of 22 patients given captopril and nine given enalapril.
Topics: Abortion, Spontaneous; Captopril; Ductus Arteriosus, Patent; Enalapril; Female; Fetal Death; Humans; Hypertension; Infant, Newborn; Infant, Small for Gestational Age; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Trimester, Third | 1988 |
Kalemia during combined therapy with an angiotensin converting enzyme inhibitor and a potassium-sparing diuretic.
Topics: Adult; Captopril; Creatinine; Drug Therapy, Combination; Enalapril; Furosemide; Humans; Hypertension; Middle Aged; Potassium; Spironolactone | 1987 |
Lack of cross sensitivity between captopril and enalapril.
Topics: Captopril; Drug Eruptions; Enalapril; Female; Heart Failure; Humans; Hypertension; Hypertension, Renovascular; Male; Middle Aged; Proteinuria; Taste Disorders | 1988 |
Angiotensin converting enzyme inhibitors may cause renal impairment in diabetes mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Complications; Enalapril; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Renal Artery Obstruction | 1988 |
Suppression of in vitro granulocytopoiesis by captopril and penicillamine.
Topics: Animals; Bone Marrow; Captopril; Catalase; Cells, Cultured; Colony-Forming Units Assay; Dogs; Enalapril; Enalaprilat; Granulocytes; Hematopoiesis; Hematopoietic Stem Cells; Humans; Leukopenia; Oxygen Consumption; Penicillamine; Sulfhydryl Compounds | 1988 |
Angiotensin converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effect.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomechanical Phenomena; Blood Pressure; Captopril; Enalapril; Hemodynamics; Humans; Hypertension; Lisinopril; Middle Aged; Renal Circulation | 1988 |
[Angiotensin-converting enzyme inhibitors in angina pectoris].
Topics: Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Enalapril; Humans; Isoquinolines; Quinapril; Tetrahydroisoquinolines | 1988 |
Diagnosis of unilateral renovascular hypertension: comparative effect of intravenous enalaprilat and oral captopril.
Topics: Administration, Oral; Aldosterone; Blood Pressure; Captopril; Enalapril; Enalaprilat; False Negative Reactions; Humans; Hypertension, Renovascular; Infusions, Intravenous; Renin | 1988 |
Resistance to blockade by saralasin of effect of ACE inhibitors in conscious sodium-restricted dog.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Flow Velocity; Blood Pressure; Bradykinin; Captopril; Diet, Sodium-Restricted; Dogs; Enalapril; Enalaprilat; Female; Kidney; Male; Renal Circulation; Renin; Renin-Angiotensin System; Saralasin; Vascular Resistance | 1988 |
Reduced lymphocyte stimulatory guanine nucleotide regulatory protein and beta-adrenergic receptors in congestive heart failure and reversal with angiotensin converting enzyme inhibitor therapy.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; GTP-Binding Proteins; Heart Failure; Heart Ventricles; Humans; Lisinopril; Lymphocytes; Male; Middle Aged; Myocardium; Receptors, Adrenergic, beta; Reference Values | 1988 |
Prevalence of cough during angiotensin-converting enzyme inhibitor therapy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cilazapril; Cough; Enalapril; Female; Humans; Male; Pharynx; Pyridazines | 1988 |
ACE inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Hypertension | 1988 |
[Effects of angiotensin-converting enzyme inhibitors in hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Drug Therapy, Combination; Enalapril; Humans; Hypertension | 1988 |
Comparison of the effects of the dipeptidyl peptidase inhibitors captopril, ramipril, and enalapril on water intake and sodium appetite of Sprague-Dawley rats.
Topics: Angiotensin I; Angiotensin II; Animals; Appetite; Brain; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Dose-Response Relationship, Drug; Drinking; Enalapril; Ramipril; Rats; Rats, Inbred Strains; Renin; Sodium Chloride | 1988 |
Effect of captopril on murine systemic lupus erythematosus disease.
Topics: Animals; Blood Pressure; Bretylium Compounds; Captopril; Enalapril; Hypertension; Lupus Erythematosus, Systemic; Mice; Mice, Mutant Strains | 1988 |
Onset of action of captopril, enalapril, enalaprilic acid and lisinopril in normal man.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Enalapril; Heart Rate; Hemodynamics; Humans; Lisinopril; Male; Reference Values | 1987 |
Converting enzyme inhibitors (captopril, enalapril, perindopril) prevent early-post infarction ventricular fibrillation in the anaesthetized rat.
Topics: Anesthesia; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Indoles; Male; Myocardial Infarction; Perindopril; Rats; Rats, Inbred Strains; Ventricular Fibrillation | 1987 |
Cytolytic hepatitis with captopril but not with enalapril.
Topics: Captopril; Chemical and Drug Induced Liver Injury; Enalapril; Humans; Male; Middle Aged | 1988 |
Safety of angiotensin-converting-enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Enalapril; Humans; Proline | 1985 |
Safety of angiotensin-converting-enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Enalapril; Humans; Proline | 1985 |
Relative safety of angiotensin-converting-enzyme inhibitors.
Topics: Captopril; Dipeptides; Enalapril; Humans; Hypertension; Proline | 1985 |
Angiotensin converting enzyme inhibition. Unique and effective therapy for hypertension and congestive heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Enalapril; Erythema; Heart Failure; Humans; Hypotension; Neutropenia; Renin-Angiotensin System; Taste | 1985 |
[Pharmacokinetic properties and indications for modern vasodilators. 1. Pharmacodynamic properties of vasodilators].
Topics: Adrenergic alpha-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Cardiac; Captopril; Coronary Disease; Diazoxide; Drug Tolerance; Enalapril; Hemodynamics; Humans; Hydralazine; Hypertension; Minoxidil; Muscle, Smooth; Nitroglycerin; Vasodilator Agents | 1985 |
[Treatment of arterial hypertension in diabetics. Contribution of converting enzyme inhibitors].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diuretics; Enalapril; Humans; Hypertension; Obesity; Vasodilator Agents | 1985 |
Captopril, enalapril, and blood glucose.
Topics: Blood Glucose; Captopril; Diabetes Mellitus; Enalapril; Humans; Hypertension | 1986 |
A comprehensive analysis of renal DTPA studies. III. Renal artery stenosis.
Topics: Adrenergic beta-Antagonists; Captopril; Enalapril; Glomerular Filtration Rate; Humans; Kidney Transplantation; Middle Aged; Organometallic Compounds; Pentetic Acid; Radionuclide Imaging; Renal Artery Obstruction; Renal Circulation; Technetium Tc 99m Pentetate | 1986 |
[ACE inhibitors in the diagnosis and therapy of various forms of hypertension].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Diagnosis, Differential; Enalapril; Humans; Hypertension; Hypertension, Renovascular | 1988 |
Effect of ace-inhibitors, calmodulin antagonists, acetylcholine receptor blocking, and alpha receptor blocking agents on motility of human sperm.
Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biological Transport; Bromocriptine; Bungarotoxins; Calmodulin; Captopril; Enalapril; Gossypol; Humans; In Vitro Techniques; Lisuride; Male; Membranes; Sperm Motility; Trifluoperazine | 1988 |
[New momentum in cardiovascular therapy. Further development of ACE inhibitors: from captopril to lisinopril].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Enalapril; Humans; Lisinopril | 1988 |
Cough induced by enalapril and captopril.
Topics: Aged; Aged, 80 and over; Captopril; Cough; Enalapril; Female; Humans; Middle Aged | 1988 |
A need for new converting enzyme inhibitors?
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Enalapril; Enzyme Inhibitors; Humans | 1985 |
Impairment of granulomatous inflammatory response to Histoplasma capsulatum by inhibitors of angiotensin-converting enzyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dipeptides; Enalapril; Granuloma; Histoplasma; Histoplasmosis; Hypersensitivity, Delayed; Inflammation; Liver; Lymphocyte Activation; Macrophages; Male; Mice; Mice, Inbred C57BL; Peptidyl-Dipeptidase A; Proline; Spleen | 1985 |
Temporal relationships of treatment with angiotensin converting enzyme inhibitors on the hypertension and cardiac hypertrophy in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomegaly; Dipeptides; Enalapril; Hypertension; Male; Proline; Rats; Rats, Inbred SHR; Renin | 1985 |
Correlation between anti-hypertensive activity in rats and plasma angiotensin I-converting enzyme (ACE) inhibition in mice following oral administration of ACE inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Captopril; Dipeptides; Enalapril; Hypertension, Renal; Lung; Male; Mice; Peptidyl-Dipeptidase A; Rabbits; Rats | 1985 |
Kinetics of captopril- and enalapril-induced inhibition of pulmonary angiotensin converting enzyme in vivo.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dipeptides; Enalapril; Kinetics; Lung; Male; Oligopeptides; Proline; Rabbits | 1985 |
Comparison of the acute effects of three structurally different converting enzyme inhibitors (captopril, SA-446 and MK-421) on blood pressure, the renin-angiotensin system and the kallikrein-kinin system.
Topics: 3-Mercaptopropionic Acid; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Dipeptides; Enalapril; Female; Humans; Kallikreins; Kinins; Male; Middle Aged; Oligopeptides; Proline; Renin-Angiotensin System; Sulfhydryl Compounds; Teprotide; Thiazolidines | 1985 |
[Converting enzyme inhibitors in the therapy of primary arterial hypertension].
Topics: Antihypertensive Agents; Captopril; Dipeptides; Drug Evaluation; Enalapril; Female; Humans; Hypertension; Male; Proline | 1985 |
[Drugs that block the angiotensin converting enzyme].
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Drug Administration Schedule; Enalapril; Humans; Hypertension; Kidney; Kidney Glomerulus | 1985 |
Usefulness of plasma renin activity in predicting haemodynamic and clinical responses and survival during long term converting enzyme inhibition in severe chronic heart failure. Experience in 100 consecutive patients.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Renin | 1985 |
Imidazolyl derivatives of enalapril as potential angiotensin converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Chemical Phenomena; Chemistry; Enalapril; Imidazoles; Rats; Rats, Inbred Strains; Stereoisomerism | 1985 |
Synthesis and pharmacology of the potent angiotensin-converting enzyme inhibitor N-[1(S)-(ethoxycarbonyl)-3-phenylpropyl]-(S)-alanyl-(S)-pyroglutamic acid.
Topics: Anesthesia; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Chemical Phenomena; Chemistry; Diet, Sodium-Restricted; Dipeptides; Enalapril; Heart Rate; Hydrochlorothiazide; Hypertension; Hypertension, Renovascular; Male; Rats; Rats, Inbred SHR | 1985 |
Cough and wheeze caused by inhibitors of angiotensin-converting enzyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cough; Enalapril; Female; Humans; Male; Middle Aged; Respiratory Sounds | 1986 |
[Converting enzyme inhibitors in the treatment of essential hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Humans; Hypertension | 1985 |
Angiotensin-converting enzyme inhibitors potentiate the analgesic activity of [Met]-enkephalin-Arg6-Phe7 by inhibiting its degradation in mouse brain.
Topics: Analgesics; Angiotensin-Converting Enzyme Inhibitors; Animals; Brain; Captopril; Enalapril; Enalaprilat; Enkephalin, Methionine; Hydrolysis; In Vitro Techniques; Male; Mice; Mice, Inbred Strains; Peptidyl-Dipeptidase A; Synaptic Membranes; Thiorphan; Tiopronin | 1985 |
[Inhibition of angiotensin converting enzyme in human pregnancy. 15 cases].
Topics: Abortion, Spontaneous; Anuria; Captopril; Enalapril; Female; Fetal Diseases; Humans; Hypertension; Infant, Newborn; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Exposure Delayed Effects; Product Surveillance, Postmarketing; Renin-Angiotensin System; Respiratory Insufficiency | 1985 |
Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Heart Failure; Humans; Male; Middle Aged; Prognosis; Sodium; Vasodilator Agents | 1986 |
[Effects of single and repeated oral administration of MK-421 and captopril on blood pressures in normotensive and experimental hypertensive rats].
Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Desoxycorticosterone; Enalapril; Hypertension; Hypertension, Renal; Male; Rats; Rats, Inbred SHR; Rats, Inbred Strains | 1985 |
[Correlation between the inhibition of renin-angiotensin system and antihypertensive effect of MK-421 and captopril in 2-kidney, 1-clip renal hypertensive rats after single and repeated oral administration of MK-421 or captopril].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta; Captopril; Enalapril; Hypertension, Renal; Kidney; Lung; Male; Rats; Rats, Inbred Strains; Renin; Renin-Angiotensin System | 1985 |
[Coronary and renal circulation in patients with cardiac failure after converting enzyme inhibitors].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiac Output; Coronary Circulation; Enalapril; Heart Failure; Humans; Myocardium; Oxygen Consumption; Renal Circulation; Renin-Angiotensin System; Vasoconstriction | 1985 |
Provocation of hyper- and hypokalemic sudden death during treatment with and withdrawal of converting-enzyme inhibition in severe chronic congestive heart failure.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Death, Sudden; Enalapril; Heart Arrest; Heart Failure; Humans; Hyperkalemia; Hypokalemia; Male; Middle Aged; Potassium; Resuscitation; Substance Withdrawal Syndrome | 1986 |
Pharmacological comparison of captopril and MK-422 by a new method for measuring activity of angiotensin converting enzyme (ACE).
Topics: Animals; Antihypertensive Agents; Captopril; Enalapril; Enalaprilat; Enzyme Inhibitors; Hypertension, Renovascular; Peptidyl-Dipeptidase A; Radioimmunoassay; Renin-Angiotensin System; Swine; Swine, Miniature | 1985 |
Effects of enalapril and captopril on urinary excretion of kinins and electrolytes in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Captopril; Cerebrovascular Disorders; Electrolytes; Enalapril; Hypertension; Kinins; Male; Potassium; Rats; Rats, Inbred SHR; Sodium; Time Factors | 1985 |
Characterization of angiotensin converting enzyme by [3H]captopril binding.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Bromides; Captopril; Cobalt; Enalapril; Enalaprilat; Kinetics; Peptidyl-Dipeptidase A; Rats; Sodium Chloride; Thermodynamics; Tritium; Zinc | 1986 |
Centrally administered inhibitors of the generation and action of angiotensin II do not attenuate the increase in ACTH secretion produced by ether stress in rats.
Topics: Adrenocorticotropic Hormone; Angiotensin II; Animals; Captopril; Corticosterone; Corticotropin-Releasing Hormone; Enalapril; Enalaprilat; Male; Peptides; Rats; Renin; Renin-Angiotensin System; Saralasin; Stress, Physiological | 1986 |
Converting enzyme inhibitor-induced changes of plasma angiotensinogen concentration in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Angiotensins; Animals; Bridged Bicyclo Compounds; Captopril; Enalapril; Liver; Male; Ramipril; Rats; Renin; Water-Electrolyte Balance | 1986 |
Enalapril following captopril-induced nephrotic syndrome.
Topics: Adult; Captopril; Enalapril; Female; Humans; Hypertension; Nephrotic Syndrome; Proteinuria | 1986 |
Combined spironolactone and converting-enzyme inhibitor therapy for refractory heart failure.
Topics: Adult; Captopril; Diuresis; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Male; Middle Aged; Oligopeptides; Spironolactone; Teprotide | 1986 |
Renal insufficiency during angiotensin-converting enzyme inhibitor therapy in hypertensive patients with no renal artery stenosis.
Topics: Acute Kidney Injury; Captopril; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Hypertension, Renovascular; Kidney Diseases; Male; Middle Aged; Oligopeptides; Teprotide | 1985 |
[Inhibition of angiotensin converting enzyme as a therapeutic approach: the pros and cons].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Humans; Hypertension | 1986 |
Severe coughing during captopril and enalapril therapy.
Topics: Captopril; Cough; Enalapril; Female; Humans; Hypertension, Renal; Middle Aged | 1986 |
Effects of tetradecapeptide renin substrate on isolated preparations of rat caudal artery, guinea-pig atria and on pithed rat blood pressure.
Topics: Angiotensin II; Animals; Blood Pressure; Captopril; Decerebrate State; Enalapril; Female; Guinea Pigs; In Vitro Techniques; Male; Norepinephrine; Oligopeptides; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Renin; Saralasin; Synaptic Transmission; Vasoconstriction | 1986 |
Intra-individual comparison of captopril and enalapril in patients undergoing regular haemodialysis.
Topics: Adult; Captopril; Electrocardiography; Enalapril; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Renal Dialysis; Time Factors | 1986 |
Differential renal function during angiotensin converting enzyme inhibition in renovascular hypertension.
Topics: Acute Kidney Injury; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Creatinine; Enalapril; Female; Humans; Hypertension, Renovascular; Male; Prospective Studies | 1986 |
[Therapy of chronic heart failure with vasodilator agents].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Enalapril; Heart Failure; Hemodynamics; Humans; Regional Blood Flow; Vascular Resistance; Vasodilator Agents | 1986 |
Severe cutaneous reactions to captopril and enalapril; histological study and comparison with early mycosis fungoides.
Topics: Captopril; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Eruptions; Enalapril; Humans; Mycosis Fungoides; Skin | 1986 |
Effects of acute angiotensin converting enzyme inhibition on renal blood flow in patients with stable congestive heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Enalaprilat; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Renal Circulation; Thermodilution | 1986 |
Response of rat jejunum to changes in sodium and volume balance.
Topics: Adrenalectomy; Aldosterone; Animals; Blood Volume; Captopril; Diet; Enalapril; Extracellular Space; Intestinal Absorption; Jejunum; Male; Nephrectomy; Rats; Rats, Inbred Strains; Renin; Serum Albumin, Bovine; Sodium | 1986 |
Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Enalapril; Female; Glomerular Filtration Rate; Heart Failure; Humans; Male; Renal Circulation; Renin-Angiotensin System | 1986 |
[Calcium channel blockers and angiotensin converting enzyme inhibitors in the treatment of high blood pressure].
Topics: Calcium Channel Blockers; Captopril; Drug Interactions; Enalapril; Humans; Hypertension; Nifedipine; Oligopeptides; Teprotide; Verapamil | 1986 |
Severe coughing during captopril and enalapril therapy.
Topics: Captopril; Cough; Enalapril; Humans; Hypotension | 1986 |
[Calcium entry blockers and angiotensin converting enzyme antagonists in the treatment of high blood pressure].
Topics: Antihypertensive Agents; Captopril; Enalapril; Humans | 1986 |
Effect of nifedipine in hypertension not controlled by converting enzyme inhibitor and diuretic.
Topics: Adult; Aldosterone; Blood Pressure; Captopril; Drug Therapy, Combination; Enalapril; Female; Furosemide; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nifedipine; Potassium | 1986 |
Adverse effects of converting-enzyme inhibition in patients with severe congestive heart failure: pathophysiology and management.
Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Hyperkalemia; Hypotension; Sodium Chloride | 1986 |
Renal effects of angiotensin converting enzyme inhibitors in hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Body Fluids; Captopril; Enalapril; Glomerular Filtration Rate; Humans; Hypertension; Hypertension, Renal; Kidney; Oligopeptides; Proteinuria; Regional Blood Flow; Renin-Angiotensin System; Sodium Chloride; Teprotide | 1986 |
Angiotensin converting enzyme inhibitors in congestive heart failure. Overview in comparison of captopril and enalapril.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Hemodynamics; Humans; Renin; Renin-Angiotensin System; Therapeutic Equivalency; Vascular Resistance | 1986 |
Specific binding and proteolytic inactivation of bradykinin by membrane vesicles from pig intestinal smooth muscle.
Topics: 5'-Nucleotidase; Animals; Binding Sites; Bradykinin; Captopril; Cell Membrane; Drug Interactions; Enalapril; Endopeptidases; Enzyme Repression; Glycopeptides; In Vitro Techniques; Muscle, Smooth; Nucleotidases; Phenanthrolines; Swine | 1986 |
Angiotensin I converting enzyme inhibitors containing unnatural alpha-amino acid analogues of phenylalanine.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Coarctation; Blood Pressure; Captopril; Enalapril; In Vitro Techniques; Isoquinolines; Lung; Male; Quinolines; Rabbits; Rats; Rats, Inbred Strains; Tetrahydroisoquinolines | 1987 |
Bradykinin potentiating peptides isolated from alpha-casein tryptic hydrolysate.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Captopril; Caseins; Chromatography, Gel; Drug Synergism; Enalapril; Enalaprilat; Guinea Pigs; Trypsin | 1987 |
Cough with angiotensin converting-enzyme inhibitors.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cough; Enalapril; Female; Humans; Hypertension; Male; Middle Aged | 1987 |
[The renin-angiotensin system. Applications in pediatrics. (II)].
Topics: Adolescent; Captopril; Cardiovascular Diseases; Child; Child, Preschool; Enalapril; Endocrine System Diseases; Humans; Hypertension, Renal; Infant; Infant, Newborn; Renin-Angiotensin System | 1986 |
Carboxyalkyl peptide inhibitors of kininase II: chiral synthesis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Chromatography, Thin Layer; Enalapril; Enalaprilat; Indicators and Reagents; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1986 |
Aggregate anaphylaxis and carboxypeptidase N.
Topics: 3-Mercaptopropionic Acid; Anaphylaxis; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Carboxypeptidases; Enalapril; Enalaprilat; Guinea Pigs; Lung; Lysine Carboxypeptidase; Ovalbumin; Sulfhydryl Compounds | 1986 |
Kininase II of human seminal fluid: kinetics and inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Binding, Competitive; Captopril; Chlorides; Enalapril; Humans; Kinetics; Male; Peptidyl-Dipeptidase A; Piperidines; Piperidones; Semen; Spermatozoa | 1986 |
Effects of three different kininase II inhibitors on blood pressure and renal vasoactive substances in essential hypertensives.
Topics: 3-Mercaptopropionic Acid; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Enalapril; Female; Humans; Hypertension; Kallikreins; Kidney; Kinins; Male; Middle Aged; Pulse; Renin; Sulfhydryl Compounds; Thiazolidines | 1986 |
Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Blood Urea Nitrogen; Captopril; Creatinine; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged | 1987 |
The use of angiotensin converting enzyme inhibitors in elderly patients with hypertension.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Interactions; Enalapril; Hemodynamics; Humans; Hypertension; Myocardial Infarction | 1987 |
Inhibition of angiotensin-converting enzyme in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans | 1987 |
Side effect of captopril and enalapril.
Topics: Aged; Captopril; Cough; Enalapril; Female; Humans; Hypertension; Middle Aged | 1987 |
Angioneurotic edema, agranulocytosis, and fatal septicemia following captopril therapy.
Topics: Agranulocytosis; Angioedema; Captopril; Enalapril; Humans; Sepsis | 1987 |
Tailoring antihypertensive treatment: which patients, what therapy?
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Drug Therapy, Combination; Enalapril; Humans; Hypertension | 1987 |
Guidelines for vasodilator therapy of congestive heart failure in infants and children.
Topics: Captopril; Child; Child, Preschool; Enalapril; Heart Diseases; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Hydralazine; Infant; Nifedipine; Nitroglycerin; Nitroprusside; Phentolamine; Prazosin; Vasodilator Agents | 1987 |
Angio-oedema and urticaria associated with angiotensin converting enzyme inhibitors.
Topics: Aged; Aged, 80 and over; Angioedema; Captopril; Enalapril; Female; Humans; Male; Middle Aged; Time Factors; United Kingdom; Urticaria | 1987 |
Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Captopril; Enalapril; Exercise Test; Female; Heart Failure; Heart Ventricles; Humans; Hypokalemia; Hyponatremia; Male; Middle Aged; Prognosis; Prospective Studies | 1987 |
Systemic and regional hemodynamic profile of five angiotensin I converting enzyme inhibitors in the spontaneously hypertensive rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bridged Bicyclo Compounds; Captopril; Enalapril; Indoles; Perindopril; Ramipril; Rats; Rats, Inbred SHR; Regional Blood Flow; Vascular Resistance | 1987 |
Effect of converting enzyme inhibitors on tissue converting enzyme and angiotensin II: therapeutic implications.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bridged Bicyclo Compounds; Captopril; Enalapril; Injections, Intraventricular; Myocardium; Peptidyl-Dipeptidase A; Rabbits; Ramipril; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Tissue Distribution | 1987 |
[Mechanisms of action and clinical use of converting enzyme inhibitors].
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Enalapril; Humans; Hypertension | 1986 |
[A secondary effect of converting enzyme inhibitors: cough].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cough; Enalapril; Female; Humans; Male; Middle Aged | 1987 |
Antihypertensive activity of a new ACE-inhibitor, SCH 33844, during repeated administration in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Enalapril; Male; Rats; Rats, Inbred SHR; Substance Withdrawal Syndrome | 1987 |
[The treatment of chronic cardiac decompensation].
Topics: Captopril; Enalapril; Heart Failure; Humans | 1987 |
Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Kidney; Rats; Renal Circulation; Renin-Angiotensin System; Water-Electrolyte Balance | 1987 |
Influence of diabetes mellitus on changes in left ventricular performance and renal function produced by converting enzyme inhibition in patients with severe chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Kidney; Male; Middle Aged; Renin-Angiotensin System | 1987 |
Cough associated with captopril and enalapril.
Topics: Captopril; Cough; Dose-Response Relationship, Drug; Enalapril; Female; Humans; Male; Middle Aged; Product Surveillance, Postmarketing | 1987 |
Angiotensin-converting enzyme inhibitors: accomplishments and challenges.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Chemical Phenomena; Chemistry; Enalapril; Fosinopril; Humans; Proline | 1987 |
Antihypertensive action of angiotensin-I converting enzyme inhibitors in the kidney.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Enalapril; Enalaprilat; Female; Rabbits; Renal Circulation; Saralasin | 1987 |
Effects of angiotensin converting enzyme inhibitors MK 421, SA 446 and captopril on renal prostaglandin E and kinins in conscious normotensive rats.
Topics: 3-Mercaptopropionic Acid; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dinoprostone; Enalapril; Kidney; Kinins; Male; Prostaglandins E; Rats; Rats, Inbred Strains; Sulfhydryl Compounds; Thiazolidines | 1987 |
Prevention of renal damage and decrease of urinary kinins excretion by chronic treatments with enalapril and captopril in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Captopril; Cerebrovascular Disorders; Enalapril; Hypertension, Renal; Kidney Diseases; Kinins; Male; Rats; Rats, Inbred SHR | 1987 |
Side effects and metabolic effects of converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Humans; Hypertension; Propranolol | 1987 |
Angiotensin converting enzyme inhibition reduces ACTH release due to hypoglycaemia.
Topics: Adrenocorticotropic Hormone; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Captopril; Depression, Chemical; Enalapril; Humans; Hydrocortisone; Hypertension; Male; Middle Aged | 1987 |
Effect of chronic treatment with angiotensin I converting enzyme inhibitors on circulating atrial natriuretic polypeptide in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Captopril; Enalapril; Heart Rate; Hypertension; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1987 |
Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arterioles; Captopril; Enalapril; Enalaprilat; Heart Failure; Humans; Hypertension; Kinetics; Male; Nifedipine; Renin; Renin-Angiotensin System; Sodium; Teprotide; Vascular Resistance | 1983 |
Comparative effects of enalapril, enalaprilic acid and captopril in blocking angiotensin I-induced pressor and dipsogenic responses in spontaneously hypertensive rats.
Topics: Angiotensin I; Angiotensins; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Dipeptides; Drug Evaluation, Preclinical; Enalapril; Enalaprilat; Hypertension; Male; Pressoreceptors; Proline; Rats; Rats, Inbred Strains; Renin-Angiotensin System; Thirst; Time Factors | 1984 |
Renal kallikrein-kinin system and the depressor effect of angiotensin converting enzyme inhibitors MK 421, SA 446, and captopril in rats.
Topics: 3-Mercaptopropionic Acid; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Diet, Sodium-Restricted; Dipeptides; Drug Evaluation, Preclinical; Enalapril; Hypertension; Kallikreins; Kinins; Male; Proline; Rats; Rats, Inbred Strains; Sulfhydryl Compounds; Thiazolidines | 1984 |
Hemodynamic results of perorally administered converting enzyme inhibitors in congestive heart failure.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Enalapril; Exercise Test; Furosemide; Heart Failure; Hemodynamics; Humans; Hypertension | 1984 |
Enalapril treatment in a patient with impaired renal function and intolerance to captopril.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Creatinine; Dipeptides; Enalapril; Female; Humans; Hypertension, Malignant; Kidney Diseases; Peptidyl-Dipeptidase A; Proline | 1984 |
Hormonal and metabolic effects of angiotensin converting enzyme inhibitors. Possible differences between enalapril and captopril.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Enalapril; Humans; Hypertension; Kinins; Posture; Potassium; Proline; Prostaglandins; Renin; Renin-Angiotensin System; Sodium | 1984 |
Captopril and enalapril: angiotensin converting enzyme (ACE) inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Enalapril; Heart Failure; Humans; Hypertension; Proline | 1984 |
[Effects of 3 different angiotensin converting enzyme inhibitors, MK 421, SQ 14225 and SA 446 on renal function and blood pressure in patients with essential hypertension].
Topics: 3-Mercaptopropionic Acid; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Dipeptides; Enalapril; Humans; Hypertension; Kidney; Middle Aged; Natriuresis; Potassium; Proline; Renin-Angiotensin System; Sulfhydryl Compounds; Thiazolidines | 1984 |
2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S) -2-azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498)--a new and highly effective angiotensin I converting enzyme inhibitor.
Topics: Adenylyl Cyclase Inhibitors; Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Colforsin; Cyclic AMP; Dipeptides; Diterpenes; Enalapril; Heart; In Vitro Techniques; Kinetics; Lung; Membranes; Muscle Proteins; Myocardium; Peptidyl-Dipeptidase A; Rabbits; Ramipril; Rats; Rats, Inbred Strains | 1984 |
Inhibition of angiotensin converting enzyme by 2-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498 diacid). Comparison with captopril and enalaprilat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Carboxypeptidases; Carboxypeptidases A; Dipeptides; Enalapril; Proline; Ramipril; Thermolysin; Zinc | 1984 |
Pharmacological properties of the new orally active angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl] -(1S,3S,5S)-2-azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498).
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Dipeptides; Dogs; Enalapril; Male; Ramipril; Rats; Rats, Inbred Strains; Species Specificity | 1984 |
Two inhibitors of angiotensin-converting enzyme, enalapril and captopril, increase salt appetite of rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dipeptides; Drinking; Enalapril; Female; Fertility; Food Preferences; Male; Pregnancy; Proline; Rats; Rats, Inbred Strains; Seminal Vesicles; Sodium Chloride | 1984 |
[Renal adaptation to a restriction of sodium intake in the rat: effects of inhibition of the renin-angiotensin system].
Topics: Adaptation, Physiological; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Diet, Sodium-Restricted; Dipeptides; Enalapril; Kidney; Male; Natriuresis; Proline; Rats; Rats, Inbred Strains; Renin-Angiotensin System | 1984 |
Effect of converting enzyme inhibition by enalapril on sodium homeostasis in the rat.
Topics: Administration, Oral; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Diet, Sodium-Restricted; Dipeptides; Enalapril; Enzyme Inhibitors; Homeostasis; Kidney; Natriuresis; Potassium; Rats; Renin-Angiotensin System; Sodium; Water-Electrolyte Balance | 1984 |
Plasma enalapril levels and hormonal effects after short- and long-term administration in essential hypertension.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Dipeptides; Drug Interactions; Enalapril; Enalaprilat; Humans; Hypertension; Liver; Renin; Time Factors | 1984 |
Influence of the converting enzyme inhibitors Hoe 498, enalapril and captopril on vascular reactivity of isolated arterial preparations.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta; Arteries; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Dipeptides; Enalapril; Guinea Pigs; In Vitro Techniques; Mesenteric Arteries; Norepinephrine; Proline; Pulmonary Artery; Ramipril | 1984 |
Enalapril and autonomic reflexes and exercise performance.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Autonomic Nervous System; Blood Pressure; Captopril; Cold Temperature; Double-Blind Method; Enalapril; Exercise Test; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Physical Exertion; Placebos; Posture; Reflex; Time Factors | 1983 |
Regulation of angiotensin converting enzyme.
Topics: Adult; Animals; Captopril; Enalapril; Endothelium; Female; Heart Failure; Humans; Hypertension, Renovascular; Kinetics; Macrophages; Male; Middle Aged; Peptidyl-Dipeptidase A; Pregnancy; Rats; Umbilical Arteries | 1983 |
The effects of converting enzyme inhibitors on plasma angiotensinogen and plasma aldosterone in sodium-depleted rats.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Angiotensins; Animals; Captopril; Diet, Sodium-Restricted; Enalapril; Male; Rats; Rats, Inbred Strains; Renin-Angiotensin System | 1983 |
Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
Topics: Adrenalectomy; Angiotensin II; Animals; Blood Pressure; Captopril; Dogs; Enalapril; Female; Heart Failure; Heart Ventricles; Hindlimb; Hypertension; Hypertension, Renal; Kidney; Male; Muscles; Rats; Rats, Inbred SHR; Renin; Sodium; Vasoconstriction | 1983 |
Effect of central administration of MK-422 (the diacid form of enalapril) on the development of hypertension in the spontaneously hypertensive rat.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electric Stimulation; Enalapril; Enalaprilat; Hypertension; Male; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Sympathetic Nervous System; Time Factors; Vascular Resistance | 1984 |
The role of the renin-angiotensin system in blood pressure regulation in normotensive animals and man.
Topics: Angiotensin II; Animals; Blood Pressure; Blood Volume; Callithrix; Captopril; Dipodomys; Enalapril; Homeostasis; Humans; Male; Rats; Rats, Inbred Strains; Renin; Renin-Angiotensin System; Sodium | 1984 |
Absence of cross-reactivity between captopril and enalapril.
Topics: Antihypertensive Agents; Captopril; Cross Reactions; Dipeptides; Drug Hypersensitivity; Enalapril; Eosinophilia; Humans; Hypertension, Renovascular; Male; Middle Aged; Proline | 1984 |
Complex competitive and non-competitive inhibition of rat lung angiotensin-converting enzyme by inhibitors containing thiol groups: captopril and SA 446.
Topics: 3-Mercaptopropionic Acid; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dipeptides; Enalapril; Lung; Proline; Rats; Sulfhydryl Compounds; Teprotide; Thiazolidines | 1981 |
Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.
Topics: Angiotensin I; Angiotensins; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Dipeptides; Enalapril; Hypertension; Hypertension, Renal; Oligopeptides; Proline; Rats; Rats, Inbred Strains; Teprotide | 1981 |
A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats.
Topics: 3-Mercaptopropionic Acid; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Dipeptides; Enalapril; Female; Oligopeptides; Proline; Rats; Rats, Inbred Strains; Sulfhydryl Compounds; Teprotide; Thiazolidines | 1982 |
Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aprotinin; Captopril; Dipeptides; Drug Synergism; Drug Therapy, Combination; Enalapril; Hydrochlorothiazide; Hypertension; Hypertension, Renovascular; Indomethacin; Proline; Rats; Rats, Inbred Strains; Renin; Renin-Angiotensin System | 1984 |
Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
Topics: Administration, Oral; Anesthesia; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Blood Pressure; Bradykinin; Captopril; Dipeptides; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Enalapril; Enalaprilat; Esterification; Female; Guinea Pigs; In Vitro Techniques; Male; Rats | 1981 |
New inhibitor of angiotensin-converting enzyme is stable on storage in plasma.
Topics: Captopril; Dipeptides; Drug Stability; Enalapril; Humans; Proline | 1981 |
Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dipeptides; Dose-Response Relationship, Drug; Enalapril; Hypertension; Male; Proline; Rats; Time Factors | 1982 |
In vivo comparison of three orally active inhibitors of angiotensin-converting enzyme.
Topics: 3-Mercaptopropionic Acid; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dipeptides; Enalapril; Female; Hypertension; Hypertension, Renovascular; Proline; Rats; Rats, Inbred Strains; Sulfhydryl Compounds; Thiazolidines | 1982 |
Comparative effects of captopril and MK 421 on sympathetic function in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dipeptides; Enalapril; Hypertension; Male; Norepinephrine; Pressoreceptors; Proline; Rats; Rats, Inbred Strains; Sympathetic Nervous System | 1982 |
Comparison in normal volunteers of three converting enzyme inhibitors: RHC 3659, MK 421 and captopril.
Topics: Adult; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cyclopentanes; Dipeptides; Dose-Response Relationship, Drug; Enalapril; Humans; Proline | 1982 |
"Scalded mouth" caused by angiotensin-converting-enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Enalapril; Female; Glossalgia; Humans; Hypertension; Male; Middle Aged; Mouth Diseases; Proline | 1982 |
MK 421 and prevention of genetic hypertension development in young spontaneously hypertensive rats.
Topics: Aging; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Captopril; Dipeptides; Enalapril; Hemodynamics; Hypertension; Male; Norepinephrine; Rats | 1982 |
Comparison of angiotensin converting enzyme inhibitors captopril and MK421-diacid in guinea pig atria.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Captopril; Dipeptides; Enalapril; Female; Guinea Pigs; Heart Rate; In Vitro Techniques; Male; Proline | 1982 |
Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Captopril; Dipeptides; Enalapril; Humans; Lisinopril; Male; Renin-Angiotensin System | 1982 |
Selective activation of the converting enzyme inhibitor MK 421 and comparison of its active diacid form with captopril in different tissues of the rat.
Topics: Adrenal Glands; Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Availability; Biotransformation; Brain; Captopril; Dipeptides; Enalapril; Hydrolysis; Kidney; Lung; Male; Proline; Rats; Rats, Inbred Strains | 1982 |
Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).
Topics: Administration, Oral; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Diet, Sodium-Restricted; Dipeptides; Dogs; Dose-Response Relationship, Drug; Enalapril; Rats; Rats, Inbred Strains | 1983 |
Captopril and MK-421: stability on storage, distribution to the central nervous system, and onset of activity.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Brain; Captopril; Dipeptides; Drug Stability; Drug Storage; Enalapril; Humans; Injections, Intravenous; Kinetics; Proline; Rats; Rats, Inbred Strains; Time Factors; Tissue Distribution | 1983 |
Modulation of angiotensin II pressor responsiveness by circulating levels of angiotensin II in pregnant sheep.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dipeptides; Dose-Response Relationship, Drug; Enalapril; Female; Pregnancy; Pregnancy, Animal; Sheep | 1983 |
Repeated renal failure with captopril.
Topics: Acute Kidney Injury; Captopril; Child; Dipeptides; Enalapril; Female; Humans; Hypertension; Proline | 1983 |
Attenuation of pressor responses to intracerebroventricular angiotensin I by angiotensin converting enzyme inhibitors and their effects on systemic blood pressure in conscious rats.
Topics: Administration, Oral; Angiotensin I; Angiotensin II; Angiotensins; Animals; Blood Pressure; Brain; Captopril; Cerebral Ventricles; Dipeptides; Enalapril; Hypertension; Male; Peptidyl-Dipeptidase A; Proline; Rats; Rats, Inbred Strains | 1983 |
Effect of acute oral administration of captopril and MK-421 on vascular angiotensin converting enzyme activity in the spontaneously hypertensive rat.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Vessels; Captopril; Dipeptides; Enalapril; Hypertension; Male; Proline; Rats; Time Factors | 1983 |
Captopril and enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Proline | 1983 |
The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Enalapril; Epinephrine; Heart Failure; Hemodynamics; Humans; Norepinephrine; Proline; Renin; Renin-Angiotensin System | 1983 |
Converting enzyme inhibitors in hemodialysis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Dipeptides; Enalapril; Humans; Hypertension; Peptidyl-Dipeptidase A; Proline; Renal Dialysis | 1983 |
Captopril and enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Enalapril; Humans; Proline | 1983 |
Leakage of angiotensin converting enzyme inhibitors from the cerebral ventricles into the peripheral circulation in conscious, spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood-Brain Barrier; Captopril; Cerebral Ventricles; Dipeptides; Enalapril; Hypertension; Injections, Intravenous; Injections, Intraventricular; Rats; Time Factors | 1983 |
Postsynaptic alpha adrenoceptors and attenuation of vascular sympathetic responses in SHRs by captopril and enalapril.
Topics: Animals; Blood Pressure; Brimonidine Tartrate; Captopril; Dipeptides; Enalapril; Heart Rate; Imidazoles; Male; Pressoreceptors; Proline; Quinoxalines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Vascular Resistance; Vasoconstriction | 1983 |
New potent inhibitors of angiotensin converting enzyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Captopril; Cilazapril; Dipeptides; Enalapril; Humans; Molecular Conformation; Proline; Pyridazines; Rabbits; Structure-Activity Relationship; Swine | 1984 |
Coronary vascular actions of the converting enzyme inhibitor, enalapril.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Captopril; Cats; Coronary Vessels; Dipeptides; Dose-Response Relationship, Drug; Enalapril; In Vitro Techniques; Kinetics; Vasoconstriction | 1984 |
Responses of the kallikrein-kinin system to angiotensin converting enzyme inhibitors in the rat.
Topics: 3-Mercaptopropionic Acid; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Captopril; Diet, Sodium-Restricted; Dipeptides; Enalapril; Kallikreins; Kinins; Male; Muscle, Smooth, Vascular; Norepinephrine; Proline; Rats; Rats, Inbred Strains; Renin-Angiotensin System; Sulfhydryl Compounds; Thiazolidines; Vasopressins | 1984 |
[Reproducibility of acute captopril-induced renal insufficiency with enalapril].
Topics: Acute Kidney Injury; Aged; Angiotensin II; Antihypertensive Agents; Captopril; Dipeptides; Drug Therapy, Combination; Enalapril; Furosemide; Humans; Hypertension, Renovascular; Male; Proline; Renin-Angiotensin System | 1984 |
Enalapril, a rash, and captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Drug Eruptions; Enalapril; Humans; Male; Middle Aged; Proline | 1984 |
Renal insufficiency with combinations of angiotensin converting enzyme inhibitors and diuretics.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chlorothiazide; Dipeptides; Diuretics; Enalapril; Female; Furosemide; Humans; Kidney Diseases; Nephrosclerosis; Proline | 1984 |
CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Blood Vessels; Captopril; Dipeptides; Dogs; Enalapril; Guinea Pigs; Heart Rate; Hypertension, Renovascular; In Vitro Techniques; Indoles; Isoquinolines; Muscle Contraction; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Quinapril; Rabbits; Rats; Tetrahydroisoquinolines | 1984 |
Antihypertensive profile of the angiotensin-converting enzyme inhibitors CI-906 and CI-907.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Dipeptides; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Enalapril; Female; Hypertension; Hypertension, Renal; Hypertension, Renovascular; Indoles; Isoquinolines; Kinetics; Male; Quinapril; Rats; Rats, Inbred Strains; Renin-Angiotensin System; Tetrahydroisoquinolines | 1984 |
Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dipeptides; Dogs; Enalapril; Kallikreins; Kinins; Natriuresis; Proline; Propranolol; Renin; Saralasin; Sodium | 1984 |
Effects of angiotensin I converting enzyme inhibitors on the renal excretory function, hemodynamics and renin release in isolated perfused rat kidney.
Topics: 3-Mercaptopropionic Acid; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Creatinine; Dipeptides; Enalapril; Hemodynamics; In Vitro Techniques; Kidney; Natriuresis; Perfusion; Potassium; Proline; Rats; Rats, Inbred Strains; Renin; Sulfhydryl Compounds; Thiazolidines; Vascular Resistance | 1983 |
Tissue distribution of angiotensin converting enzyme in the rat: effect of captopril treatment.
Topics: Animals; Captopril; Cell Membrane; Dipeptides; Enalapril; Epididymis; Intestine, Small; Kidney; Lung; Male; Microvilli; Peptidyl-Dipeptidase A; Proline; Rats; Rats, Inbred Strains; Testis | 1984 |
Kinetics of inhibition of angiotensin converting enzyme by captopril and by enalapril diacid.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dipeptides; Enalapril; Kinetics; Lung; Proline; Rabbits; Spectrophotometry, Ultraviolet | 1984 |
Effect of captopril, MK-421 and MK-422 on fibrinolysis determined by 3 "in vitro" assays.
Topics: Animals; Captopril; Cattle; Dipeptides; Enalapril; Enalaprilat; Fibrin; Fibrinolysin; Fibrinolysis; Humans; In Vitro Techniques; Proline | 1984 |
Mechanisms of converting enzyme inhibition: studies in experimental animals.
Topics: 3-Mercaptopropionic Acid; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Dipeptides; Drug Evaluation, Preclinical; Enalapril; Female; Hypertension; Hypertension, Renal; Male; Rats; Rats, Inbred Strains; Thiazolidines | 1984 |
Hypertensive crisis in systemic sclerosis: treatment with the new oral angiotensin converting enzyme inhibitor MK, 421 (Enalapril) in captopril-intolerant patients.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Drug Tolerance; Enalapril; Female; Humans; Hypertension, Malignant; Male; Middle Aged; Proline; Scleroderma, Systemic | 1984 |
Angiotensin converting enzyme inhibitors and the otolaryngologist.
Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cough; Dose-Response Relationship, Drug; Enalapril; Humans; Hypertension; Isoquinolines; Kidney Diseases; Lisinopril; Otolaryngology; Quinapril; Tetrahydroisoquinolines | 1995 |
Comparative effects of losartan, captopril, and enalapril on murine acute myocarditis due to encephalomyocarditis virus.
Topics: Acute Disease; Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Body Weight; Captopril; Cardiovirus Infections; Enalapril; Encephalomyocarditis virus; Female; Heart; Heart Failure; Hypertrophy, Left Ventricular; Imidazoles; Injections, Intraperitoneal; Losartan; Mice; Mice, Inbred C3H; Myocarditis; Myocardium; Organ Size; Random Allocation; Tetrazoles; Therapeutic Equivalency | 1995 |
Suppression of hypotensive responses of captopril and enalapril by the kallikrein inhibitor aprotinin in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aprotinin; Blood Pressure; Captopril; Enalapril; Heart Rate; Hypertension; Kallikreins; Male; Rats; Rats, Inbred SHR | 1995 |
Comparison of the transplacental transfer of enalapril, captopril and losartan in sheep.
Topics: Angiotensin I; Angiotensin Receptor Antagonists; Animals; Biological Transport; Biphenyl Compounds; Blood Pressure; Captopril; Enalapril; Female; Fetus; Imidazoles; Injections, Intravenous; Losartan; Placenta; Sheep; Tetrazoles | 1995 |
Bronchospasm and cough as adverse reactions to the ACE inhibitors captopril, enalapril and lisinopril. A controlled retrospective cohort study.
Topics: Aged; Bronchial Spasm; Captopril; Chi-Square Distribution; Cohort Studies; Computer Simulation; Cough; Enalapril; Female; Humans; Hypolipidemic Agents; Lisinopril; Male; Middle Aged; Prevalence; Retrospective Studies; Sex Factors; Surveys and Questionnaires | 1995 |
Increased frequency and severity of angio-oedema related to long-term therapy with angiotensin-converting enzyme inhibitor in two patients.
Topics: Acute Disease; Adult; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Facial Dermatoses; Female; Humans; Male; Middle Aged | 1995 |
Bradykinin-induced water intake and brain fos-like immunoreactivity in rats.
Topics: Angiotensin I; Animals; Blood Pressure; Bradykinin; Brain; Captopril; Drinking; Enalapril; Male; Proto-Oncogene Proteins c-fos; Rats; Renin | 1995 |
An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Captopril; Coronary Disease; Diltiazem; Enalapril; Female; Heart Transplantation; Humans; Hyperplasia; Lisinopril; Male; Middle Aged; Nifedipine; Transplantation, Homologous; Tunica Intima; Ultrasonography, Interventional; Verapamil | 1995 |
Racial difference in incidence of cough with angiotensin-converting enzyme inhibitors (a tale of two cities).
Topics: Angiotensin-Converting Enzyme Inhibitors; Asian People; Captopril; Case-Control Studies; China; Cough; Double-Blind Method; Enalapril; Female; Humans; Incidence; Male; Middle Aged; Prospective Studies; White People | 1995 |
Effect of captopril and enalapril on left ventricular geometry, function and collagen during healing after anterior and inferior myocardial infarction in a dog model.
Topics: Animals; Captopril; Collagen; Dogs; Echocardiography; Electrocardiography; Enalapril; Hemodynamics; Hypertrophy, Left Ventricular; Myocardial Infarction; Systole; Time Factors; Ventricular Function, Left | 1995 |
Angiotensin converting enzyme inhibitor associated cough: a population-based case-control study.
Topics: Adult; Captopril; Case-Control Studies; Cough; Enalapril; Female; Humans; Male; Middle Aged; Netherlands; Odds Ratio; Pharmacoepidemiology; Risk Factors | 1995 |
Substrate- and inhibitor-specificity of a non-endothelial enzyme which forms [Met5]-enkephalin from [Met5]-enkephalin-Arg6,Phe7 in isolated rabbit ear artery: pharmacological characterization.
Topics: Amino Acid Sequence; Angiotensin I; Animals; Arteries; Bradykinin; Captopril; Disease Models, Animal; Ear, External; Enalapril; Endopeptidases; Endothelium, Vascular; Enkephalin, Methionine; Male; Migraine Disorders; Molecular Sequence Data; Rabbits; Substrate Specificity; Thiorphan | 1995 |
Angiotensin-converting enzyme inhibition, intracellular Na+, and Na(+)-K+ pumping in cardiac myocytes.
Topics: Action Potentials; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Heart; Hydralazine; Hydrogen-Ion Concentration; Intracellular Membranes; Male; Myocardium; Rabbits; Sarcolemma; Sodium; Sodium-Potassium-Exchanging ATPase; Time Factors | 1995 |
Effects of long-term treatment of captopril and enalapril on rat intestinal angiotensin converting enzyme specific activities.
Topics: Animals; Captopril; Culture Techniques; Enalapril; Intestinal Mucosa; Microvilli; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Time Factors | 1994 |
Superoxide dismutase and glutathione peroxidase activities are increased by enalapril and captopril in mouse liver.
Topics: Animals; Captopril; Catalase; Enalapril; Female; Glutathione Peroxidase; Liver; Mice; Superoxide Dismutase | 1995 |
[The antiproteinuric action of angiotensin-converting enzyme inhibitors in chronic glomerulonephritis and diabetic nephropathy].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Diabetic Nephropathies; Drug Evaluation; Enalapril; Female; Glomerulonephritis; Hemodynamics; Humans; Male; Middle Aged; Nephrotic Syndrome; Proteinuria | 1994 |
Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II.
Topics: Adult; Angiotensin II; Captopril; Enalapril; Female; Humans; Hypertension; Lipid Peroxidation; Lipoproteins, LDL; Macrophages; Male; Middle Aged | 1994 |
[Adverse reactions from angiotensin-converting enzyme inhibitor drugs reported by the yellow card].
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Captopril; Chi-Square Distribution; Drug Utilization; Enalapril; Female; Humans; Male; Middle Aged; Odds Ratio; Product Surveillance, Postmarketing; Sex Distribution; Spain | 1994 |
Action of angiotensin converting enzyme inhibitors in rat brain: interaction with isoproterenol assessed by Fos immunocytochemistry.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Brain Chemistry; Captopril; Drinking Behavior; Enalapril; Immunohistochemistry; Isoproterenol; Male; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley | 1994 |
Lack of efficacy of angiotensin-converting enzyme inhibitors in reducing interdialytic weight gain.
Topics: Angiotensin-Converting Enzyme Inhibitors; Black People; Captopril; Enalapril; Fosinopril; Humans; Hypertension; Kidney Failure, Chronic; Middle Aged; Renal Dialysis; Retrospective Studies; Weight Gain | 1994 |
Captopril amelioration of renal reperfusion injury.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; In Vitro Techniques; Kidney; Male; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Renal Circulation; Reperfusion Injury | 1994 |
Prophylaxis of experimental bone marrow transplant nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bone Marrow Transplantation; Captopril; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Enalapril; Kidney; Kidney Diseases; Male; Proteinuria; Radiation Injuries, Experimental; Rats; Time Factors; Uremia; Verapamil; Whole-Body Irradiation | 1994 |
ACE inhibitors and cough.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cough; Enalapril; Female; Humans; Hypertension; Indoles; Lisinopril; Male; Middle Aged; Perindopril; Retrospective Studies | 1994 |
Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism.
Topics: Acetylcholine; Adenosine; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Bradykinin; Captopril; Coronary Circulation; Dogs; Drug Synergism; Enalapril; Endothelium, Vascular; Female; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Regional Blood Flow; Vasodilation | 1994 |
Stability and in vitro absorption of captopril, enalapril and lisinopril across the rat intestine.
Topics: Animals; Biological Transport, Active; Captopril; Drug Stability; Enalapril; In Vitro Techniques; Intestinal Absorption; Intestinal Mucosa; Kinetics; Lisinopril; Rats; Rats, Wistar; Skin | 1994 |
The angiotensin converting enzyme inhibitors captopril and enalapril inhibit apomorphine-induced oral stereotypy in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apomorphine; Captopril; Dose-Response Relationship, Drug; Enalapril; Haloperidol; Lung; Male; Neostriatum; Rats; Rats, Sprague-Dawley; Stereotyped Behavior | 1994 |
Are ACE inhibitors equal in congestive heart failure?
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans | 1993 |
Chronic effects of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, in experimental hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Enalapril; Hypertension, Renovascular; Male; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR | 1993 |
Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors.
Topics: Captopril; Chronic Disease; Digoxin; Enalapril; Heart Failure; Humans | 1993 |
Decision analysis applied to the selection of angiotensin-converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Decision Support Techniques; Drug Utilization; Enalapril; Humans; Lisinopril | 1993 |
Chronic converting enzyme inhibition facilitates baroreceptor resetting to hypertensive levels.
Topics: Angiotensin I; Angiotensin II; Animals; Aorta; Biphenyl Compounds; Blood Pressure; Bradykinin; Captopril; Enalapril; Hypertension; Imidazoles; Losartan; Male; Pressoreceptors; Rats; Rats, Wistar; Reference Values; Regression Analysis; Tetrazoles | 1994 |
Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Asthma; Bronchial Spasm; Captopril; Cough; Dyspnea; Enalapril; Female; Humans; Lisinopril; Male; Middle Aged; Ramipril | 1994 |
Elevated breath pentane in heart failure reduced by free radical scavenger.
Topics: Aged; Captopril; Enalapril; Female; Free Radical Scavengers; Free Radicals; Heart Failure; Humans; Lipid Peroxidation; Male; Middle Aged; Pentanes; Reactive Oxygen Species; Respiration | 1993 |
Captopril, enalapril, and quality of life.
Topics: Captopril; Enalapril; Humans; Hypertension; Pharmaceutical Vehicles; Quality of Life | 1993 |
Captopril, enalapril, and quality of life.
Topics: Captopril; Enalapril; Humans; Hypertension; Quality of Life; Research Design | 1993 |
Captopril, enalapril, and quality of life.
Topics: Captopril; Confidence Intervals; Enalapril; Humans; Hypertension; Quality of Life | 1993 |
Captopril, enalapril, and quality of life.
Topics: Captopril; Enalapril; Female; Humans; Hypertension; Male; Quality of Life | 1993 |
[Antihypertensive activity of the angiotensin converting enzyme inhibitor quinapril HCl: (S)-2-[(S)-N-[(S)-1-ethoxycarbonyl-3-phenylpropyl) alanyl]-1,2,3,4- tetrahydro-3-isoquinolinecarboxylic acid monohydrochloride in various hypertensive animal models].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Disease Models, Animal; Dose-Response Relationship, Drug; Enalapril; Heart Rate; Hypertension; Hypertension, Renal; Isoquinolines; Male; Quinapril; Rats; Rats, Inbred SHR; Rats, Wistar; Tetrahydroisoquinolines | 1993 |
Release of nitric oxide from glyceryl trinitrate by captopril but not enalaprilat: in vitro and in vivo studies.
Topics: Acetylcysteine; Animals; Captopril; Cattle; Enalapril; Endothelium, Vascular; Glutathione; Humans; In Vitro Techniques; Isosorbide Dinitrate; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitrites; Nitroglycerin; Platelet Aggregation; Rats; Rats, Wistar; Vasodilator Agents | 1993 |
Treatment of radiation nephropathy with ACE inhibitors.
Topics: Animals; Blood Urea Nitrogen; Bone Marrow Transplantation; Captopril; Drug Evaluation, Preclinical; Enalapril; Female; Kidney; Male; Nephritis; Radiation Injuries, Experimental; Rats; Whole-Body Irradiation | 1993 |
Nonpeptide angiotensin II receptor antagonists: potential advantages over ACE inhibitors.
Topics: Acrylates; Acute Kidney Injury; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cough; Dogs; Enalapril; Female; Glomerular Filtration Rate; Imidazoles; Male; Renal Circulation; Thiophenes | 1993 |
Captopril, enalapril, and quality of life.
Topics: Captopril; Enalapril; Female; Humans; Hypertension; Male; Quality of Life | 1993 |
Drug-induced, life-threatening angioedema revisited.
Topics: Adult; Aged; Aged, 80 and over; Airway Obstruction; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dexamethasone; Dipeptides; Diphenhydramine; Enalapril; Epinephrine; Female; Humans; Injections, Intravenous; Laryngeal Edema; Lisinopril; Male; Middle Aged; Mouth Diseases; Pharyngeal Diseases; Prognosis | 1993 |
Angiotensin-converting enzyme inhibitors and psoriasis.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Enalapril; Female; Humans; Lisinopril; Male; Middle Aged; Psoriasis; Time Factors | 1993 |
Myocardial infarction and heart failure. The common ground.
Topics: Captopril; Cardiac Output, Low; Enalapril; Humans; Myocardial Infarction | 1993 |
Antihypertensive therapy--efficacy and quality of life.
Topics: Antihypertensive Agents; Black People; Captopril; Enalapril; Humans; Hypertension; Male; Quality of Life | 1993 |
Dose-dependent effects of angiotensin converting enzyme (ACE) inhibitors on glomerular prostanoid production by normotensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Enalapril; Fosinopril; In Vitro Techniques; Kidney Glomerulus; Male; Prostaglandins; Rats; Rats, Inbred WKY; Reference Values | 1993 |
Reliability of ACE inhibitor-enhanced 99Tcm-DTPA gamma camera renography in the detection of renovascular hypertension.
Topics: Adult; Aged; Captopril; Enalapril; Female; Humans; Hypertension, Renovascular; Male; Middle Aged; Radioisotope Renography; Reproducibility of Results; Technetium Tc 99m Pentetate | 1993 |
The effect of treatment with angiotensin-converting enzyme inhibitors on survival of pediatric patients with dilated cardiomyopathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiomyopathy, Dilated; Child, Preschool; Enalapril; Female; Humans; Life Tables; Male; Retrospective Studies; Survival Analysis; Time Factors | 1993 |
ACE-inhibitors, calcium antagonists and low systemic vascular resistance following cardiopulmonary bypass. A case-control study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Captopril; Cardiopulmonary Bypass; Case-Control Studies; Coronary Artery Bypass; Critical Care; Diltiazem; Dopamine; Enalapril; Female; Heart Valves; Humans; Length of Stay; Male; Middle Aged; Nifedipine; Norepinephrine; Retrospective Studies; Single-Blind Method; Syndrome; Vascular Resistance; Verapamil | 1993 |
[Angiotensin converting enzyme inhibitor-induced cough: patterns and incidence. Consequences for continuation of therapy].
Topics: Aged; Captopril; Cilazapril; Cough; Enalapril; Female; Heart Failure; Humans; Hypertension; Long-Term Care; Male; Middle Aged | 1993 |
Rat heart allograft survival after treatment with verapamil, captopril, and enalapril.
Topics: Animals; Captopril; Drug Interactions; Enalapril; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Rats; Rats, Inbred Strains; Time Factors; Transplantation, Homologous; Verapamil | 1995 |
Acute renal failure associated with use of angiotensin converting enzyme inhibitor--a report of two children with Down's syndrome.
Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Captopril; Child, Preschool; Down Syndrome; Enalapril; Female; Heart Failure; Humans; Infant; Male | 1996 |
ACE inhibitors as a shield against diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Enalapril; Humans; Kidney Failure, Chronic | 1996 |
Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction.
Topics: Adenine Nucleotides; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Energy Metabolism; Heart Failure; Hemodynamics; Indoles; Lactates; Male; Mitochondria, Heart; Myocardial Infarction; Myocardium; Organ Size; Oxygen Consumption; Phosphocreatine; Rats; Rats, Wistar | 1995 |
Angiotensin-converting enzyme inhibitors in adults with cyanotic congenital heart disease.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cyanosis; Enalapril; Female; Heart Defects, Congenital; Heart Diseases; Humans; Male; Treatment Outcome; Ventricular Dysfunction | 1996 |
Do ACE inhibitors influence the dose of human recombinant erythropoietin in dialysis patients?
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Enalapril; Erythropoietin; Female; Follow-Up Studies; Fosinopril; Hematocrit; Humans; Hypertension; Kidney Failure, Chronic; Male; Recombinant Proteins; Renal Dialysis; Retrospective Studies | 1996 |
Effect of angiotensin converting enzyme inhibitors on tolerance of nitroglycerin.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Captopril; Drug Tolerance; Enalapril; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroglycerin; Rats; Rats, Wistar; Vasodilator Agents | 1995 |
Are acantholysis and transglutaminase inhibition related phenomena?
Topics: Acantholysis; Angiotensin-Converting Enzyme Inhibitors; Binding, Competitive; Biochemical Phenomena; Biochemistry; Breast; Captopril; Cell Adhesion; Cells, Cultured; Cystamine; Disulfides; Enalapril; Enzyme Inhibitors; Humans; Keratinocytes; Pemphigus; Skin; Sulfhydryl Compounds; Tiopronin; Transglutaminases | 1996 |
ACE inhibitors unmask incoordinate diastolic wall motion in restrictive left ventricular disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Echocardiography; Enalapril; Female; Heart Failure; Humans; Lisinopril; Male; Middle Aged; Signal Processing, Computer-Assisted; Ventricular Dysfunction, Left | 1996 |
A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Heart Failure; Hospital Mortality; Humans; Hyponatremia; Length of Stay; Male; Nigeria; Prognosis; Retrospective Studies | 1996 |
Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Cytokines; Enalapril; Fibrin; Fibrinolysin; Fibrosis; Gene Expression Regulation, Enzymologic; Growth Substances; Imidazoles; In Situ Hybridization; Kidney; Male; Plasminogen Activator Inhibitor 1; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin; RNA, Messenger; Tetrazoles; Thrombosis; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator; Vasoconstrictor Agents | 1997 |
In vivo inhibition of nitric oxide synthesis does not depend on renin-angiotensin system activation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Cerebellum; Dogs; Enalapril; Enzyme Inhibitors; Female; Hemodynamics; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Renin-Angiotensin System | 1996 |
Distribution of Fos-immunoreactivity in rat brain following a dipsogenic dose of captopril and effects of angiotensin receptor blockade.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Brain Chemistry; Captopril; Drinking; Enalapril; Hypothalamus; Immunohistochemistry; Male; Naphthyridines; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley | 1997 |
PGE2 production after angiotensin-converting enzyme inhibition.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Captopril; Dinoprostone; Enalapril; Female; Humans; Immune Tolerance; In Vitro Techniques; Indomethacin; Lymphocyte Activation; Male; Muromonab-CD3; T-Lymphocytes | 1997 |
Serum angiotensin converting enzyme activity and response to angiotensin I in horses.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Enalapril; Enalaprilat; Female; Hemodynamics; Horses; Injections, Intravenous; Male; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 1989 |
Enalapril and captopril enhance antioxidant defenses in mouse tissues.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Brain; Captopril; Enalapril; Female; Kidney; Lisinopril; Luminescent Measurements; Mice; Mice, Inbred Strains; Muscles; Myocardium; Oxidoreductases; Peroxides; tert-Butylhydroperoxide; Thiobarbituric Acid Reactive Substances; Tissue Distribution | 1997 |
Changes of lipid peroxides and antioxidative factors levels in blood of patients treated with ACE inhibitors.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Catalase; Enalapril; Erythrocytes; Female; Glutathione; Glutathione Transferase; Humans; Hypertension; Lipid Peroxides; Male; Middle Aged | 1997 |
Inhibitory effects of angiotensin-converting enzyme inhibitor on cefroxadine uptake by rabbit small intestinal brush border membrane vesicles.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Transport; Captopril; Carrier Proteins; Cephalosporins; Cephradine; Enalapril; Intestine, Small; Isoquinolines; Membrane Transport Proteins; Microvilli; Quinapril; Rabbits; Tetrahydroisoquinolines | 1997 |
[Angioedema of the mucous membranes of the upper aerodigestive tract after administration of ACE inhibitors].
Topics: Airway Obstruction; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Deglutition Disorders; Enalapril; Humans; Hypertension; Lisinopril; Male; Middle Aged | 1997 |
Anti-free radical mechanisms in captopril protection against reperfusion injury in isolated rat hearts.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Catalase; Enalapril; Free Radicals; Glutathione Peroxidase; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 1996 |
"Scalded mouth syndrome" caused by angiotensin converting enzyme inhibitors: two case reports.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Burning Mouth Syndrome; Captopril; Enalapril; Female; Humans; Male; Middle Aged | 1997 |
Effect of angiotensin-converting enzyme inhibition on infarct collagen deposition and remodelling during healing after transmural canine myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Collagen; Dogs; Enalapril; Heart Ventricles; Hydroxyproline; Hypertrophy, Left Ventricular; Myocardial Infarction; Ultrasonography | 1997 |
The effect of ACE inhibitors on atheroma formation is potentiated by association with a calcium channel blocker. A biochemical and ultrastructural study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve; Arteriosclerosis; Calcium Channel Blockers; Captopril; Cholesterol; Coronary Vessels; Cricetinae; Diet, Atherogenic; Diltiazem; Drug Synergism; Enalapril; Male; Maleates; Mesocricetus; Microscopy, Electron | 1997 |
Protective effect of the angiotensin-converting enzyme inhibitor captopril on postischemic myocardial damage in perfused rat heart.
Topics: Adenine Nucleotides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Captopril; Coronary Circulation; Enalapril; Energy Metabolism; Heart Rate; Imidazoles; In Vitro Techniques; Lactic Acid; Losartan; Male; Myocardial Reperfusion Injury; Myocardium; Phosphocreatine; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles | 1997 |
Antioxidant and prooxidant properties of captopril and enalapril.
Topics: Adenosine Triphosphatases; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Ascorbic Acid; Captopril; Deoxyribose; DNA Damage; Enalapril; Erythrocyte Membrane; Hemolysis; Humans; Lipid Peroxidation; Oxidation-Reduction | 1997 |
[The effect of angiotensin-converting enzyme inhibitors on left ventricular hypertrophy in patients with chronic glomerulonephritis and pronounced kidney failure].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Drug Evaluation; Enalapril; Female; Glomerulonephritis; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Remission Induction; Time Factors | 1997 |
Internal mammary artery graft function is not affected in hypertensive patients on therapy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Endothelium, Vascular; Female; Humans; Hypertension; In Vitro Techniques; Male; Mammary Arteries; Middle Aged; Nitric Oxide; Vasoconstriction | 1997 |
Sheep testicular and epididymal angiotensin converting enzyme: inhibitions by captopril, lisinopril and enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Enzyme Activation; Epididymis; Kinetics; Lisinopril; Male; Peptidyl-Dipeptidase A; Sheep; Testis | 1997 |
Angiotensin-converting enzyme inhibitors can potentiate ozone-induced airway hyperresponsiveness.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bronchial Hyperreactivity; Captopril; Drug Synergism; Enalapril; Guinea Pigs; Imidazoles; Imidazolidines; Male; Ozone; Respiratory Function Tests | 1997 |
Antioxidant power of angiotensin-converting enzyme inhibitors in vitro.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Captopril; Colorimetry; Dose-Response Relationship, Drug; Enalapril; Ferric Compounds; Ferrous Compounds; Fosinopril; Indoles; Isoquinolines; Oxidation-Reduction; Perindopril; Quinapril; Tetrahydroisoquinolines | 1998 |
[Is the profile of antihypertensive drug utilization justified?].
Topics: Adolescent; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Contraindications; Cross-Sectional Studies; Diuretics; Drug Prescriptions; Drug Utilization; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Spain; Urban Population | 1997 |
Hemodynamic changes during administration of drugs for mitral regurgitation in dogs.
Topics: Animals; Captopril; Cardiotonic Agents; Digoxin; Dog Diseases; Dogs; Echocardiography, Doppler, Color; Enalapril; Hemodynamics; Hydralazine; Mitral Valve Insufficiency; Prazosin; Vasodilator Agents | 1998 |
Alacepril, an angiotensin-converting enzyme inhibitor, prevents cerebral vasospasm in subarachnoid hemorrhage model in rats.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Basilar Artery; Captopril; Disease Models, Animal; Enalapril; In Vitro Techniques; Ischemic Attack, Transient; Male; Muscle Relaxation; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage | 1997 |
Patterns of angiotensin-converting enzyme inhibitor prescriptions, educational interventions, and outcomes among hospitalized patients with heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Prescriptions; Enalapril; Female; Heart Failure; Hospitalization; Humans; Male; Patient Discharge; Patient Education as Topic; Retrospective Studies; Treatment Outcome; Ventricular Function, Left | 1998 |
Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; In Vitro Techniques; Kidney; Kinetics; Lisinopril; Lung; Oligopeptides; Peptidyl-Dipeptidase A; Sheep | 1997 |
Acute ACE inhibition causes plasma extravasation in mice that is mediated by bradykinin and substance P.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Coloring Agents; Data Interpretation, Statistical; Enalapril; Evans Blue; Extravasation of Diagnostic and Therapeutic Materials; Indicators and Reagents; Indoles; Injections, Intravenous; Male; Mice; Mice, Inbred C57BL; Neurokinin-1 Receptor Antagonists; Organometallic Compounds; Piperidines; Quinuclidines; Substance P; Time Factors | 1998 |
Asymptomatic childhood hypertension.
Topics: Adolescent; Ambulatory Care; Angiography; Antihypertensive Agents; Captopril; Diagnosis, Differential; Enalapril; Female; Humans; Hypertension, Renal; Kidney; Proteinuria; Renal Artery; Ultrasonography, Doppler; Urodynamics | 1998 |
Plasma ACE inhibition by five different ACE inhibitors.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Captopril; Dogs; Enalapril; Lisinopril; Peptidyl-Dipeptidase A; Ramipril | 1998 |
Nitric oxide and prostacyclin are involved in antithrombotic action of captopril in venous thrombosis in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cyclooxygenase Inhibitors; Drug Synergism; Enalapril; Enzyme Inhibitors; Epoprostenol; Fibrinolytic Agents; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Platelet Aggregation; Rats; Rats, Wistar; Thrombosis; Vena Cava, Inferior | 1998 |
NaCl appetite in two strains of rat reported to be resistant to mineralocorticoid-induced hypertension.
Topics: Analysis of Variance; Animals; Appetite Regulation; Captopril; Desoxycorticosterone; Disease Models, Animal; Drinking; Enalapril; Furosemide; Hypertension; Male; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Rats, Wistar; Sodium Chloride; Species Specificity | 1998 |
[Hospital intensive monitoring of adverse reactions of ACE inhibitors].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiotonic Agents; Data Collection; Drug Monitoring; Enalapril; Hospitals; Humans; Hypertension; Italy; Lisinopril; Renin-Angiotensin System; Risk Assessment | 1998 |
The effects of preoperative therapy with angiotensin-converting enzyme inhibitors on clinical outcome after cardiovascular surgery.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiopulmonary Bypass; Cardiovascular Diseases; Cardiovascular Surgical Procedures; Case-Control Studies; Electrocardiography; Enalapril; Female; Follow-Up Studies; Hospital Mortality; Humans; Incidence; Intra-Aortic Balloon Pumping; Lisinopril; Male; Middle Aged; Multiple Organ Failure; Postoperative Complications; Preoperative Care; Retrospective Studies; Treatment Outcome; Ventricular Dysfunction, Left | 1998 |
Effect of angiotensin convertase inhibitors on lipid peroxidation and peroxyl radical-trapping capacity in rats with experimental diabetes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Diabetes Mellitus, Experimental; Enalapril; Erythrocytes; Free Radicals; Lipid Peroxidation; Male; Malondialdehyde; Peroxides; Rats; Rats, Wistar | 1998 |
Enhancement of neonatal rat ductal responsiveness to prostaglandin E2 after maternal treatment with enalapril or captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Captopril; Dinoprostone; Ductus Arteriosus; Enalapril; Female; Pregnancy; Prenatal Exposure Delayed Effects; Pulmonary Artery; Rats; Rats, Wistar | 1998 |
Effects of captopril and enalapril on intracellular Ca2+ in vascular smooth muscle cell.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Biological Transport, Active; Calcium; Captopril; Cells, Cultured; Enalapril; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1996 |
Prolonged rat heart allograft survival after treatment with angiotensin converting enzyme inhibitor or a calcium antagonist.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Captopril; Drug Therapy, Combination; Enalapril; Female; Graft Survival; Heart Transplantation; Immunosuppression Therapy; Male; Rats; Rats, Inbred Strains; Time Factors; Transplantation, Homologous; Verapamil | 1998 |
Cutaneous reaction to captopril with positive patch test and lack of cross-sensitivity to enalapril and benazepril.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Cross Reactions; Double-Blind Method; Drug Eruptions; Enalapril; Facial Dermatoses; Humans; Hypertension; Male; Middle Aged; Patch Tests | 1998 |
False-positive result of a captopril-enhanced radionuclide renogram in a child secondary to dehydration.
Topics: Anesthesia, General; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Child, Preschool; Dehydration; Diagnosis, Differential; Enalapril; False Positive Reactions; Fluid Therapy; Glomerular Filtration Rate; Humans; Hypertension, Renovascular; Hypnotics and Sedatives; Hypotension; Kidney; Male; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Mertiatide | 1999 |
Partial left ventriculectomy: preoperative risk factors for perioperative mortality.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiac Surgical Procedures; Cardiomyopathy, Dilated; Diuretics; Echocardiography; Electrocardiography; Enalapril; Female; Furosemide; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Perioperative Care; Postoperative Complications; Preoperative Care; Risk Factors; Shock, Cardiogenic | 1998 |
Cardiovascular effects of captopril and enalapril in obese Zucker rats.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Captopril; Cardiomegaly; Diabetes Mellitus, Type 2; Diaphragm; Enalapril; Female; Glucose; In Vitro Techniques; Insulin; Muscle, Skeletal; Nitroprusside; Norepinephrine; Organ Size; Potassium Chloride; Proteinuria; Rats; Rats, Zucker | 1999 |
Acute renal failure from multiple myeloma precipitated by ACE inhibitors.
Topics: Acute Kidney Injury; Aged; Angiotensin-Converting Enzyme Inhibitors; Back Pain; Captopril; Diabetes Mellitus, Type 1; Enalapril; Humans; Hypertension; Male; Multiple Myeloma | 1999 |
Captopril inhibits peptidylglycine- alpha-hydroxylating monooxygenase: implications for therapeutic effects.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Binding, Competitive; Captopril; CHO Cells; Copper; Cricetinae; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enalapril; Enalaprilat; Heart Atria; Kinetics; Male; Mixed Function Oxygenases; Multienzyme Complexes; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Sulfhydryl Compounds | 1999 |
Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicles: interaction of ACE inhibitors with high-affinity H+/peptide symporter.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Binding, Competitive; Captopril; Carrier Proteins; Cell Membrane; Dipeptides; Dose-Response Relationship, Drug; Enalapril; Fosinopril; Isoquinolines; Kidney; Kinetics; Lipid Metabolism; Lipids; Lisinopril; Male; Microvilli; Peptide Transporter 1; Quinapril; Rabbits; Ramipril; Symporters; Tetrahydroisoquinolines | 1999 |
How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Enalapril; Female; Fosinopril; Heart Failure; Humans; Indoles; Lisinopril; Male; Peptidyl-Dipeptidase A; Perindopril; Treatment Failure | 1999 |
Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cattle; Dipeptides; Enalapril; Kinetics; Kinins; Lisinopril; Lung; Male; Peptidyl-Dipeptidase A; Structure-Activity Relationship; Substrate Specificity; Testis | 1999 |
[Neuroprotective activity of angiotensin-converting enzyme inhibitors during cerebral ischemia].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Brain Ischemia; Captopril; Cerebral Cortex; Enalapril; Neuroprotective Agents; Rats | 1999 |
Cough is common in children prescribed converting enzyme inhibitors.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Captopril; Child; Child, Preschool; Cough; Enalapril; Female; Humans; Infant; Kidney Diseases; Male; Perindopril; Time Factors | 2000 |
ACE inhibitor dosage at the time of listing predicts survival.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Lisinopril; Male; Middle Aged; Prognosis; Ramipril; Survival Analysis | 2000 |
Enalapril and captopril enhance glutathione-dependent antioxidant defenses in mouse tissues.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Captopril; Enalapril; Female; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Mice; Oxidative Stress | 2000 |
Effect of kininase II inhibitors on bradykinin-stimulated bovine sperm motility.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Captopril; Cattle; Drug Synergism; Enalapril; Male; Sperm Motility | 1998 |
[The influence of angiotensin-converting enzyme inhibitors on collagen content of the aorta wall in experimental hypercholesterolemia].
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Captopril; Collagen; Connective Tissue; Enalapril; Hypercholesterolemia; Isoquinolines; Male; Quinapril; Rabbits; Tetrahydroisoquinolines | 1999 |
Extracorporal therapy with AN69 membranes in combination with ACE inhibition causing severe anaphylactoid reactions: still a current problem?
Topics: Acrylic Resins; Acrylonitrile; Adolescent; Anaphylaxis; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Hemofiltration; Humans; Membranes, Artificial; Middle Aged; Renal Dialysis | 2000 |
Lipid peroxidation and activities of antioxidant enzymes in the diabetic kidney: effect of treatment with angiotensin convertase inhibitors.
Topics: Albuminuria; Animals; Antioxidants; Blood Glucose; Captopril; Catalase; Diabetes Mellitus, Experimental; Enalapril; Hemoglobin A; Kidney; Lipid Peroxidation; Male; Malondialdehyde; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Superoxide Dismutase; Time Factors | 2000 |
The influence of angiotensin converting enzyme inhibitors on lipid peroxidation in sera and aorta of rabbits in diet-induced hypercholesterolemia.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Captopril; Cholesterol; Diet, Atherogenic; Enalapril; Hypercholesterolemia; Isoquinolines; Lipid Peroxidation; Male; Quinapril; Rabbits; Tetrahydroisoquinolines; Thiobarbituric Acid Reactive Substances | 2000 |
Effects of converting enzyme inhibitors on renal P-450 metabolism of arachidonic acid.
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arachidonic Acid; Benzimidazoles; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Desoxycorticosterone; Enalapril; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Kidney; Kidney Cortex; Kidney Medulla; Male; Microsomes; Mixed Function Oxygenases; NADPH-Ferrihemoprotein Reductase; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Spironolactone; Tetrazoles | 2001 |
[Efficacy of quadropril (spirapril) vs capropril in treatment of essential hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Enalapril; Female; Heart Ventricles; Humans; Hypertension; Middle Aged; Myocardial Contraction; Prognosis; Severity of Illness Index; Ultrasonography; Vascular Resistance | 2000 |
Strict volume control normalizes hypertension in peritoneal dialysis patients.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Combined Modality Therapy; Diet, Sodium-Restricted; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Ultrafiltration; Water-Electrolyte Imbalance | 2001 |
Angiotensin-converting enzyme inhibitor dosages in elderly patients with heart failure.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Heart Failure; Humans; Lisinopril; Male; Retrospective Studies; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
[ACE inhibition in patients with myocardial infarct and ventricular dysfunction: inappropriate application of therapy standards in patient samples].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Confidence Intervals; Echocardiography; Enalapril; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Practice Guidelines as Topic; Ramipril; Registries; Sampling Studies; Surveys and Questionnaires; Time Factors; Ventricular Dysfunction, Left | 2001 |
What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors?
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Indoles; Isoquinolines; Myocardial Infarction; Perindopril; Prodrugs; Quinapril; Ramipril; Stroke; Stroke Volume; Tetrahydroisoquinolines; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
Angiotensin converting enzyme inhibitors and cough--a north Indian study.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cough; Enalapril; Female; Follow-Up Studies; Humans; Hypertension; Incidence; India; Indomethacin; Lisinopril; Male; Middle Aged; Prospective Studies; Ramipril; Risk Assessment | 1998 |
Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Blood Pressure; Captopril; Enalapril; Lisinopril; Losartan; Male; Pancreatic Elastase; Rats; Rats, Wistar | 2001 |
[Difficulties in cleaning molar teeth in patient with type 2 diabetes and enalapril medication].
Topics: Antihypertensive Agents; Captopril; Dental Calculus; Diabetes Mellitus, Type 2; Enalapril; Humans; Hypertension; Male; Middle Aged; Molar; Risk Assessment; Toothbrushing | 1997 |
Significance of ACE genotypes and medical treatments in childhood focal glomerulosclerosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Benzazepines; Captopril; Child; Disease Progression; Drug Resistance; Enalapril; Female; Glomerulosclerosis, Focal Segmental; Humans; Incidence; Japan; Kidney Failure, Chronic; Male; Peptidyl-Dipeptidase A; Prednisolone; Proteinuria; Regression Analysis; Retrospective Studies; Survival Rate | 2001 |
[Effects of pathogenetic therapy on blood cholesterol in patients with glomerulonephritis].
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Anticholesteremic Agents; Antihypertensive Agents; Azathioprine; Captopril; Cholesterol; Creatinine; Cyclophosphamide; Data Interpretation, Statistical; Enalapril; Female; Glomerulonephritis; Humans; Immunosuppressive Agents; Lovastatin; Male; Nephrotic Syndrome; Prednisolone; Retrospective Studies; Tetrazoles; Time Factors; Valine; Valsartan | 2001 |
[In contrast to captopril and enalapril, losartan does not increase mortality of gerbils after carotid ligation].
Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Cardiovascular Surgical Procedures; Carotid Arteries; Disease Models, Animal; Enalapril; Gerbillinae; Ligation; Losartan; Myocardial Ischemia; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Survival Analysis | 2001 |
Inhibitory effect of the angiotensin converting enzyme inhibitors captopril and enalapril on the conversion of procollagen to collagen.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cartilage; Chick Embryo; Collagen; Culture Techniques; Enalapril; Peptide Fragments; Procollagen; Tendons | 2001 |
[Long-term effect of angiotensin-converting inhibitors in children with proteinuria].
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Captopril; Child; Child, Preschool; Enalapril; Female; Humans; Male; Proteinuria; Time Factors | 2001 |
Prevention of radiation-induced nephropathy and fibrosis in a model of bone marrow transplant by an angiotensin II receptor blocker.
Topics: Aldosterone; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Bone Marrow Transplantation; Captopril; Disease Models, Animal; Enalapril; Enzyme Inhibitors; Fibrosis; Imidazoles; Kidney Diseases; Male; Radiotherapy; Rats; Tetrazoles; Time Factors | 2001 |
Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Stenosis; Apolipoproteins E; Arteries; Arteriosclerosis; Blood Pressure; Captopril; Cholesterol; Disease Models, Animal; Dose-Response Relationship, Drug; Enalapril; Epitopes; Immunohistochemistry; Lipid Peroxidation; Lipoproteins, LDL; Male; Mice; Mice, Knockout; Oxidation-Reduction; Oxidative Stress; Peptidyl-Dipeptidase A; Random Allocation; Sulfhydryl Reagents; Time Factors; Treatment Outcome | 2001 |
Reversibility of ventricular dysfunction. Clinical experience in a medical office.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Captopril; Digoxin; Diuretics; Enalapril; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
Usefulness of patch tests for diagnosing selective allergy to captopril.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cross Reactions; Drug Hypersensitivity; Enalapril; Female; Glyburide; Humans; Lisinopril; Patch Tests; Skin Tests | 2001 |
The influence of angiotensin-converting enzyme inhibitors on the aorta elastin metabolism in diet-induced hypercholesterolaemia in rabbits.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Calcium; Captopril; Cholesterol, Dietary; Dose-Response Relationship, Drug; Elastin; Enalapril; Hypercholesterolemia; Isoquinolines; Male; Quinapril; Rabbits; Tetrahydroisoquinolines | 2001 |
Hypotension after first-dose ACE inhibitor administration in heart failure--should doctors stop worrying?
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Hypotension; Lisinopril; Perindopril | 2001 |
[Hypertensive patient with diabetes. "Blood pressure cosmetics" are not enough here].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Diabetes Mellitus, Type 2; Enalapril; Evidence-Based Medicine; Humans; Hypertension; Treatment Outcome | 2002 |
Age-related underutilization of angiotensin-converting enzyme inhibitors in older hospitalized heart failure patients.
Topics: Age Factors; Aged; Aged, 80 and over; Alabama; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiac Output, Low; Cardiology; Drug Utilization; Enalapril; Female; Hospitalization; Humans; Logistic Models; Male; Odds Ratio; Referral and Consultation; Retrospective Studies; Ventricular Dysfunction, Left | 2002 |
Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Captopril; Circadian Rhythm; Dose-Response Relationship, Drug; Enalapril; Endothelin-1; Fosinopril; Hypertrophy, Left Ventricular; Male; Peptidyl-Dipeptidase A; Ramipril; Rats; Rats, Inbred SHR | 2002 |
Angiotensins in plasma of hypertensive rats and human.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Chromatography, High Pressure Liquid; Disease Models, Animal; Enalapril; Humans; Hypertension; Male; Middle Aged; Radioimmunoassay; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Rats, Wistar | 2003 |
Effect of light exercise on renal hemodynamics in patients with hypertension and chronic renal disease.
Topics: Adult; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Captopril; Enalapril; Exercise; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Norepinephrine; Renal Circulation; Renal Plasma Flow, Effective; Verapamil | 2002 |
[Drug therapy of coronary heart disease--are therapeutic guidelines being paid attention to?].
Topics: Adrenergic beta-Antagonists; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Captopril; Coronary Disease; Drug Prescriptions; Enalapril; Evidence-Based Medicine; Female; Guideline Adherence; Humans; Hypolipidemic Agents; Inpatients; Male; Middle Aged; Myocardial Infarction; Nitrates; Outpatients; Platelet Aggregation Inhibitors; Practice Guidelines as Topic | 2003 |
Interaction of noscapine with the bradykinin mediation of the cough response.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antitussive Agents; Bradykinin; Capsaicin; Captopril; Cough; Dose-Response Relationship, Drug; Drug Interactions; Enalapril; Guinea Pigs; Male; Naloxone; Narcotic Antagonists; Noscapine; Quinolines; Receptor, Bradykinin B2 | 2003 |
Ramipril-associated hepatotoxicity.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Chemical and Drug Induced Liver Injury, Chronic; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis, Intrahepatic; Enalapril; Fosinopril; Humans; Jaundice; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Ramipril | 2003 |
The preventive effect of captopril or enalapril on reperfusion injury of the kidney of rats is independent of angiotensin II AT1 receptors.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dose-Response Relationship, Drug; Enalapril; Kidney; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Reperfusion Injury | 2003 |
Angiotensin converting anzyme (ACE) activity in porcine ocular tissue: effects of diet and ACE inhibitors.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Captopril; Diet, Atherogenic; Enalapril; Female; Peptidyl-Dipeptidase A; Retina; Swine; Swine, Miniature; Time Factors; Uvea | 2003 |
The problem of underdosing of angiotensin-converting enzyme inhibitors is markedly overrated: results from a study of patients discharged from hospital after an acute myocardial infarction.
Topics: Acute Disease; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Utilization; Enalapril; Evaluation Studies as Topic; Female; Hospitalization; Humans; Lisinopril; Male; Myocardial Infarction; Patient Discharge; Pharmacoepidemiology; Ramipril; Randomized Controlled Trials as Topic | 2004 |
Renoprotection by ACE inhibitors after severe hemolytic uremic syndrome.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Child, Preschool; Creatinine; Enalapril; Follow-Up Studies; Glomerular Filtration Rate; Hemolytic-Uremic Syndrome; Humans; Hypertension; Kidney; Proteinuria; Time Factors | 2004 |
Captopril and enalapril improve cognition and depressed mood in hypertensive patients.
Topics: Affect; Captopril; Cognition Disorders; Depression; Educational Status; Enalapril; Female; Humans; Hypertension; Learning; Male; Memory, Short-Term; Mental Recall; Middle Aged; Postmenopause; Psychiatric Status Rating Scales; Semantics; Single-Blind Method; Verbal Learning; Wechsler Scales; Word Association Tests | 2003 |
[Prophylactic use of angiotensin-converting enzyme inhibitors in indomethacin-induced ulcer and erosion lesions of the stomach].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Captopril; Disease Models, Animal; Enalapril; Gastric Mucosa; Indomethacin; Lisinopril; Male; Rats; Stomach Ulcer; Treatment Outcome | 2004 |
Pemphigus serum and captopril induce heat shock protein 70 and inducible nitric oxide synthase overexpression, triggering apoptosis in human keratinocytes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Apoptosis; Autoantibodies; Blotting, Western; Captopril; Cells, Cultured; Culture Media, Conditioned; Cytoskeleton; DNA Fragmentation; Dose-Response Relationship, Drug; Enalapril; Enzyme Activation; HSP70 Heat-Shock Proteins; Humans; Keratinocytes; Microscopy, Fluorescence; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Pemphigus; Proto-Oncogene Proteins c-myc; Reverse Transcriptase Polymerase Chain Reaction; Transglutaminases; Tumor Suppressor Protein p53 | 2004 |
Changes in skeletal muscle SR Ca2+ pump in congestive heart failure due to myocardial infarction are prevented by angiotensin II blockade.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Calcium; Calcium-Transporting ATPases; Captopril; Cyclic AMP-Dependent Protein Kinases; Enalapril; Heart Failure; Imidazolidines; Losartan; Male; Muscle, Skeletal; Muscular Atrophy; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum; Time Factors | 2004 |
The inhibitory effect of alacepril, an angiotensin-converting enzyme inhibitor, on endothelial inflammatory response induced by oxysterol and TNF-alpha.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cell Adhesion; Dose-Response Relationship, Drug; Enalapril; Endothelium, Vascular; Inflammation; Intercellular Adhesion Molecule-1; Ketocholesterols; Monocytes; Reactive Oxygen Species; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2004 |
Angiotensin-converting enzyme inhibitors prevent LDL-induced endothelial dysfunction by reduction of asymmetric dimethylarginine level.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Captopril; Cholesterol, LDL; Enalapril; Endothelium, Vascular; Models, Animal; Rats | 2005 |
The effect of 'tissue' and 'plasma' angiotensin converting enzyme inhibitors on overall haemostatic potentials in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Enalapril; Hemostasis; Male; Perindopril; Quinapril; Rats; Rats, Wistar; Renin-Angiotensin System; Tetrahydroisoquinolines | 2006 |
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzopyrans; Biphenyl Compounds; Bisoprolol; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Ethanolamines; Evidence-Based Medicine; Guideline Adherence; Heart Failure; Humans; Indoles; Lisinopril; Metoprolol; Mineralocorticoid Receptor Antagonists; Nebivolol; Practice Guidelines as Topic; Propanolamines; Ramipril; Spironolactone; Stroke Volume; Tetrazoles; Valine; Valsartan | 2005 |
Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Diuretics; Drug Therapy, Combination; Enalapril; Hydrochlorothiazide; Hypertension; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Rats; Rats, Sprague-Dawley; Tyrosine | 2006 |
Validated ligand mapping of ACE active site.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Catalytic Domain; Computer Simulation; Crystallography, X-Ray; Enalapril; Humans; Ligands; Lisinopril; Models, Molecular; Molecular Conformation; Molecular Structure; Peptidyl-Dipeptidase A; Ramipril; Zinc | 2005 |
Comparison of captopril and enalapril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE inhibitors in high dieted methionine mice.
Topics: Acetylcysteine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aryldialkylphosphatase; Captopril; Enalapril; Endothelium, Vascular; Male; Malondialdehyde; Methionine; Nitric Oxide; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds; Superoxide Dismutase; Vasodilation | 2006 |
Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril.
Topics: Adenosine Diphosphate; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Cardiovascular Diseases; Clopidogrel; Collagen; Coronary Artery Disease; Electric Impedance; Enalapril; Female; Fibrinolytic Agents; Germany; Humans; Hypertension; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Ramipril; Ticlopidine; Treatment Outcome | 2006 |
Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Apolipoprotein B-100; Apolipoproteins B; Atherosclerosis; Captopril; Enalapril; Fosinopril; Humans; Hydrogen Peroxide; Hypochlorous Acid; Lipoproteins, LDL; Lisinopril; Oxidation-Reduction; Peroxidase; Ramipril; Recombinant Proteins | 2006 |
ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Captopril; Cysteine; Dinoprost; Dose-Response Relationship, Drug; Enalapril; Femoral Artery; Glutathione Disulfide; Hydralazine; Hypertension; Male; Nitric Oxide Donors; Oxidative Stress; Rats; Rats, Inbred SHR; S-Nitrosothiols; Splanchnic Circulation; Vascular Resistance; Vasodilation; Vasodilator Agents | 2006 |
Antithrombotic effect of tissue and plasma type angiotensin converting enzyme inhibitors in experimental thrombosis in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Carotid Arteries; Disease Models, Animal; Enalapril; Fibrillar Collagens; Fibrin; Hemostasis; Male; Perindopril; Platelet Adhesiveness; Platelet Aggregation; Quinapril; Rats; Rats, Wistar; Regional Blood Flow; Tetrahydroisoquinolines; Thromboembolism | 2006 |
Total peripheral resistance responsiveness during the development of secondary renal hypertension in dogs.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine Vasopressin; Blood Pressure; Captopril; Cardiac Output; Disease Models, Animal; Dogs; Enalapril; Ganglionic Blockers; Hypertension, Renovascular; Male; Pentolinium Tartrate; Phenylephrine; Vascular Resistance; Vasoconstrictor Agents | 2007 |
Chronic pretreatment of ACEI reduces no-reflow in patients with acute myocardial infarction treated with primary angioplasty.
Topics: Adult; Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Captopril; Coronary Angiography; Coronary Circulation; Electrocardiography; Enalapril; Female; Fosinopril; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Research Design; Stroke Volume; Time Factors; Treatment Outcome | 2007 |
Heart failure treatment profile at the beta blockers era.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Losartan; Male; Middle Aged; Propanolamines; Severity of Illness Index | 2007 |
Role of the brain renin-angiotensin system in blood pressure regulation.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Brain; Captopril; Enalapril; Injections, Intraventricular; Kallikreins; Kidney; Male; Rats; Renin-Angiotensin System; Saralasin | 2007 |
Contribution of captopril thiol group to the prevention of spontaneous hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Captopril; Cardiomegaly; Cyclic GMP; Disease Models, Animal; Enalapril; Hypertension; Male; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Rats; Rats, Inbred SHR; Sulfhydryl Compounds; Time Factors; Up-Regulation | 2007 |
Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Bile Duct Diseases; Captopril; Common Bile Duct; Constriction, Pathologic; Enalapril; Glutathione; Hydroxyproline; Ligation; Liver; Liver Cirrhosis; Male; Malondialdehyde; Rats; Rats, Wistar | 2008 |
Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Urea Nitrogen; Captopril; Creatinine; Dose-Response Relationship, Drug; Enalapril; Endothelium, Vascular; Enzyme Inhibitors; Glutathione Peroxidase; Glycation End Products, Advanced; Injections, Intravenous; Kidney; Male; Malondialdehyde; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Serum Albumin, Bovine; Superoxide Dismutase; Vasodilation; Vasodilator Agents | 2008 |
Recovery of heart function in children with acute severe heart failure.
Topics: Acute Disease; Captopril; Carbazoles; Cardiotonic Agents; Carvedilol; Child; Child, Preschool; Databases, Factual; Digoxin; Enalapril; Enoximone; Female; Heart Failure; Heart Function Tests; Humans; Infant; Infant, Newborn; Male; Propanolamines; Treatment Outcome | 2008 |
[Anaphylactoid reactions with the use of ST-AN69 dialysers in patients taking ACE inhibitors].
Topics: Aged; Anaphylaxis; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Equipment Design; Female; Hemofiltration; Humans; Hypertension; Kidney Failure, Chronic; Male; Membranes, Artificial; Middle Aged; Renal Dialysis | 2008 |
RAS inhibitors decrease apoptosis of acinar cells and increase elimination of pancreatic stellate cells after in the course of experimental chronic pancreatitis induced by dibutyltin dichloride.
Topics: Actins; Aldosterone; Animals; Apoptosis; Captopril; Cell Proliferation; Enalapril; Immunohistochemistry; Lisinopril; Losartan; Male; Organotin Compounds; Pancreas; Pancreatitis, Chronic; Rats; Rats, Inbred Lew; Renin-Angiotensin System | 2008 |
The relationship between heart rate reserve and oxygen uptake reserve in heart failure patients on optimized and non-optimized beta-blocker therapy.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Losartan; Male; Middle Aged; Oxygen Consumption; Propanolamines | 2008 |
The ACE inhibitors enalapril and captopril modulate cytokine responses in Balb/c and C57Bl/6 normal mice and increase CD4(+)CD103(+)CD25(negative) splenic T cell numbers.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antigens, CD; Captopril; CD4 Antigens; Cells, Cultured; Cytokines; Enalapril; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Integrin alpha Chains; Interleukin-10; Interleukin-2; Interleukin-2 Receptor alpha Subunit; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Species Specificity; Spleen; T-Lymphocytes | 2010 |
Influence of selected angiotensin-converting enzyme inhibitors on alloxan-induced diabetic cataract in rabbits.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Captopril; Cataract; Diabetes Mellitus, Experimental; Enalapril; Rabbits | 2009 |
Stimulation of renin secretion by angiotensin II blockade is Gsalpha-dependent.
Topics: Adenylyl Cyclases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Captopril; Catecholamines; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enalapril; Female; GTP-Binding Protein alpha Subunits, Gs; Juxtaglomerular Apparatus; Male; Mice; Mice, Knockout; Models, Animal; Nitric Oxide; Prostaglandins; Renin; Signal Transduction; Tetrahydroisoquinolines; Tetrazoles | 2010 |
Brain renin-angiotensin system modifies the blood pressure response to intracerebroventricular cadmium in rats.
Topics: Adrenergic alpha-Agonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Brain; Cadmium; Captopril; Clonidine; Enalapril; Heart; Histocytochemistry; Hypertension; Kallikrein-Kinin System; Kallikreins; Kidney; Male; Rats; Rats, Wistar; Renin-Angiotensin System; Saralasin | 2010 |
Angiotensin-converting enzyme (ACE) inhibitors exacerbate histological damage and motor deficits after experimental traumatic brain injury.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Brain Injuries; Captopril; Cerebral Cortex; Disease Models, Animal; Enalapril; Gene Expression Regulation; Male; Motor Activity; Movement Disorders; Rats; Rats, Sprague-Dawley; Rotarod Performance Test; Substance P | 2010 |
Interactions of urate transporter URAT1 in human kidney with uricosuric drugs.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzbromarone; Benzothiazoles; Biological Transport; Captopril; Cells, Cultured; Dogs; Enalapril; Indomethacin; Inhibitory Concentration 50; Organic Anion Transporters; Organic Cation Transport Proteins; Phenylbutazone; Probenecid; Pyridines; Salicylates; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 2011 |
Carboxypeptidase activity common to viridans group streptococci cleaves angiotensin I to angiotensin II: an activity homologous to angiotensin-converting enzyme (ACE).
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Base Sequence; Captopril; Carboxypeptidases; Chromatography, High Pressure Liquid; Electrophoresis, Polyacrylamide Gel; Enalapril; Endocarditis, Bacterial; Fibrinogen; Humans; Lisinopril; Molecular Sequence Data; Peptidyl-Dipeptidase A; Sequence Analysis, DNA; Streptococcal Infections; Streptococcus gordonii | 2011 |
Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anticonvulsants; Captopril; Drug Synergism; Enalapril; Female; Fosinopril; Male; Mice; Motor Activity; Seizures | 2012 |
Inhibition of the renin-angiotensin system downregulates tissue factor and vascular endothelial growth factor in human breast carcinoma cells.
Topics: Adenocarcinoma; Angiotensin-Converting Enzyme Inhibitors; Breast Neoplasms; Captopril; Cell Line, Tumor; Down-Regulation; Enalapril; Female; Humans; MCF-7 Cells; Neovascularization, Pathologic; Renin-Angiotensin System; Thromboplastin; Vascular Endothelial Growth Factor A | 2012 |
Angiotensin converting enzyme inhibitors mitigate collagen synthesis induced by a single dose of radiation to the whole thorax.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Collagen; Dose-Response Relationship, Radiation; Drug Evaluation, Preclinical; Enalapril; Female; Fibrosis; Fosinopril; Gene Expression Regulation; Lung; Pulmonary Fibrosis; Radiation Pneumonitis; Rats; Renin-Angiotensin System; Thorax | 2012 |
Cardioprotective effects of zofenopril, enalapril and valsartan against ischaemia/reperfusion injury as well as doxorubicin cardiotoxicity.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Doxorubicin; Enalapril; Heart Diseases; Hemodynamics; Humans; Male; Rats; Rats, Wistar; Reperfusion Injury; Tetrazoles; Valine; Valsartan | 2012 |
Combined treatment with gabapentin and drugs affecting the renin-angiotensin system against electroconvulsions in mice.
Topics: Amines; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticonvulsants; Avoidance Learning; Benzimidazoles; Benzoates; Brain; Captopril; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Electroshock; Enalapril; Gabapentin; gamma-Aminobutyric Acid; Losartan; Male; Mice; Motor Skills; Seizures; Telmisartan | 2013 |
Captopril may influence tone of human oviduct ampulla.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Dose-Response Relationship, Drug; Enalapril; Fallopian Tubes; Female; Humans; Middle Aged; Oviducts | 2013 |
Angiotensin-converting enzyme inhibitor nephrotoxicity in neonates with cardiac disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Creatinine; Enalapril; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Infant, Premature; Kidney Diseases; Male; Retrospective Studies | 2014 |
Physicochemical stability of captopril and enalapril extemporaneous formulations for pediatric patients.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Compounding; Drug Stability; Drug Storage; Enalapril; Humans; Mass Spectrometry; Pediatrics; Rheology; Temperature; Time Factors | 2015 |
Hypotension as the etiology for angiotensin-converting enzyme (ACE) inhibitor-associated acute kidney injury in pediatric patients.
Topics: Acute Kidney Injury; Adolescent; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiovascular Diseases; Case-Control Studies; Child; Child, Preschool; Creatinine; Enalapril; Female; Humans; Hypotension; Infant; Male; Retrospective Studies | 2014 |
Mitigation of experimental radiation nephropathy by renin-equivalent doses of angiotensin converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Bone Marrow Transplantation; Calibration; Captopril; Enalapril; Fosinopril; Kidney; Kidney Diseases; Lisinopril; Male; Radiation Injuries; Ramipril; Rats; Renin; Renin-Angiotensin System; Whole-Body Irradiation | 2014 |
Inhibition of neutrophil-dependent cytotoxicity for human endothelial cells by ACE inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cell Adhesion; Cells, Cultured; Cytotoxicity, Immunologic; Enalapril; Human Umbilical Vein Endothelial Cells; Humans; Immunologic Factors; Immunomodulation; Intercellular Adhesion Molecule-1; Lipoxins; Myocardial Infarction; Neutrophils; Receptors, Tumor Necrosis Factor; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2014 |
Comparing individual angiotensin-converting enzyme inhibitors with losartan in the risk of hospitalization for pneumonia and related mortality: a nationwide cohort study.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cohort Studies; Enalapril; Female; Hospitalization; Humans; Incidence; Losartan; Male; Middle Aged; Pneumonia; Ramipril; Risk; Taiwan | 2015 |
Profibrosing effect of angiotensin converting enzyme inhibitors in human lung fibroblasts.
Topics: Amides; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cells, Cultured; Collagen Type I; Collagen Type I, alpha 1 Chain; Enalapril; Fibroblasts; Fibrosis; Fumarates; Humans; Losartan; Lung; Protein Biosynthesis; Renin; Transcription, Genetic; Transforming Growth Factor beta1 | 2015 |
Application of quantitative NMR for purity determination of standard ACE inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calibration; Captopril; Carbon; Deuterium Oxide; Enalapril; Enzyme Inhibitors; Hydrogen-Ion Concentration; Imidazolidines; Lisinopril; Magnetic Resonance Spectroscopy; Maleates; Methanol; Quinapril; Reference Standards; Solvents; Stereoisomerism; Tetrahydroisoquinolines | 2015 |
Angiotensin Receptor Blocker Losartan Inhibits Spontaneous Motility of Isolated Human Ureter.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Carcinoma, Renal Cell; Enalapril; Female; Humans; In Vitro Techniques; Losartan; Male; Middle Aged; Muscle Contraction; Osmolar Concentration; Ureter | 2016 |
Angiotensin-converting enzyme inhibitors reduce oxidative stress intensity in hyperglicemic conditions in rats independently from bradykinin receptor inhibitors.
Topics: Adrenergic beta-Agonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin Receptor Antagonists; Captopril; Catalase; Enalapril; Glutathione Peroxidase; Hydrogen Peroxide; Hyperglycemia; Male; Malondialdehyde; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase | 2016 |
Angiotensin converting enzyme immobilized on magnetic beads as a tool for ligand fishing.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Captopril; Cattle; Chromatography, Liquid; Enalapril; Enzymes, Immobilized; Inhibitory Concentration 50; Iron; Kinetics; Ligands; Lisinopril; Lung; Magnetite Nanoparticles; Peptidyl-Dipeptidase A; Reproducibility of Results; Surface Properties; Tandem Mass Spectrometry; Trypsin | 2017 |
Captopril/enalapril inhibit promiscuous esterase activity of carbonic anhydrase at micromolar concentrations: An in vitro study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Enalapril; Erythrocytes; Esterases; Humans; In Vitro Techniques | 2017 |
Antidepressant-like effect of losartan involves TRKB transactivation from angiotensin receptor type 2 (AGTR2) and recruitment of FYN.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Antidepressive Agents; Captopril; Carbazoles; Cells, Cultured; Cerebral Cortex; Enalapril; Hippocampus; Imidazoles; Immobility Response, Tonic; Indole Alkaloids; Losartan; Male; Mice; Microinjections; Prefrontal Cortex; Proto-Oncogene Proteins c-fyn; Pyridines; Rats; Receptor, Angiotensin, Type 2; Receptor, trkB; Transcriptional Activation | 2018 |
Cytotoxic and genotoxic effects of antihypertensives distributed in Brazil by social programs: Are they safe?
Topics: Antihypertensive Agents; Atenolol; Brazil; Captopril; Cell Survival; Cells, Cultured; DNA Damage; Dose-Response Relationship, Drug; Enalapril; Government Programs; Humans; Hydrochlorothiazide; Hypertension; Losartan; Lymphocytes; Macrophages; Male; Mutagenicity Tests; Program Evaluation; Propranolol | 2018 |
Potential Angiotensin Converting Enzyme Inhibitors from Moringa oleifera.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Catalytic Domain; Enalapril; Gene Expression; Humans; Hypertension; Kinetics; Molecular Docking Simulation; Moringa oleifera; Patents as Topic; Peptidyl-Dipeptidase A; Plant Extracts; Plant Leaves; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; Substrate Specificity; Thermodynamics; Thiocarbamates | 2019 |
Angiotensin-converting enzyme inhibitors attenuated advanced glycation end products-induced renal tubular hypertrophy via enhancing nitric oxide signaling.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cell Enlargement; Cell Line; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enalapril; Enzyme Activation; Glycation End Products, Advanced; Humans; Hypertrophy; Kidney Tubules, Proximal; MAP Kinase Signaling System; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Thionucleotides | 2019 |
Dipeptidyl peptidase-4 inhibitors can inhibit angiotensin converting enzyme.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enalapril; Female; Glucagon-Like Peptide 1; Humans; Hypertension; Linagliptin; Peptidyl-Dipeptidase A; Protein Binding; Rats; Rats, Sprague-Dawley; Sitagliptin Phosphate | 2019 |
Inhibitors of angiotensin I converting enzyme potentiate fibromyalgia-like pain symptoms via kinin receptors in mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Behavior, Animal; Captopril; Disease Models, Animal; Enalapril; Fibromyalgia; Male; Mice; Nervous System; Nociceptive Pain; Pain Threshold; Peptidyl-Dipeptidase A; Receptors, Bradykinin; Reserpine; Signal Transduction | 2021 |
Inhibition of angiotensin converting enzyme increases PKCβI isoform expression via activation of substance P and bradykinin receptors in cultured astrocytes of mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Astrocytes; Captopril; Enalapril; Mice; Peptidyl-Dipeptidase A; Protein Kinase C-alpha; Receptors, Bradykinin; Substance P | 2023 |